细胞株Cell Lines 53-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV53
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID MDAH 2774
AC CVCL_0420
SY MDAH-2774; MDAH2774; 2774; #2774; OV-2774; OV-CA-2774; SK-2774
DR BTO; BTO:0003942
DR MCCL; MCC:0000317
DR ATCC; CRL-10303
DR BCRJ; 0163
DR Cosmic; 724881
DR Cosmic; 844345
DR Cosmic; 875291
DR Cosmic; 897431
DR Cosmic; 923109
DR Cosmic; 1044237
DR Cosmic; 1113282
DR Cosmic; 1524360
DR Cosmic; 1708386
DR Cosmic; 1709262
DR Cosmic; 2186588
RX PubMed=719612;
RX PubMed=6582512;
RX PubMed=11314036;
RX PubMed=15153938;
RX PubMed=19288585;
RX PubMed=22328975;
RX PubMed=22710073;
RX PubMed=25230021;
RX PubMed=27235858;
WW http://www.addexbio.com/productdetail?pid=57
CC Part of: OCCP ovarian cancer cell line panel.
CC Omics: Deep proteome analysis.
ST Source(s): ATCC; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 10,14 (ATCC)
ST CSF1PO: 10,11 (PubMed=25230021)
ST D13S317: 8,9,12 (ATCC)
ST D13S317: 8,9 (PubMed=25230021)
ST D16S539: 10,11,12,14 (ATCC)
ST D16S539: 10,11,12 (PubMed=25230021)
ST D18S51: 14,15
ST D21S11: 30,31
ST D3S1358: 16,18
ST D5S818: 10,12,13 (ATCC)
ST D5S818: 10,11,12 (PubMed=25230021)
ST D7S820: 8,9.3,10.1,11 (ATCC)
ST D7S820: 10,11,12 (PubMed=25230021)
ST D8S1179: 14
ST FGA: 24,25
ST Penta D: 13,14
ST Penta E: 13,14
ST TH01: 6,8
ST TPOX: 8,11 (ATCC)
ST TPOX: 8 (PubMed=25230021)
ST vWA: 14,16,19,21 (ATCC)
ST vWA: 15,19 (PubMed=25230021)
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MDAH041
AC CVCL_E212
RX PubMed=2000218;
RX PubMed=2253239;
RX PubMed=7667317;
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MDAH087
AC CVCL_E213
SY MDAH 087
RX PubMed=2000218;
RX PubMed=2253239;
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MDAH172
AC CVCL_E214
RX PubMed=2253239;
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MDAH174
AC CVCL_E215
RX PubMed=2253239;
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MDAY-D2
AC CVCL_S411
DR ChEMBL-Cells; CHEMBL3308420
DR ChEMBL-Targets; CHEMBL614337
RX PubMed=6591445;
RX PubMed=6929020;
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MDBK
AC CVCL_0421
SY MDBK (NBL-1); NBL-1; Madin-Darby Bovine Kidney; Madin Darby Bovine Kidney
DR BTO; BTO:0000836
DR CLO; CLO_0007642
DR CLO; CLO_0007643
DR CLO; CLO_0050865
DR MCCL; MCC:0000318
DR CLDB; cl3412
DR CLDB; cl3413
DR CLDB; cl3414
DR CLDB; cl3415
DR CLDB; cl3416
DR ATCC; CCL-22
DR ATCC; CRL-6071
DR BCRC; 60126
DR BCRJ; 0167
DR CCLV; CCLV-RIE 0084
DR CCLV; CCLV-RIE 0261
DR CCRID; 3111C0001CCC000288
DR CCRID; 3111C0002000000076
DR CCRID; 3131C0001000400007
DR CCRID; 3153C0001000000033
DR CLS; 600396/p848_MDBK_(NBL-1)
DR DSMZ; ACC-174
DR ECACC; 90050801
DR IFO; IFO50014
DR IZSLER; BS CL 63
DR JCRB; JCRB9028
DR KCB; KCB 90031YJ
DR KCLB; 10022
DR Lonza; 925
DR NCBI_Iran; C500
DR RCB; RCB0180
RX PubMed=5587551;
RX PubMed=5988125;
RX PubMed=13567776;
RX PubMed=19941903;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MDBK
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-133.html
WW http://microscopyu.com/moviegallery/livecellimaging/mdbk/index.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: ~35 hours (DSMZ).
CC Discontinued: ATCC; CRL-6071; true.
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Spontaneously immortalized cell line
//
ID MDBK clone 955-1
AC CVCL_DD20
RX PubMed=5988125;
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_0421 ! MDBK
SX Male
CA Spontaneously immortalized cell line
//
ID MDBK clone 958-9
AC CVCL_DD21
RX PubMed=5988125;
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_0421 ! MDBK
SX Male
CA Spontaneously immortalized cell line
//
ID MDBK-Bu100
AC CVCL_4541
SY MDBK(BU 100); MDBK(BU100)
DR CLO; CLO_0007644
DR CLDB; cl5228
DR IZSLER; BS CL 118
RX PubMed=2824831;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_0421 ! MDBK
SX Male
CA Spontaneously immortalized cell line
//
ID MDBK-NST
AC CVCL_E073
DR CLO; CLO_0050864
DR RCB; RCB1859
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_0421 ! MDBK
SX Male
CA Spontaneously immortalized cell line
//
ID MDBK-PES
AC CVCL_0I74
DR CCLV; CCLV-RIE 0154
RX PubMed=25565633;
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_0421 ! MDBK
SX Male
CA Spontaneously immortalized cell line
//
ID MDBK.P3
AC CVCL_3021
DR JCRB; JCRB0716
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_0421 ! MDBK
SX Male
CA Spontaneously immortalized cell line
//
ID MDCC-3867K
AC CVCL_6E15
SY 3867K
RX PubMed=26612074;
CC Group: Bird cell line.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-AL1
AC CVCL_T748
SY AL1
RX PubMed=7390658;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-AL2
AC CVCL_U116
SY AL2
RX PubMed=7390658;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-AL3
AC CVCL_U117
SY AL3
RX PubMed=7390658;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-BMCL2-1C10
AC CVCL_T649
RX CelloPub=CLPUB00078;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-BMCL2-1C2
AC CVCL_T650
RX CelloPub=CLPUB00078;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-BMCL2-20C1
AC CVCL_T651
RX CelloPub=CLPUB00078;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-BP1
AC CVCL_T645
SY JMV-YS-1
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-BP2
AC CVCL_T646
SY JMV-YS-2
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-BP3
AC CVCL_T647
SY JMV-YS-3
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-BP4
AC CVCL_T648
SY JMV-YS-4
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-HP10
AC CVCL_T607
SY HP10
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP11
AC CVCL_T608
SY HP11
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP12
AC CVCL_T609
SY HP12
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP13
AC CVCL_T610
SY HP13
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP14
AC CVCL_T611
SY HP14
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP15
AC CVCL_T612
SY HP15
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP16
AC CVCL_T613
SY HP16
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP17
AC CVCL_T614
SY HP17
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP18
AC CVCL_T615
SY HP18
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP19
AC CVCL_T616
SY HP19
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-HP20
AC CVCL_T617
SY HP20
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP21
AC CVCL_T618
SY HP21
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP22
AC CVCL_T619
SY HP22
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP23
AC CVCL_T620
SY HP23
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP24
AC CVCL_T621
SY HP24
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-HP25
AC CVCL_T622
SY HP25
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP26
AC CVCL_T623
SY HP26
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP27
AC CVCL_T624
SY HP27
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-HP28
AC CVCL_T625
SY HP28
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP29
AC CVCL_T626
SY HP29
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP3
AC CVCL_T600
SY HP3
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP30
AC CVCL_T627
SY HP30
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP31
AC CVCL_T628
SY HP31
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-HP4
AC CVCL_T601
SY HP4
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP5
AC CVCL_T602
SY HP5
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP6
AC CVCL_T603
SY HP6
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP7
AC CVCL_T604
SY HP7
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP8
AC CVCL_T605
SY HP8
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-HP9
AC CVCL_T606
SY HP9
RX PubMed=7199514;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-JM-1
AC CVCL_T448
SY JM-1
RX PubMed=208974;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-JMV-1
AC CVCL_T449
SY JMV-1
DR ATCC; CRL-9093
RX Patent=EP0244760A2;
RX PubMed=208974;
RX PubMed=18670936;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC Discontinued: ATCC; CRL-9093; probable.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-JP1
AC CVCL_8459
SY JP-1; JP1; MOGA-1
RX PubMed=231432;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-JP2
AC CVCL_8460
SY JP-2; JP2; MOGA-2
RX PubMed=231432;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-LS1
AC CVCL_H687
SY LS1; MKT-1
RX PubMed=209622;
RX PubMed=225531;
RX PubMed=6251256;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID MDCC-MOB1
AC CVCL_8456
SY MDCC-MOB-1; MOB-1; MOB1
RX PubMed=69431;
RX PubMed=180968;
RX PubMed=4596339;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-MOB2
AC CVCL_8457
SY MDCC-MOB-2; MOB-2; MOB2
RX PubMed=69431;
RX PubMed=180968;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-MOB3
AC CVCL_8458
SY MDCC-MOB-3; MOB-3; MOB3
RX PubMed=69431;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-MSB1
AC CVCL_4542
SY MDCC MSB1; MDCC-MSB-1; MSB-1; MSB1
DR CLO; CLO_0007645
DR EFO; EFO_0002659
DR CLDB; cl5229
DR CLS; 601413/p659_MDCC-MSB1
DR IZSLER; BS TCL 7
RX PubMed=69431;
RX PubMed=163334;
RX PubMed=180968;
RX PubMed=18766641;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/amdcc.htm
CC Group: Bird cell line.
CC Doubling time: 8-10 hours (PubMed=163334).
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-MSB1-33C
AC CVCL_T660
RX PubMed=6628902;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_4542 ! MDCC-MSB1
SX Female
CA Cancer cell line
//
ID MDCC-MSB1-41C
AC CVCL_T661
RX PubMed=6628902;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_4542 ! MDCC-MSB1
SX Female
CA Cancer cell line
//
ID MDCC-MSB1-Clo. 18
AC CVCL_T662
SY MDCC-MSB1-CLO
RX PubMed=6090745;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_4542 ! MDCC-MSB1
SX Female
CA Cancer cell line
//
ID MDCC-PA5
AC CVCL_T629
SY PA5
RX PubMed=2433209;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-PA9
AC CVCL_T630
SY PA9
RX PubMed=2433209;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-RP1
AC CVCL_T461
SY MDCC-RP-1; MDCC-RP 1; RP-1; RP1; RPL1; RPL-1
RX PubMed=190995;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-RP2
AC CVCL_T462
SY MCL-R2; RP-2; RP2
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-RP22
AC CVCL_T652
RX PubMed=6314315;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-RP23
AC CVCL_T653
RX PubMed=6314315;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-RP24
AC CVCL_T654
RX PubMed=6314315;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-RP25
AC CVCL_T655
RX PubMed=6314315;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-RP26
AC CVCL_T656
RX PubMed=6314315;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-RP27
AC CVCL_T657
RX PubMed=6314315;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-RP28
AC CVCL_T658
RX PubMed=6314315;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-RP29
AC CVCL_T659
RX PubMed=6314315;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Male
CA Cancer cell line
//
ID MDCC-RP4
AC CVCL_T463
SY MDCC-RP-4; RP-4; RP4
RX PubMed=6326737;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID MDCC-TV1
AC CVCL_R816
SY TV-1; TV1
RX PubMed=226481;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11636; Reticuloendotheliosis virus (REV) [Strain T].
CC Breed/subspecies: White Leghorn SPAFAS.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Transformed cell line
//
ID MDCK
AC CVCL_0422
SY MDCK (NBL-2); NBL-2; Madin-Darby Canine Kidney; Madin Darby Canine Kidney
DR BTO; BTO:0000837
DR CLO; CLO_0007646
DR CLO; CLO_0007647
DR CLO; CLO_0050861
DR MCCL; MCC:0000319
DR CLDB; cl3417
DR CLDB; cl3418
DR CLDB; cl3419
DR CLDB; cl3420
DR CLDB; cl3421
DR CLDB; cl3422
DR CLDB; cl3423
DR CLDB; cl3424
DR CLDB; cl3425
DR ATCC; CCL-34
DR ATCC; CRL-6253
DR BCRC; 60004
DR BCRJ; 0168
DR CCLV; CCLV-RIE 0083
DR CCRID; 3111C0001CCC000078
DR CCRID; 3111C0002000000045
DR CCRID; 3131C0001000400014
DR CCRID; 3131C0001000400024
DR CCRID; 3142C0001000000012
DR CCRID; 3142C0001000000149
DR ChEMBL-Cells; CHEMBL3308370
DR ChEMBL-Targets; CHEMBL614068
DR CLS; 602280/p823_MDCK_(NBL-2)
DR ECACC; 02050101
DR ECACC; 84121903
DR ECACC; 85011435
DR IFO; IFO50071
DR IZSLER; BS CL 64
DR JCRB; JCRB9029
DR KCB; KCB 2006105YJ
DR KCLB; 10034
DR Lonza; 153
DR NCBI_Iran; C426
DR MeSH; D061985
DR RCB; RCB0995
DR TOKU-E; 2403
DR TOKU-E; 3636
DR Wikidata; Q28335011
RX PubMed=5918973;
RX PubMed=19941903;
RX PubMed=21819694;
RX PubMed=21982418;
RX PubMed=24058646;
RX PubMed=25903999;
WW http://www.atcc.org/support/faqs/5889f/Morphology%20of%20ATCC%20CCL34%20MDCK-444.aspx
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/mdck/mdckcells.html
WW http://en.vircell.com/products/mdck-cell-line/
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-89.html
CC Group: Vaccine production cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C426.
CC Discontinued: ATCC; CRL-6253; true.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK 33016
AC CVCL_2A36
SY MDCK-33016
RX Patent=US6455298;
RX PubMed=18485545;
CC Group: Vaccine production cell line.
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2219.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK 33016-PF
AC CVCL_2A37
SY MDCK 33016 PF; MDCK 33016PF; MDCK-33016PF; MDCK subline 33016-PF
RX PubMed=20071567;
CC Group: Vaccine production cell line.
CC Biotechnology: Used for the production of the influenza vaccine Optaflu.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_2A36 ! MDCK 33016
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK 9B9-1B1
AC CVCL_DF69
DR ATCC; PTA-7909
RX Patent=US8846032;
CC Group: Vaccine production cell line.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK 9B9-1E4
AC CVCL_DF70
DR ATCC; PTA-7910
RX Patent=US8846032;
RX PubMed=20307595;
RX PubMed=22902973;
CC Group: Vaccine production cell line.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK Sky1023
AC CVCL_AP67
RX Patent=US9447383;
CC Group: Vaccine production cell line.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK Sky10234
AC CVCL_AP68
RX Patent=US9447383;
CC Group: Vaccine production cell line.
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3114.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK Sky3851
AC CVCL_AP69
RX Patent=US9447383;
CC Group: Vaccine production cell line.
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3113.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK Tet-Off
AC CVCL_V359
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-AD
AC CVCL_K177
DR CLO; CLO_0050862
DR RCB; RCB2611
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-B-702
AC CVCL_AP66
SY B-702
RX Patent=US6825036;
CC Group: Vaccine production cell line.
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7449.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-C11
AC CVCL_AP70
RX PubMed=7790388;
RX PubMed=7971172;
RX PubMed=11211115;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-C7
AC CVCL_0423
DR MCCL; MCC:0000320
DR Lonza; 688
RX PubMed=7790388;
RX PubMed=7971172;
RX PubMed=10864013;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-chAbcb1
AC CVCL_DF31
RX PubMed=27234533;
CC Transfected with: UniProtKB; F1NKW0; Chicken ABCB1.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-E [Korea]
AC CVCL_AQ31
SY MDCK-epithelial-like
RX CelloPub=CLPUB00313;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-E [Taiwan]
AC CVCL_Y089
DR BCRC; 60567
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-F
AC CVCL_AP75
SY MDCK-fibroblast-like
RX CelloPub=CLPUB00313;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-I
AC CVCL_0592
SY MDCK I; MDCK1; MDCK-1
DR BTO; BTO:0004606
DR CLO; CLO_0007649
DR ECACC; 00062106
RX PubMed=21982418;
RX PubMed=24975811;
CC Group: Vaccine production cell line.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-II
AC CVCL_0424
SY MDCK II; MDCKII; MDCK2; MDCK-2
DR BTO; BTO:0004607
DR MCCL; MCC:0000321
DR CCLV; CCLV-RIE 1061
DR ChEMBL-Cells; CHEMBL3308862
DR ECACC; 00062107
DR Lonza; 811
RX PubMed=19941903;
RX PubMed=21982418;
RX PubMed=24975811;
CC Group: Vaccine production cell line.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-MDR1
AC CVCL_S586
SY MDCK MDR1; MDCKII-MRP1; MDCKII-MDR1; MDCKII x ABCB1-Neo
DR BTO; BTO:0005423
RX PubMed=9426231;
RX PubMed=12134945;
RX PubMed=16749865;
WW http://www.creativecell.hu/cell-line_rtu_abc.html
CC Transfected with: HGNC; 40; ABCB1.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0424 ! MDCK-II
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-MRP2
AC CVCL_X022
SY MDCKII-MRP2; MDCKII-MOAT17
RX PubMed=9525973;
RX PubMed=12134946;
CC Transfected with: HGNC; 53; ABCC2.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0424 ! MDCK-II
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-S
AC CVCL_IQ72
DR ATCC; PTA-6500
RX Patent=US7670837;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-SF101
AC CVCL_IQ73
SY MDCK-SF 101
DR ATCC; PTA-6501
RX Patent=US7670837;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-SF102
AC CVCL_IQ74
SY MDCK-SF 102
DR ATCC; PTA-6502
RX Patent=US7670837;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-SF103
AC CVCL_IQ75
SY MDCK-SF 103
DR ATCC; PTA-6503
RX Patent=US7670837;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK-SIAT1
AC CVCL_Z936
DR ECACC; 05071502
RX PubMed=12857911;
WW http://en.vircell.com/products/mdck-siat1-cell-line/
CC Transfected with: HGNC; 10860; ST6GAL1.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK.1
AC CVCL_B033
DR ATCC; CRL-2935
DR BCRJ; 0169
RX PubMed=21982418;
WW http://www.atcc.org/support/faqs/5bd5e/MDCK%20Cells%20Clonal%20Deriviatives-744.aspx
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK.2
AC CVCL_B034
DR ATCC; CRL-2936
DR BCRJ; 0170
RX PubMed=21982418;
WW http://www.atcc.org/support/faqs/5bd5e/MDCK%20Cells%20Clonal%20Deriviatives-744.aspx
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK.5F1
AC CVCL_DE56
SY BV-5F1; BV5F1
DR ATCC; CRL-12042
RX Patent=US20080254067;
RX PubMed=10494965;
CC Group: Vaccine production cell line.
CC Discontinued: ATCC; CRL-12042; probable.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK.P3
AC CVCL_2586
DR JCRB; JCRB0717
RX PubMed=21982418;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCK/60
AC CVCL_K241
SY MDCK 60
DR BCRJ; 0171
RX PubMed=10738110;
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Spontaneously immortalized cell line
//
ID MDCKII-MRP2/UGT1A1
AC CVCL_9U72
SY MDCKII-UGT1A1/MRP2
RX PubMed=26833852;
CC Transfected with: HGNC; 53; ABCC2.
CC Transfected with: HGNC; 12530; UGT1A1.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_X022 ! MDCK-MRP2
SX Female
CA Spontaneously immortalized cell line
//
ID MDCKts.src
AC CVCL_GZ12
SY MDCKts.src, cl2; ts-src MDCK clone ts-31-2
DR TOKU-E; 4072
RX PubMed=8425900;
CC Transfected with: UniProtKB; P00524; Avian leukosis virus RSA v-Src.
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0592 ! MDCK-I
SX Female
CA Spontaneously immortalized cell line
//
ID mDD1
AC CVCL_9T74
SY mouse Ductus Deferens 1
RX PubMed=11850199;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mDD2
AC CVCL_9T75
SY mouse Ductus Deferens 2
RX PubMed=11850199;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID MDEC-07114
AC CVCL_IM31
RX CelloPub=CLPUB00364;
CC Group: Insect cell line.
CC Doubling time: 44 hours (CelloPub=CLPUB00364).
OX NCBI_TaxID=7370; ! Musca domestica
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID MDG2.1
AC CVCL_6685
RX PubMed=8143903;
RX PubMed=15541573;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Transformed cell line
//
ID MDGK
AC CVCL_U237
SY MDG.K; Madin-Darby Goat Kidney
DR ATCC; CRL-6280
RX PubMed=5587551;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6280; true.
OX NCBI_TaxID=9925; ! Capra hircus
CA Spontaneously immortalized cell line
//
ID MDM2-RNB
AC CVCL_D272
DR IFO; IFO50490
RX PubMed=8895524;
CC Transfected with: HGNC; 6973; MDM2.
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_D273 ! RNB
CA Transformed cell line
//
ID MDN
AC CVCL_HX07
RX PubMed=10583232;
RX PubMed=16956823;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MDOK
AC CVCL_2587
SY Madin-Darby Ovine Kidney
DR CLO; CLO_0007650
DR CLDB; cl3427
DR ATCC; CRL-1633
DR BCRJ; 0172
DR IZSLER; BS CL 65
RX PubMed=5587551;
RX PubMed=13567776;
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/mdok/mdokcells.html
CC Discontinued: IZSLER; BS CL 65; probable.
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Spontaneously immortalized cell line
//
ID MDPC-23
AC CVCL_0E50
SY MDPC 23
DR ATCC; CRL-2537
RX PubMed=9862224;
RX PubMed=22770625;
CC Discontinued: ATCC; CRL-2537; true.
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MDR3
AC CVCL_Z836
DR DGRC; 8
RX PubMed=432755;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z838 ! Kc-HP
SX Female
CA Spontaneously immortalized cell line
//
ID MDS
AC CVCL_L807
DR BioSample; SAMN03151806
RX PubMed=1438250;
RX PubMed=12592342;
RX PubMed=19344951;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Jurkat derivative (PubMed=12592342, PubMed=19344951, PubMed=20143388).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID MDS1r(17)-1 iPSC
AC CVCL_DF95
SY MDS1 iPSC clone 1
DR GEO; GSM1274193
RX PubMed=24413397;
DI NCIt; C124852; Miller-Dieker syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5U19 ! GM06047
SX Male
CA Induced pluripotent stem cell
//
ID MDS1r(17)-2 iPSC
AC CVCL_DF96
SY MDS1 iPSC clone 2
DR GEO; GSM1274194
RX PubMed=24413397;
DI NCIt; C124852; Miller-Dieker syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5U19 ! GM06047
SX Male
CA Induced pluripotent stem cell
//
ID MDS2-1 iPSC
AC CVCL_DF97
SY MDS2 iPSC clone 1
DR GEO; GSM1274195
RX PubMed=24413397;
DI NCIt; C124852; Miller-Dieker syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5U20 ! GM06097
SX Female
CA Induced pluripotent stem cell
//
ID MDS2-2 iPSC
AC CVCL_DF98
DR GEO; GSM1274196
RX PubMed=24413397;
DI NCIt; C124852; Miller-Dieker syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5U20 ! GM06097
SX Female
CA Induced pluripotent stem cell
//
ID MDS3-1 iPSC
AC CVCL_DF99
SY MDS3 iPSC clone 1
RX PubMed=24413397;
DI NCIt; C124852; Miller-Dieker syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5U22 ! GM09208
SX Male
CA Induced pluripotent stem cell
//
ID MDS3-2 iPSC
AC CVCL_DG00
RX PubMed=24413397;
DI NCIt; C124852; Miller-Dieker syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5U22 ! GM09208
SX Male
CA Induced pluripotent stem cell
//
ID MDS92
AC CVCL_A647
DR Cosmic; 690409
DR Cosmic; 1465958
RX PubMed=7947263;
RX PubMed=8547120;
RX PubMed=19344951;
DI NCIt; C3247; Myelodysplastic syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MDST8
AC CVCL_2588
SY T8
DR EFO; EFO_0006644
DR BioSample; SAMN03473139
DR CCLE; MDST8_LARGE_INTESTINE
DR Cosmic; 1995502
DR Cosmic-CLP; 1240173
DR ECACC; 99011801
DR GDSC; 1240173
DR GEO; GSM206524
DR GEO; GSM827347
DR GEO; GSM887303
DR GEO; GSM888378
DR GEO; GSM1448122
DR GEO; GSM1670088
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,11
ST D16S539: 11
ST D18S51: 16,19.3
ST D19S433: 12,14,15
ST D21S11: 28,31
ST D2S1338: 23
ST D3S1358: 16,17
ST D5S818: 10
ST D7S820: 8,10 (Cosmic-CLP; ECACC)
ST D7S820: 10 (PubMed=25877200)
ST D8S1179: 11,14
ST FGA: 23,25
ST Penta D: 12
ST Penta E: 7,13
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 15,20
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MDTC-CU44
AC CVCL_T663
SY CU44
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-CU45
AC CVCL_T664
SY CU45
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-CU46
AC CVCL_T665
SY CU46
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Female
CA Cancer cell line
//
ID MDTC-HP114-1
AC CVCL_T666
SY HP114-1
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
OI CVCL_T667 ! MDTC-HP114-2
SX Female
CA Cancer cell line
//
ID MDTC-HP114-2
AC CVCL_T667
SY HP114-2
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
OI CVCL_T666 ! MDTC-HP114-1
SX Female
CA Cancer cell line
//
ID MDTC-HP115
AC CVCL_T668
SY HP115
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Female
CA Cancer cell line
//
ID MDTC-HP116
AC CVCL_T669
SY HP116
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Female
CA Cancer cell line
//
ID MDTC-HP117
AC CVCL_T670
SY HP117
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-HP118
AC CVCL_T671
SY HP118
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Female
CA Cancer cell line
//
ID MDTC-HP119
AC CVCL_T672
SY HP119
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-HP121
AC CVCL_T673
SY HP121
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-HP122
AC CVCL_T674
SY HP122
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Female
CA Cancer cell line
//
ID MDTC-HP41-1
AC CVCL_T675
SY HP41-1
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
OI CVCL_T676 ! MDTC-HP41-2
SX Male
CA Cancer cell line
//
ID MDTC-HP41-2
AC CVCL_T676
SY HP41-2
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
OI CVCL_T675 ! MDTC-HP41-1
SX Male
CA Cancer cell line
//
ID MDTC-HP48-3
AC CVCL_T677
SY HP48-3
RX PubMed=18766837;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-RP16
AC CVCL_N505
SY RP16; RP-16
RX PubMed=6277804;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
OI CVCL_N506 ! MDTC-RP17
SX Male
CA Cancer cell line
//
ID MDTC-RP17
AC CVCL_N506
SY RP17; RP-17
RX PubMed=6277804;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
OI CVCL_N505 ! MDTC-RP16
SX Male
CA Cancer cell line
//
ID MDTC-RP18
AC CVCL_N507
SY RP18; RP-18
RX PubMed=6277804;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
OI CVCL_2589 ! MDTC-RP19
SX Male
CA Cancer cell line
//
ID MDTC-RP19
AC CVCL_2589
SY MDTC RP 19; RP19; RP-19
DR CLO; CLO_0007651
DR CLO; CLO_0007652
DR CLDB; cl3428
DR ATCC; CRL-8135
DR IZSLER; BS TCL 39
RX Patent=US4388298;
RX PubMed=6277804;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
OI CVCL_N507 ! MDTC-RP18
SX Male
CA Cancer cell line
//
ID MDTC-RP30
AC CVCL_T450
SY RP30
RX PubMed=2848484;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-RP31
AC CVCL_T451
SY RP31
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
CA Cancer cell line
//
ID MDTC-RP32
AC CVCL_T452
SY RP32
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-RP34
AC CVCL_T453
SY RP34
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
CA Cancer cell line
//
ID MDTC-RP35
AC CVCL_T454
SY RP35
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
CA Cancer cell line
//
ID MDTC-RP36
AC CVCL_T455
SY RP36
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Female
CA Cancer cell line
//
ID MDTC-RP37
AC CVCL_T456
SY RP37
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Female
CA Cancer cell line
//
ID MDTC-RP38
AC CVCL_T457
SY RP38
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-RP39
AC CVCL_T458
SY RP39
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Male
CA Cancer cell line
//
ID MDTC-RP40
AC CVCL_T459
SY RP40
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Female
CA Cancer cell line
//
ID MDTC-RP41
AC CVCL_T460
SY RP41
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9103; ! Meleagris gallopavo
SX Female
CA Cancer cell line
//
ID MDTF
AC CVCL_J394
SY Mus Dunni Tail Fibroblast
RX PubMed=6092693;
RX PubMed=8510216;
OX NCBI_TaxID=254704; ! Mus terricolor
CA Finite cell line
//
ID MDV OU2.1
AC CVCL_Y591
SY OU2.1
RX Patent=US5866117;
RX PubMed=8553556;
RX PubMed=9126245;
CC Group: Bird cell line.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_Y589 ! CHCC-OU2
CA Transformed cell line
//
ID MDV OU2.2
AC CVCL_Y590
SY MDVOU2.2; OU2.2
DR ATCC; CRL-11985
RX Patent=US5866117;
RX PubMed=8553556;
RX PubMed=9126245;
CC Group: Bird cell line.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC Discontinued: ATCC; CRL-11985; probable.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_Y589 ! CHCC-OU2
CA Transformed cell line
//
ID MDW1
AC CVCL_S412
SY Mdw1
RX PubMed=6935454;
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S411 ! MDAY-D2
CA Cancer cell line
//
ID MDW3
AC CVCL_S413
SY Mdw3
RX PubMed=6935454;
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S411 ! MDAY-D2
CA Cancer cell line
//
ID MDW4
AC CVCL_S414
RX PubMed=3858579;
RX PubMed=6935454;
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S411 ! MDAY-D2
CA Cancer cell line
//
ID MDW5
AC CVCL_S415
RX PubMed=6935454;
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S411 ! MDAY-D2
CA Cancer cell line
//
ID ME [Human melanoma]
AC CVCL_C666
RX PubMed=11287286;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ME [Mouse]
AC CVCL_4986
DR CLO; CLO_0007653
DR ATCC; CRL-6371
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6371; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Undefined cell line type
//
ID ME [Mouse teratocarcinoma]
AC CVCL_5T97
RX PubMed=2098280;
CC Breed/subspecies: C3H/J.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_3554 ! NE
CA Cancer cell line
//
ID ME 1
AC CVCL_4987
DR CLO; CLO_0007654
DR ATCC; HB-119
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID ME 195
AC CVCL_J840
SY ME195
DR CLO; CLO_0007658
DR ATCC; HB-8431
RX Patent=US4666845;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID ME 46
AC CVCL_J842
DR ATCC; HB-8430
RX Patent=US4666845;
CC Discontinued: ATCC; HB-8430; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Me Jon
AC CVCL_3746
DR CLO; CLO_0007655
DR ATCC; CRL-1288
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Me Kam
AC CVCL_U673
SY XP15BE
DR ATCC; CRL-1279
CC Discontinued: ATCC; CRL-1279; true.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Me Lor
AC CVCL_U786
DR ATCC; CRL-1368
DR BioSample; SAMN03471359
CC Discontinued: ATCC; CRL-1368; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 7.3,11
ST D13S317: 8,10
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Me Mon
AC CVCL_3747
DR CLO; CLO_0007656
DR ATCC; CRL-1342
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Me Rey
AC CVCL_U787
DR ATCC; CRL-1346
CC Discontinued: ATCC; CRL-1346; true.
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID Me We
AC CVCL_U677
DR ATCC; CRL-1194
CC Discontinued: ATCC; CRL-1194; true.
DI NCIt; C34568; Ehlers-Danlos syndrome
DI NCIt; C85036; Pseudoxanthoma elasticum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ME-1 [Human leukemia]
AC CVCL_2110
SY ME1
DR EFO; EFO_0006645
DR BioSample; SAMN03472157
DR CCLE; ME1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787450
DR Cosmic; 975268
DR Cosmic; 999732
DR Cosmic; 1281326
DR Cosmic; 1524833
DR Cosmic; 2131544
DR Cosmic; 2306217
DR Cosmic-CLP; 1330942
DR DSMZ; ACC-537
DR GDSC; 1330942
DR GEO; GSM236788
DR GEO; GSM236824
DR GEO; GSM887304
DR GEO; GSM888379
DR GEO; GSM1374666
DR GEO; GSM1670089
DR Lonza; 157
RX PubMed=2070080;
RX PubMed=15843827;
RX PubMed=16523483;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~3-5 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 12
ST D18S51: 16,23
ST D21S11: 29
ST D3S1358: 14,16
ST D5S818: 9,11
ST D7S820: 10,11
ST D8S1179: 11,14
ST FGA: 21,25
ST Penta D: 9
ST Penta E: 5,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ME-1 [Human myeloma]
AC CVCL_M535
RX CelloPub=CLPUB00079;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me-116
AC CVCL_C598
DR ESTDAB; ESTDAB-122
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 9,11
ST FGA: 21,22
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ME-180
AC CVCL_1401
SY Me-180; ME 180; ME180
DR CLO; CLO_0007657
DR CLO; CLO_0050924
DR EFO; EFO_0006646
DR CLDB; cl3429
DR ATCC; HTB-33
DR ATCC; CRL-7932
DR BioSample; SAMN03471125
DR BioSample; SAMN03472007
DR BioSample; SAMN03472511
DR BioSample; SAMN03473047
DR ChEMBL-Cells; CHEMBL3308114
DR ChEMBL-Targets; CHEMBL1075499
DR Cosmic; 687514
DR Cosmic; 760223
DR Cosmic; 809228
DR Cosmic; 846185
DR Cosmic; 877466
DR Cosmic; 928909
DR Cosmic; 1071909
DR Cosmic; 1102582
DR Cosmic; 1131524
DR Cosmic; 1175837
DR Cosmic; 1176609
DR Cosmic; 1193031
DR Cosmic; 1995503
DR Cosmic; 2301541
DR Cosmic; 2546868
DR Cosmic-CLP; 687514
DR GDSC; 687514
DR GEO; GSM113864
DR GEO; GSM253300
DR GEO; GSM595618
DR GEO; GSM675736
DR GEO; GSM685436
DR GEO; GSM827202
DR GEO; GSM1670090
DR ICLC; HTL96027
DR IGRhCellID; ME180%20GEO
DR JCRB; JCRB0810
DR KCLB; 30033
DR RCB; RCB2106
DR TKG; TKG 0437
DR TOKU-E; 2410
RX DOI=10.1007/978-1-4757-1647-4_13;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=2990217;
RX PubMed=3371749;
RX PubMed=4317734;
RX PubMed=6500159;
RX PubMed=6582512;
RX PubMed=7459858;
RX PubMed=7751322;
RX PubMed=8931502;
RX PubMed=9290701;
RX PubMed=15531914;
RX PubMed=17325662;
RX PubMed=22710073;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27561551;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-612.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Characteristics: Contains a complete HPV68 genome.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Discontinued: ATCC; CRL-7932; true.
CC Derived from metastatic site: Omentum.
ST Source(s): ATCC; Cosmic-CLP; JCRB; KCLB; PubMed=22710073; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13 (ATCC; Cosmic-CLP; JCRB; KCLB; PubMed=25877200; RCB; TKG)
ST D13S317: 11,12 (PubMed=22710073)
ST D16S539: 12,13
ST D18S51: 12
ST D19S433: 13,15.2
ST D21S11: 30,31
ST D2S1338: 18
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 14
ST FGA: 23
ST Penta D: 9,14
ST Penta E: 12,14
ST TH01: 8,9.3 (ATCC; Cosmic-CLP; JCRB; KCLB; PubMed=22710073; PubMed=25877200; TKG)
ST TH01: 8 (RCB)
ST TPOX: 8,10
ST vWA: 15,17 (ATCC; Cosmic-CLP; KCLB; PubMed=22710073; PubMed=25877200; RCB; TKG)
ST vWA: 15,16,17 (JCRB)
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ME-F1
AC CVCL_G312
RX PubMed=8018932;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2110 ! ME-1 [Human leukemia]
SX Male
CA Cancer cell line
//
ID ME-F2
AC CVCL_G313
RX PubMed=8018932;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2110 ! ME-1 [Human leukemia]
SX Male
CA Cancer cell line
//
ID ME-F2/ADM100
AC CVCL_G315
RX PubMed=9177449;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_G313 ! ME-F2
SX Male
CA Cancer cell line
//
ID ME-F2/ADM200
AC CVCL_G316
RX PubMed=9177449;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_G313 ! ME-F2
SX Male
CA Cancer cell line
//
ID ME-F3
AC CVCL_G314
RX PubMed=8018932;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2110 ! ME-1 [Human leukemia]
SX Male
CA Cancer cell line
//
ID ME1
AC CVCL_L911
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME10
AC CVCL_L917
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me1007
AC CVCL_C668
SY ME1007; ME-1007; Mel-007; Mel007; INT-MEL-20
DR BTO; BTO:0005711
DR Cosmic; 889005
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=2469723;
RX PubMed=7520026;
RX PubMed=8980186;
RX PubMed=9725211;
RX PubMed=15048078;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Me10221
AC CVCL_HE43
SY Me 10221; INT-MEL-50
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Me10258
AC CVCL_HF01
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me10538
AC CVCL_A648
SY ME10538; Me 10538; Me1053/8; 10538; INT-MEL-12
DR Cosmic; 889006
DR Cosmic; 928710
DR Cosmic; 1211153
DR GEO; GSM1403082
DR GEO; GSM1403083
DR GEO; GSM1403084
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=2469723;
RX PubMed=2776368;
RX PubMed=7520026;
RX PubMed=8459226;
RX PubMed=8980186;
RX PubMed=9354451;
RX PubMed=9725211;
RX PubMed=9973437;
RX PubMed=15048078;
RX PubMed=25576923;
CC Misspelling: Occasionally 'ME10358'.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C690 ! LCL10538
SX Female
CA Cancer cell line
//
ID Me11-TG6
AC CVCL_G351
DR ECACC; 11120838
CC Breed/subspecies: PVG/c.
DI NCIt; C60453; Rat malignant mesothelioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID Me1274
AC CVCL_HF02
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me13294
AC CVCL_HE36
SY Me1329/4; INT-MEL-11
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Me1340
AC CVCL_C669
RX PubMed=8459226;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me13443
AC CVCL_C670
SY 13443-Mel; MI13443-MEL; Mi13443; INT-MEL-23
DR Cosmic; 1295338
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=8459226;
WW http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===MI13443-MEL%20cells&-Find
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me13923
AC CVCL_HE94
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me13924
AC CVCL_C671
RX PubMed=8459226;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me1402
AC CVCL_C672
SY ME1402; Me 1402; Me1402/R; Me1402r; Me1402/P
DR Cosmic; 720625
DR Cosmic; 889007
DR Cosmic; 928698
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=2469723;
RX PubMed=2776368;
RX PubMed=7520026;
RX PubMed=8459226;
RX PubMed=9354451;
RX PubMed=9973437;
RX PubMed=15048078;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me14362
AC CVCL_HF03
SY Me#14362
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=22553342;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me14464
AC CVCL_HF04
SY 14464
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=25576923;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me14932
AC CVCL_C673
SY Me1493/2; INT-MEL-19
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=8459226;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ME15.C2
AC CVCL_5999
RX PubMed=1905566;
CC Transformant: MYC.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Me1509
AC CVCL_HE40
SY INT-MEL-43
RX DOI=10.1007/0-306-46872-7_16;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Me15094
AC CVCL_HF05
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=22553342;
CC Derived from metastatic site: Soft tissue.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me15392
AC CVCL_C604
SY Me-15392; Me 15392; 15392; 15392M
DR Cosmic; 2163824
DR ESTDAB; ESTDAB-114
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9973437;
RX PubMed=22553342;
RX PubMed=25576923;
CC Derived from metastatic site: Lymph node.
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D3S1358: 17
ST D5S818: 14
ST D7S820: 9,10
ST FGA: 22
ST TH01: 6
ST TPOX: 11
ST vWA: 15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_HE34 ! LCL15392
CA Cancer cell line
//
ID Me15479
AC CVCL_HF06
RX PubMed=22553342;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME16
AC CVCL_L918
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me16938
AC CVCL_C674
SY Me1693/8; INT-MEL-39
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=8459226;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ME17 [Human melanoma]
AC CVCL_L919
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME17 [Mouse fetal erythroid]
AC CVCL_6000
RX PubMed=1905566;
CC Transformant: MYC.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Me17-TG6
AC CVCL_G352
DR ECACC; 11120837
CC Breed/subspecies: PVG/c.
DI NCIt; C60453; Rat malignant mesothelioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID Me17088/1
AC CVCL_V024
RX PubMed=9743519;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me17697
AC CVCL_V019
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9743519;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME18
AC CVCL_L920
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me1811
AC CVCL_C675
SY ME1811; Me 1811
RX PubMed=8459226;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C689 ! LCL1811
CA Cancer cell line
//
ID Me18588
AC CVCL_HE45
SY Me1858/8; INT-MEL-10
RX DOI=10.1007/0-306-46872-7_16;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Me18656
AC CVCL_HF07
SY 18656
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=22553342;
RX PubMed=25576923;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me18732
AC CVCL_C676
SY 18732
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=8459226;
RX PubMed=9743519;
RX PubMed=25576923;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me18816
AC CVCL_HF08
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME19
AC CVCL_L921
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me19-TG2
AC CVCL_G353
DR ECACC; 11120836
CC Breed/subspecies: PVG/c.
DI NCIt; C60453; Rat malignant mesothelioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID Me19410
AC CVCL_HF09
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME2
AC CVCL_L912
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME20
AC CVCL_L922
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me20842
AC CVCL_V020
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9743519;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_HE92 ! Me20842M1
OI CVCL_HE93 ! Me20842M2
CA Cancer cell line
//
ID Me20842M1
AC CVCL_HE92
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V020 ! Me20842
OI CVCL_HE93 ! Me20842M2
CA Cancer cell line
//
ID Me20842M2
AC CVCL_HE93
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=22553342;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V020 ! Me20842
OI CVCL_HE92 ! Me20842M1
CA Cancer cell line
//
ID ME21
AC CVCL_L923
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me21158
AC CVCL_HE95
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME22
AC CVCL_L924
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me2211
AC CVCL_HF10
SY Me#2211
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=22553342;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME23
AC CVCL_L925
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me23526
AC CVCL_HF11
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=22553342;
CC Misspelling: 'Me2352' in DOI=10.13130/grazia-giulia_phd2016-02-18.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me23682
AC CVCL_HF12
DR GEO; GSE34686
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=22553342;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me2559/1
AC CVCL_V025
SY Me2559
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9743519;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me26635
AC CVCL_HF13
DR GEO; GSM1403055
DR GEO; GSM1403056
DR GEO; GSM1403057
DR GEO; GSM1403058
DR GEO; GSM1403059
DR GEO; GSM1403060
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me28
AC CVCL_HE39
SY Me 28; Melanoma 28
RX PubMed=3121738;
RX PubMed=3158614;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me29318
AC CVCL_HF14
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me2934
AC CVCL_HE96
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me3044
AC CVCL_HF15
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
CC Derived from metastatic site: Soft tissue.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me3046
AC CVCL_HE42
SY INT-MEL-8
RX DOI=10.1007/0-306-46872-7_16;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Me3046/2
AC CVCL_C677
RX PubMed=8459226;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_HE42 ! Me3046
SX Male
CA Cancer cell line
//
ID Me3068
AC CVCL_C678
SY ME3068
RX PubMed=2469723;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me32562
AC CVCL_HF16
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me32669
AC CVCL_HF17
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=22553342;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME361
AC CVCL_J760
SY ME 361
DR ATCC; HB-9325
RX Patent=US4849509;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID ME361-S2a
AC CVCL_J761
SY ME 361-S2a; ME361S2a
DR CLO; CLO_0007659
DR ATCC; HB-9326
RX Patent=US4849509;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Me3700
AC CVCL_HE97
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me4023
AC CVCL_V021
SY 4023
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9743519;
RX PubMed=25576923;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me4024
AC CVCL_C679
SY INT-MEL-52
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=8459226;
RX PubMed=9973437;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Me4024/1
AC CVCL_V022
SY Me 4024/1
DR Cosmic; 720623
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C679 ! Me4024
SX Female
CA Cancer cell line
//
ID Me4024/2
AC CVCL_V023
SY Me 4024/2
DR Cosmic; 720624
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C679 ! Me4024
SX Female
CA Cancer cell line
//
ID Me43
AC CVCL_C665
SY ME43 ME-43; Me-43
RX PubMed=6746112;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me4405
AC CVCL_C680
SY ME4405; ME-4405; INT-MEL-17
DR BTO; BTO:0005716
DR Cosmic; 889008
DR Cosmic; 929202
DR GEO; GSM1403049
DR GEO; GSM1403050
DR GEO; GSM1403051
DR GEO; GSM1403052
DR GEO; GSM1403053
DR GEO; GSM1403054
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=7520026;
RX PubMed=8459226;
RX PubMed=8980186;
RX PubMed=9725211;
RX PubMed=10338330;
RX PubMed=15048078;
RX PubMed=22553342;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C688 ! LCL4405
SX Female
CA Cancer cell line
//
ID Me4473
AC CVCL_HE98
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me45
AC CVCL_K048
SY Me-45
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=87
CC From: Department of Radiobiology; M. Sklodowska-Curie Cancer Centre and Institute of Oncology; Gliwice; Poland.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Me4686
AC CVCL_HE99
SY 4686
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=9973437;
RX PubMed=25576923;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me4840
AC CVCL_HE35
SY INT-MEL-9
RX DOI=10.1007/0-306-46872-7_16;
CC Derived from metastatic site: Omentum.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Me4855
AC CVCL_C681
RX PubMed=8459226;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME5
AC CVCL_L913
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me5810
AC CVCL_C682
SY Me5810/P; INT-MEL-1
DR Cosmic; 720626
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=8459226;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C687 ! LCL5810
SX Female
CA Cancer cell line
//
ID Me665/1
AC CVCL_C667
SY Me 665/1; 665/1; INT-MEL-60/1
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=2469723;
RX PubMed=2776368;
RX PubMed=8459226;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7077 ! Me665/2
OI CVCL_HE41 ! Me665/3
SX Female
CA Cancer cell line
//
ID Me665/2
AC CVCL_7077
AS CVCL_4725
SY ME665/2; Me 665/2; 665/2; INT-MEL-60/2
DR BTO; BTO:0003270
DR CLO; CLO_0001453
DR CLDB; cl114
DR CLDB; cl115
DR GEO; GSM1403064
DR GEO; GSM1403065
DR GEO; GSM1403066
DR Cosmic; 720621
DR Cosmic; 1026920
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=2469723;
RX PubMed=2776368;
RX PubMed=25576923;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C667 ! Me665/1
OI CVCL_HE41 ! Me665/3
SX Female
CA Cancer cell line
//
ID Me665/2/21
AC CVCL_7078
SY 665/2/21
DR BTO; BTO:0005069
DR ChEMBL-Cells; CHEMBL3307371
DR ChEMBL-Targets; CHEMBL614339
DR TOKU-E; 4285
RX PubMed=10893182;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7077 ! Me665/2
SX Female
CA Cancer cell line
//
ID Me665/2/60
AC CVCL_7079
DR BTO; BTO:0005070
RX PubMed=10893182;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7077 ! Me665/2
SX Female
CA Cancer cell line
//
ID Me665/3
AC CVCL_HE41
SY INT-MEL-60/3
RX DOI=10.1007/0-306-46872-7_16;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C667 ! Me665/1
OI CVCL_7077 ! Me665/2
SX Female
CA Cancer cell line
//
ID Me665/R
AC CVCL_W187
SY Me 665/R
RX PubMed=2469723;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7077 ! Me665/2
SX Female
CA Cancer cell line
//
ID Me6824
AC CVCL_HF18
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME7
AC CVCL_L914
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ME8
AC CVCL_L915
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me8530
AC CVCL_HE44
SY Me 8530
RX PubMed=9973437;
RX PubMed=22553342;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me879
AC CVCL_HF19
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX PubMed=22553342;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me8959
AC CVCL_C683
SY INT-MEL-13
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=8459226;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ME9
AC CVCL_L916
RX PubMed=19001446;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me9-TG3
AC CVCL_G354
SY Me9/TG3
DR ECACC; 11120841
RX PubMed=7150478;
CC Breed/subspecies: PVG/c.
DI NCIt; C60453; Rat malignant mesothelioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID Me9229
AC CVCL_F249
SY Me 9229; 9229; Melanoma 9229; INT-MEL-58
DR CLO; CLO_0001014
DR CLDB; cl139
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=2469723;
RX PubMed=3121738;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Me9229/18
AC CVCL_HE38
RX PubMed=3121738;
RX PubMed=7607705;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F249 ! Me9229
SX Male
CA Cancer cell line
//
ID Me9460
AC CVCL_C684
RX PubMed=8459226;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Me9742
AC CVCL_C685
SY ME9742
RX PubMed=8459226;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C686 ! LCL9742
CA Cancer cell line
//
ID Me9874
AC CVCL_HE33
SY ME9874; INT-MEL-4
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX DOI=10.1007/0-306-46872-7_16;
RX PubMed=9973437;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Me9923/M
AC CVCL_HE37
SY INT-MEL-16/2
RX DOI=10.1007/0-306-46872-7_16;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F250 ! Me9923/P
SX Female
CA Cancer cell line
//
ID Me9923/P
AC CVCL_F250
SY Me9923p; Me9923; Me 9923; 9923; INT-MEL-16/1
DR CLO; CLO_0001015
DR CLDB; cl141
DR Cosmic; 720622
RX DOI=10.13130/grazia-giulia_phd2016-02-18;
RX DOI=10.1007/0-306-46872-7_16;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_HE37 ! Me9923/M
SX Female
CA Cancer cell line
//
ID MEB-4
AC CVCL_4772
SY MEB4
DR BTO; BTO:0001219
DR CLO; CLO_0050761
DR RCB; RCB1027
RX PubMed=3053466;
RX PubMed=8146177;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID MEB5
AC CVCL_5221
SY MEB 5; MEB-5
DR IFO; IFO50472
DR JCRB; JCRB0145
RX PubMed=9719419;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MEB5
CC Characteristics: EGF dependent. When deprived of EGF, about 50% of the cells die due to apoptosis within 24h. The remaining cells differentiated into neurons, astrncytes, or oligndendrocytes within 2 weeks.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MEC
AC CVCL_B270
DR BioSample; SAMN03472009
DR Cosmic; 1122351
DR RCB; RCB2129
DR TKG; TKG 0629
RX CelloPub=CLPUB00275;
RX PubMed=1965684;
CC Discontinued: RCB; RCB2129; true.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,14
ST D13S317: 8,11 (RCB)
ST D13S317: 9,11 (TKG)
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 11 (RCB)
ST D7S820: 9.3,11 (TKG)
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MEC-1
AC CVCL_1870
SY MEC1
DR BTO; BTO:0005913
DR EFO; EFO_0002231
DR BioSample; SAMN03471015
DR CCLE; MEC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1762462
DR DSMZ; ACC-497
DR GDSC; 1330943
DR GEO; GSM887305
DR GEO; GSM888381
DR GEO; GSM1374667
DR GEO; GSM1670091
DR IGRhCellID; MEC1
RX PubMed=10071128;
RX PubMed=22460905;
RX PubMed=23297799;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~40 hours (DSMZ; PubMed=10071128).
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,11
ST D18S51: 14
ST D21S11: 27,29
ST D3S1358: 15,19
ST D5S818: 10,12
ST D7S820: 7,11
ST D8S1179: 13,15
ST FGA: 21,25
ST Penta D: 11,17
ST Penta E: 10,12
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1871 ! MEC-2
SX Male
CA Cancer cell line
//
ID MEC-2
AC CVCL_1871
SY MEC2
DR BTO; BTO:0005914
DR EFO; EFO_0006285
DR CCLE; MEC2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR DSMZ; ACC-500
DR GEO; GSM887306
DR GEO; GSM888382
DR GEO; GSM1374668
DR GEO; GSM1670092
RX PubMed=10071128;
RX PubMed=19358282;
RX PubMed=22460905;
RX PubMed=23297799;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 31 hours (PubMed=10071128); ~40-50 hours (DSMZ).
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 7,11
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1870 ! MEC-1
SX Male
CA Cancer cell line
//
ID MEC-HH
AC CVCL_X509
RX DOI=10.3923/javaa.2012.1166.1172;
CC Breed/subspecies: Chinese Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Finite cell line
//
ID MEC-LL
AC CVCL_X510
RX DOI=10.3923/javaa.2012.1166.1172;
CC Breed/subspecies: Chinese Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Finite cell line
//
ID MECA-367
AC CVCL_9221
DR CLO; CLO_0007662
DR ATCC; HB-9478
RX Patent=US5403919;
CC Monoclonal antibody target: UniProtKB; Q61826; Mouse Madcam1.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MECA-79
AC CVCL_9222
DR CLO; CLO_0007663
DR ATCC; HB-9479
RX Patent=US5403919;
RX PubMed=2460470;
CC Monoclonal antibody target: Sulfated N-acetylglucosamine.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MECA-89
AC CVCL_9223
DR CLO; CLO_0007664
DR ATCC; HB-292
RX Patent=US5403919;
CC Monoclonal antibody target: UniProtKB; Q61826; Mouse Madcam1.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MeCo 05
AC CVCL_3403
SY MECO
DR CLDB; cl7181
DR ICLC; HTL07001
RX PubMed=23634660;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MED-MEB-8A
AC CVCL_M137
SY MEB-Med8A; MEBMED8A; MED8A; Med8A
DR Cosmic; 2362657
DR GEO; GSM919363
RX PubMed=15793295;
RX PubMed=16946619;
RX PubMed=22976800;
CC Misspelling: 'MHH-MED-8A' in Cosmic 2362657 and PubMed=16946619.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M138 ! MED-MEB-8S
SX Male
CA Cancer cell line
//
ID MED-MEB-8S
AC CVCL_M138
SY MEBMED8S
DR Cosmic; 2362658
RX PubMed=15793295;
RX PubMed=22976800;
CC Misspelling: 'MHH-MED-8S' in Cosmic 2362658.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M137 ! MED-MEB-8A
SX Male
CA Cancer cell line
//
ID MED17.11
AC CVCL_4Y33
RX PubMed=26053673;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MedB-1
AC CVCL_A649
SY MedB1; MEDB1
DR Cosmic; 988832
DR Cosmic; 1013889
DR Cosmic; 2297036
DR Cosmic; 2437270
DR Cosmic; 2479247
DR GEO; GSM119538
DR Lonza; 197
DR PRIDE; PXD000589
RX PubMed=11291070;
RX PubMed=16960149;
RX PubMed=25894527;
CC Omics: Cell surface proteome.
DI NCIt; C9280; Mediastinal (thymic) large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MEDEP-BRC4-1
AC CVCL_E139
DR RCB; RCB2692
RX PubMed=18253492;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B981 ! BRC4
SX Sex undetermined
CA Embryonic stem cell
//
ID MEDEP-BRC4-2
AC CVCL_E136
DR RCB; RCB2932
DR RCB; RCB2699
RX PubMed=18253492;
CC Discontinued: RCB; RCB2699; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B981 ! BRC4
SX Sex undetermined
CA Embryonic stem cell
//
ID MEDEP-BRC5
AC CVCL_E137
SY MEDEP-BRC-5
DR RCB; RCB2609
DR RCB; RCB2911
RX DOI=10.4051/ibc.2010.2.4.0014;
RX PubMed=18253492;
CC Discontinued: RCB; RCB2609; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B982 ! BRC5
SX Male
CA Embryonic stem cell
//
ID MEDEP-E14
AC CVCL_E138
DR RCB; RCB2660
RX PubMed=18253492;
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9108 ! ES-E14TG2a
SX Male
CA Embryonic stem cell
//
ID MEDEP-E14 clone 4
AC CVCL_E143
DR RCB; RCB2691
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E138 ! MEDEP-E14
SX Male
CA Embryonic stem cell
//
ID MEDMC-BRC6
AC CVCL_E140
DR RCB; RCB2694
RX PubMed=18253492;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B983 ! BRC6
SX Female
CA Embryonic stem cell
//
ID MEDMC-NT2
AC CVCL_E141
DR RCB; RCB2693
RX PubMed=18253492;
CC Breed/subspecies: 129.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E142 ! NTES-2
CA Embryonic stem cell
//
ID MEF (C57BL/6)
AC CVCL_9115
SY MEF-BL/6-1
DR CLO; CLO_0007665
DR ATCC; SCRC-1008
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Mixed sex
CA Finite cell line
//
ID MEF (C57BL/6) IRR
AC CVCL_9117
DR ATCC; SCRC-1008.1
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9115 ! MEF (C57BL/6)
SX Mixed sex
CA Finite cell line
//
ID MEF (C57BL/6) MITC
AC CVCL_9118
DR ATCC; SCRC-1008.2
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9115 ! MEF (C57BL/6)
SX Mixed sex
CA Finite cell line
//
ID MEF PKCe KO
AC CVCL_AS81
SY PKCepsilonKO
DR Ximbio; 151665
RX PubMed=12110574;
CC Knockout cell: Method=KO mouse; MGI; MGI:97599; Prkce.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MEF PKCe KO KI
AC CVCL_AS82
SY PKCepsilonRE
DR Ximbio; 151663
RX PubMed=12110574;
CC Knockout cell: Method=KO mouse; MGI; MGI:97599; Prkce.
CC Transfected with: MGI; MGI:97599; Prkce.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_AS81 ! MEF PKCe KO
CA Spontaneously immortalized cell line
//
ID MEF-1 [Human myeloma]
AC CVCL_M515
RX PubMed=10223569;
RX PubMed=10936422;
CC Doubling time: ~36 hours (PubMed=10223569).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MEF-1 [Mouse fibroblast]
AC CVCL_4240
SY MEF1; Mouse Embryo Fibroblast-1
DR CLO; CLO_0007667
DR ATCC; CRL-2214
DR ECACC; 98061101
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: 129 x C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MEF3.8
AC CVCL_R997
SY Mef3.8
RX PubMed=10485464;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MEF3.8/M32
AC CVCL_R999
SY MEF3.8 M32; M32
RX PubMed=10485464;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R997 ! MEF3.8
CA Spontaneously immortalized cell line
//
ID MEF3.8/T6400
AC CVCL_R998
SY Mef3.8/T6400; T6400
DR ChEMBL-Cells; CHEMBL3307255
DR ChEMBL-Targets; CHEMBL613094
RX PubMed=10485464;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R997 ! MEF3.8
CA Spontaneously immortalized cell line
//
ID MEG-01
AC CVCL_0425
SY Meg-01; MEG01; Meg01
DR BTO; BTO:0002581
DR CLO; CLO_0007668
DR EFO; EFO_0002232
DR MCCL; MCC:0000322
DR CLDB; cl3432
DR CLDB; cl3433
DR ATCC; CRL-2021
DR BCRC; 60238
DR BCRJ; 0262
DR BioSample; SAMN01821577
DR BioSample; SAMN01821648
DR BioSample; SAMN01821734
DR BioSample; SAMN03471278
DR CCLE; MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3131C0001000700083
DR ChEMBL-Cells; CHEMBL3308539
DR ChEMBL-Targets; CHEMBL2366084
DR Cosmic; 787503
DR Cosmic; 908126
DR Cosmic; 924042
DR Cosmic; 1026578
DR Cosmic; 1070702
DR Cosmic; 1078723
DR Cosmic; 1516634
DR Cosmic; 1523830
DR Cosmic-CLP; 908126
DR DSMZ; ACC-364
DR ECACC; 94012401
DR GDSC; 908126
DR GEO; GSM482498
DR GEO; GSM887307
DR GEO; GSM888383
DR GEO; GSM1374669
DR GEO; GSM1670093
DR ICLC; HTL96017
DR IFO; IFO50151
DR IGRhCellID; MEG01
DR Lonza; 959
RX PubMed=2998511;
RX PubMed=3332852;
RX PubMed=9738977;
RX PubMed=15843827;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~35 hours (DSMZ); 36-48 hours (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 9
ST D5S818: 13
ST D7S820: 11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MEG-01s
AC CVCL_3022
SY MEG-01S; MEG01s
DR BTO; BTO:0005297
DR BioSample; SAMN03472795
DR Cosmic; 2009519
DR IFO; IFO50473
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 9
ST D5S818: 13
ST D7S820: 11
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0425 ! MEG-01
SX Male
CA Cancer cell line
//
ID MEG-01SSF
AC CVCL_3023
DR IFO; IFO50294
RX PubMed=1367286;
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 9
ST D5S818: 13
ST D7S820: 11
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3022 ! MEG-01s
SX Male
CA Cancer cell line
//
ID MEG-A2
AC CVCL_1832
DR BioSample; SAMN03473398
DR Cosmic; 1012086
DR DSMZ; ACC-718
DR IFO; IFO50478
RX PubMed=7869773;
RX PubMed=16408098;
CC Doubling time: ~40 hours (DSMZ).
ST Source(s): DSMZ; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,14
ST D16S539: 11,12
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Meg-J
AC CVCL_G311
SY MEG-J; MegJ
DR Cosmic; 919132
DR Cosmic; 1012087
RX PubMed=9722312;
RX PubMed=16408098;
DI NCIt; C3170; Acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEGAL
AC CVCL_1833
DR Cosmic; 787451
DR Cosmic; 975269
DR Cosmic; 1012088
DR Cosmic; 1281327
DR Cosmic; 2306218
DR DSMZ; ACC-719
RX PubMed=19166587;
RX PubMed=16408098;
CC Doubling time: ~70 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 9,12
ST D7S820: 11,12
ST TH01: 9.3
ST TPOX: 9
ST vWA: 16
DI NCIt; C3170; Acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MEGR 07
AC CVCL_F329
DR CLDB; cl7213
DR ICLC; HTL07005
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID mEHE/CH5
AC CVCL_Y275
RX PubMed=7670562;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Mehr-80
AC CVCL_U105
DR NCBI_Iran; C543
RX PubMed=15619644;
DI NCIt; C5672; Large cell lung neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel 12
AC CVCL_0D07
SY Melanoma-12
RX PubMed=19147538;
RX PubMed=19231960;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Mel 1241
AC CVCL_C616
SY Mel1241; MEL1241; 1241-mel
DR Cosmic; 876681
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel 224
AC CVCL_U915
SY Mel224; Melanoma cell line 224; 224
DR Cosmic; 897738
DR Cosmic; 1054849
DR Cosmic; 1507622
DR Cosmic; 2233662
RX PubMed=12446472;
RX PubMed=15688405;
RX PubMed=17308088;
CC From: Hansson J.; Karolinska Institutet; Stockholm; Sweden.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel 23
AC CVCL_0D08
SY Melanoma-23
RX PubMed=19147538;
RX PubMed=19231960;
RX PubMed=25022346;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Mel 36
AC CVCL_0D09
SY Melanoma-36
RX PubMed=19147538;
RX PubMed=25022346;
CC Derived from metastatic site: Lymph node.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Mel 50
AC CVCL_0D10
SY Melanoma-50
RX PubMed=19147538;
RX PubMed=19231960;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Mel 505
AC CVCL_U916
SY Mel-505; MEL-505; Mel505
DR Cosmic; 1054844
DR Cosmic; 1102387
DR Cosmic; 1507609
DR Cosmic; 2233663
RX PubMed=17308088;
CC From: Hansson J.; Karolinska Institutet; Stockholm; Sweden.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel 64
AC CVCL_0D11
SY Melanoma-64
RX PubMed=19147538;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Mel 69
AC CVCL_0D12
SY Melanoma-69
RX PubMed=25022346;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Mel 83
AC CVCL_0D13
SY Melanoma-83
RX PubMed=25022346;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Mel 928
AC CVCL_C694
SY Mel928; MEL928; 928-Mel; 928-mel; 928 MEL; 928 mel; 928mel; 928MEL
DR EFO; EFO_0006360
DR BioSample; SAMN03471614
DR CGH-DB; 9310-4
DR Cosmic; 876701
DR Cosmic; 905223
DR Cosmic; 1295545
DR Cosmic; 1559442
DR GEO; GSM206441
RX PubMed=15467732;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 14
ST D18S51: 12
ST D21S11: 29,30
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 12,13
ST FGA: 19
ST Penta D: 11,13
ST Penta E: 8,13
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel Ei
AC CVCL_3978
SY Ei
DR BTO; BTO:0001672
RX PubMed=6895502;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel Gerlach
AC CVCL_IS37
RX PubMed=18698037;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEL III
AC CVCL_3850
SY Mel III; Mel-III
DR CLO; CLO_0007669
DR CLDB; cl5230
DR ATCC; CRL-6308
DR IZSLER; BS TCL 114
DR NCBI_Iran; C456
CC Group: Non-human primate cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6308; true.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Cancer cell line
//
ID Mel Ho
AC CVCL_1402
SY MEL HO; MEL-HO; MEL-Ho; Mel-HO; MelHo; MELHO; Ho
DR BTO; BTO:0001587
DR CLO; CLO_0007675
DR EFO; EFO_0006647
DR CLDB; cl3439
DR BioSample; SAMN03152032
DR BioSample; SAMN03473130
DR BioSample; SAMN03473505
DR CCLE; MELHO_SKIN
DR ChEMBL-Cells; CHEMBL3308798
DR ChEMBL-Targets; CHEMBL1075500
DR Cosmic; 908124
DR Cosmic; 1995504
DR Cosmic-CLP; 908124
DR DSMZ; ACC-62
DR GDSC; 908124
DR GEO; GSM887308
DR GEO; GSM888384
DR GEO; GSM1670094
RX PubMed=6895502;
RX PubMed=10508494;
RX PubMed=20143388;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Possibly misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494, PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~24 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11
ST D18S51: 12,16
ST D21S11: 29
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 10,11,13 (Cosmic-CLP; DSMZ)
ST D7S820: 10 (PubMed=25877200)
ST D8S1179: 11,14
ST FGA: 22,23
ST Penta D: 8,9
ST Penta E: 11,16
ST TH01: 7
ST TPOX: 8,10
ST vWA: 14,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3981 ! Mel Wei
SX Female
CA Cancer cell line
//
ID Mel Im
AC CVCL_3980
SY Im
DR BTO; BTO:0001674
RX PubMed=6895502;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel Ju
AC CVCL_3979
SY Ju
DR BTO; BTO:0001673
RX PubMed=6895502;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel JuSo
AC CVCL_1403
SY MEL-Juso; MEL-JUSO; Mel-Juso; Mel Juso; MelJuSo; JuSo
DR BTO; BTO:0001588
DR CLO; CLO_0007676
DR CLDB; cl3440
DR BioSample; SAMN03471884
DR CCLE; MELJUSO_SKIN
DR ChEMBL-Cells; CHEMBL3308761
DR ChEMBL-Targets; CHEMBL1075501
DR CLS; 300282/NA
DR Cosmic; 706091
DR Cosmic; 888060
DR Cosmic; 888835
DR Cosmic; 897474
DR Cosmic; 908125
DR Cosmic; 1020272
DR Cosmic; 1022285
DR Cosmic; 1459306
DR Cosmic; 1995505
DR Cosmic-CLP; 908125
DR DSMZ; ACC-74
DR GDSC; 908125
DR GEO; GSM887309
DR GEO; GSM888385
DR GEO; GSM1374670
DR GEO; GSM1670095
RX PubMed=2174414;
RX PubMed=6895502;
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=18698037;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~28 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: CLS; 300282; true.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,9
ST D16S539: 12,13
ST D18S51: 15,18
ST D21S11: 29
ST D3S1358: 14,17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 9,14
ST FGA: 22
ST Penta D: 13
ST Penta E: 5,13
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel Neg
AC CVCL_3748
DR CLO; CLO_0007670
DR ATCC; CRL-1193
DI NCIt; C125701; Ehlers-Danlos syndrome, type VII
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Mel Wei
AC CVCL_3981
SY MEL-WEI; Wei
DR BTO; BTO:0001675
DR BioSample; SAMN03152033
RX PubMed=6895502;
RX PubMed=10508494;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Possibly contaminated/misidentified. Shown to be identical to MEL-Ho. This cell line was reported to be isogenic with LCL-Wei (CVCL_1869) but it does not have the same STR profile (PubMed=10508494, PubMed=20143388).
CC Misspelling: Occasionally 'ME-WEI'.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1402 ! Mel Ho
SX Female
CA Cancer cell line
//
ID MEL-1
AC CVCL_B863
SY Mel-1; Mel 1; Mel1; SCSe001-A
DR BioSamples; SAMEA7783168
DR hPSCreg; SCSe001-A
DR ISCR; 510
DR Millipore; SCC020
RX PubMed=17572666;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/mel-1.aspx
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=425
CC From: Monash University; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0139.
CC Registration: Swiss research registry; BAG-hES-IMP-0003.
CC Registration: UK Stem Cell Bank (UKSCB); R-08-001, Steering comm. appl. SCSC04-30.
CC Discontinued: Millipore; SCC020; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID MEL-14
AC CVCL_9224
SY MEL-14.D54
DR CLO; CLO_0007671
DR ATCC; HB-132
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Mel-18
AC CVCL_H201
SY Mel18
DR Cosmic; 2144975
RX PubMed=19035443;
RX PubMed=22578220;
CC From: Institute for Advanced Medical Research; Keio University School of Medicine; Tokyo; Japan.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mel-2
AC CVCL_H203
SY Mel2
DR Cosmic; 2144974
RX PubMed=19035443;
RX PubMed=22578220;
CC From: Institute for Advanced Medical Research; Keio University School of Medicine; Tokyo; Japan.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MEL-2
AC CVCL_B864
SY Mel-2; Mel2; MEL2; SCSe002-A
DR hPSCreg; SCSe002-A
DR ISCR; 511
DR Millipore; SCC021
RX PubMed=17572666;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=426
CC From: Monash University; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0140.
CC Registration: Swiss research registry; BAG-hES-IMP-0002.
CC Registration: UK Stem Cell Bank (UKSCB); R-08-004, Steering comm. appl. SCSC06-22.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Mel-2183
AC CVCL_L268
SY Mel 2183; Mel_2183; Mel2183
DR EFO; EFO_0005706
DR ENCODE; ENCBS255AAA
DR GEO; GSM1008599
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/Mel2183_Crawford_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mel-2a
AC CVCL_A759
SY Mel-2A; Mel 2a; Mel 2A; Mel2a; Mel2A
DR Cosmic; 1181747
DR Cosmic; 1221592
RX PubMed=3485457;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MEL-3
AC CVCL_B865
SY Mel-3; SCSe003-A
DR hPSCreg; SCSe003-A
DR ISCR; 2227
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=483
CC From: Monash University; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0141.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-21.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Mel-34
AC CVCL_W284
SY Mel34
DR CGH-DB; 9286-4
DR Cosmic; 905200
RX PubMed=15467732;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEL-4
AC CVCL_B866
SY Mel-4; SCSe004-A
DR hPSCreg; SCSe004-A
DR ISCR; 2228
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=484
CC From: Monash University; Australia.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0142.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-21.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Mel-57
AC CVCL_4454
SY Mel 57; MEL 57; Mel57
DR BTO; BTO:0002804
RX PubMed=1918136;
RX PubMed=2060184;
RX PubMed=3485457;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MEL-745A cl. DR10c3
AC CVCL_W805
SY DR10c3; MELC DR10
DR CLO; CLO_0007673
DR CLDB; cl3444
RX PubMed=177980;
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2111 ! MEL-745A cl. DS19
CA Cancer cell line
//
ID MEL-745A cl. DS19
AC CVCL_2111
SY MEL-DS19; MEL DS19; MELDS19; 745/DS19; MELC DS19; DS19; MEL
DR BTO; BTO:0003902
DR BTO; BTO:0004475
DR CLO; CLO_0002823
DR CLO; CLO_0007674
DR EFO; EFO_0003971
DR CLDB; cl1100
DR CLDB; cl3445
DR DSMZ; ACC-501
DR ENCODE; ENCBS002NUU
DR ENCODE; ENCBS046ENC
DR ENCODE; ENCBS047ENC
DR ENCODE; ENCBS048ENC
DR ENCODE; ENCBS049ENC
DR ENCODE; ENCBS050ENC
DR ENCODE; ENCBS217OGM
DR ENCODE; ENCBS243ENC
DR ENCODE; ENCBS259BOZ
DR ENCODE; ENCBS425KAG
DR ENCODE; ENCBS436ELB
DR ENCODE; ENCBS437PRW
DR ENCODE; ENCBS588DZE
DR ENCODE; ENCBS671NUO
DR ENCODE; ENCBS706GHU
DR ENCODE; ENCBS802BLF
DR ENCODE; ENCBS870FKO
DR ENCODE; ENCBS892CGC
DR GEO; GSM1014191
DR KCB; KCB 200855YJ
RX PubMed=4527790;
CC Part of: ENCODE project mouse cell lines.
CC Doubling time: ~20 hours (DSMZ).
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3988 ! FLC clone 745
CA Cancer cell line
//
ID Mel-Ab
AC CVCL_B425
SY Mel-ab
DR BTO; BTO:0003944
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MEL-AC
AC CVCL_D549
DR ChEMBL-Cells; CHEMBL3308636
DR ChEMBL-Targets; CHEMBL614732
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-AT
AC CVCL_S995
SY Mel AT
DR BTO; BTO:0005712
RX PubMed=10364001;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-BH
AC CVCL_GR36
RX PubMed=7520026;
RX PubMed=8980186;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-BP
AC CVCL_GR37
RX PubMed=7520026;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEL-c88
AC CVCL_C188
SY MEL c88; MEL-C88; MEL C88; C88 MEL; MEL cell line C88
RX PubMed=279411;
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3988 ! FLC clone 745
CA Cancer cell line
//
ID MEL-CLS-1
AC CVCL_5619
SY FO-1; FO #1; FO 1
DR BTO; BTO:0002943
DR CLS; 300175/p647_MEL-CLS-1
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=994214;
RX PubMed=2624919;
RX PubMed=8537970;
RX PubMed=15661905;
CC Doubling time: 38 hours, at 49th passage (PubMed=994214).
CC Derived from metastatic site: Iliac lymph node.
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9,12
ST D18S51: 17
ST D21S11: 27
ST D3S1358: 15,18
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 12,14
ST FGA: 19,23
ST Penta D: 9
ST Penta E: 14,17
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MEL-CLS-2
AC CVCL_6001
DR CLS; 300283/p586_MEL-CLS-2
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,10
ST D16S539: 11
ST D18S51: 12,17
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 9,11
ST D7S820: 7,10
ST D8S1179: 15
ST FGA: 23
ST Penta D: 9,13
ST Penta E: 7,11
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MEL-CLS-3
AC CVCL_6002
SY MRI-H-221
DR CLS; 300293/p646_MEL-CLS-3
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 10,13
ST D18S51: 16,17
ST D21S11: 28,31.2
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 7,10
ST D8S1179: 12,13
ST FGA: 21,25
ST Penta D: 12,13
ST Penta E: 14
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MEL-CLS-4
AC CVCL_6003
DR CLS; 300128/p649_MEL-CLS-4
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 13
ST D18S51: 11,14
ST D21S11: 30
ST D3S1358: 15,18
ST D5S818: 13
ST D7S820: 10,11
ST D8S1179: 13,16
ST FGA: 19,23
ST Penta D: 13
ST Penta E: 7,19
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mel-CV
AC CVCL_S996
SY Mel CV
DR BTO; BTO:0005713
RX PubMed=8980186;
RX PubMed=9725211;
RX PubMed=10364001;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-DA
AC CVCL_GR35
RX PubMed=7520026;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-DH
AC CVCL_GR38
RX PubMed=7520026;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-DO
AC CVCL_C500
DR ESTDAB; ESTDAB-096
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-DP
AC CVCL_GR33
RX PubMed=7520026;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-FC
AC CVCL_GR39
RX PubMed=7520026;
RX PubMed=9725211;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-FH
AC CVCL_D547
SY Mel FH
DR BTO; BTO:0005714
DR Cosmic; 889009
RX PubMed=7520026;
RX PubMed=9725211;
RX PubMed=10364001;
RX PubMed=15048078;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-FHH
AC CVCL_GR44
RX PubMed=8980186;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEL-GATA-1-ER
AC CVCL_Y480
SY mG/ER
DR EFO; EFO_0005480
DR ENCODE; ENCBS212ENC
DR ENCODE; ENCBS533WAU
RX PubMed=14559825;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/mG-ER_Stam_protocol.pdf
CC Part of: ENCODE project mouse cell lines.
CC Transfected with: HGNC; 4170; GATA1.
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: DBA/2.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2111 ! MEL-745A cl. DS19
CA Cancer cell line
//
ID Mel-GL
AC CVCL_S997
SY Mel GL
RX PubMed=10364001;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-JB
AC CVCL_S998
SY Mel JB
RX PubMed=8980186;
RX PubMed=10364001;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-JC
AC CVCL_S999
SY Mel JC
RX PubMed=10364001;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-JD
AC CVCL_BS80
SY MelJD
DR BTO; BTO:0005718
RX PubMed=8980186;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-JF
AC CVCL_T000
SY Mel JF
RX PubMed=7520026;
RX PubMed=8980186;
RX PubMed=10364001;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-JG
AC CVCL_T001
SY Mel JG
RX PubMed=10364001;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-JN
AC CVCL_GR41
RX PubMed=8980186;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-JS
AC CVCL_T002
SY Mel JS
RX PubMed=7520026;
RX PubMed=8980186;
RX PubMed=9725211;
RX PubMed=10364001;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-JW
AC CVCL_GR40
RX PubMed=7520026;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-KN
AC CVCL_T003
SY Mel KN
RX PubMed=10364001;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-LE
AC CVCL_C501
SY EST94
DR Cosmic; 1047658
DR Cosmic; 2163813
DR ESTDAB; ESTDAB-094
DR GEO; GSM156009
RX PubMed=17260012;
CC Omics: Array-based CGH.
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 9,10
ST FGA: 22,25
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mel-LG
AC CVCL_C502
DR Cosmic; 2163868
DR ESTDAB; ESTDAB-098
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,14
ST D3S1358: 14,16
ST D5S818: 12,15
ST D7S820: 10,11
ST FGA: 19,20
ST TH01: 6,8
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel-LT
AC CVCL_T004
SY Mel LT
RX PubMed=10364001;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-MC
AC CVCL_T005
SY Mel MC
RX PubMed=7520026;
RX PubMed=8980186;
RX PubMed=10364001;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-MI
AC CVCL_T006
SY Mel MI
RX PubMed=10364001;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-MM
AC CVCL_T007
SY Mel MM
RX PubMed=10364001;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-MS
AC CVCL_T008
SY Mel MS; MelMS
RX PubMed=10364001;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-NG
AC CVCL_GR42
RX PubMed=8980186;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-NT1-00
AC CVCL_C530
DR Cosmic; 2163825
DR ESTDAB; ESTDAB-115
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 9,13
ST D13S317: 9,12
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 12
ST FGA: 24
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mel-NT2-00
AC CVCL_C531
DR Cosmic; 2163815
DR ESTDAB; ESTDAB-100
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 10,12
ST D3S1358: 14,18
ST D5S818: 11,12
ST D7S820: 10,12
ST FGA: 20,23
ST TH01: 6,7
ST TPOX: 11
ST vWA: 18,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mel-NT3-00
AC CVCL_C532
DR Cosmic; 2163826
DR ESTDAB; ESTDAB-117
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10,12
ST FGA: 21,26
ST TH01: 6
ST TPOX: 11,12
ST vWA: 15,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mel-NT4-00
AC CVCL_C533
DR ESTDAB; ESTDAB-118
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-NT5-00
AC CVCL_C534
DR ESTDAB; ESTDAB-119
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,13
ST D3S1358: 15,16
ST D5S818: 9,12
ST D7S820: 8,12
ST FGA: 21
ST TH01: 9
ST TPOX: 11
ST vWA: 15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel-NT6-00
AC CVCL_C535
DR ESTDAB; ESTDAB-123
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-NT8-00
AC CVCL_C536
DR ESTDAB; ESTDAB-126
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-NT9-00
AC CVCL_C537
DR Cosmic; 2163828
DR ESTDAB; ESTDAB-125
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,11
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 8,11
ST FGA: 22
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MEL-RC08
AC CVCL_A012
DR Cosmic; 1667648
RX PubMed=22529031;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel-RM
AC CVCL_D548
SY Mel RM
DR BTO; BTO:0005715
DR Cosmic; 889010
RX PubMed=7520026;
RX PubMed=8980186;
RX PubMed=9725211;
RX PubMed=10364001;
RX PubMed=15048078;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-RMu
AC CVCL_S994
SY Mel-RMU; Mel RMu; MelRMu
DR BTO; BTO:0005719
DR Cosmic; 889011
DR Cosmic; 1941942
RX PubMed=10364001;
RX PubMed=15048078;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-RMu/DR2
AC CVCL_T017
SY MelRMu DR2; Mel-RMU-DR2
DR Cosmic; 1941943
RX PubMed=22437314;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S994 ! Mel-RMu
CA Cancer cell line
//
ID Mel-RMu/DR4
AC CVCL_T018
SY MelRMu DR4; Mel-RMU-DR4
DR Cosmic; 1941944
RX PubMed=22437314;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S994 ! Mel-RMu
CA Cancer cell line
//
ID Mel-RMu/DR6
AC CVCL_T019
SY MelRMu DR6; Mel-RMU-DR6
DR Cosmic; 1941945
RX PubMed=22437314;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S994 ! Mel-RMu
CA Cancer cell line
//
ID Mel-RMu/DR8
AC CVCL_T020
SY MelRMu DR8; Mel-RMU-DR8
DR Cosmic; 1941946
RX PubMed=22437314;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S994 ! Mel-RMu
CA Cancer cell line
//
ID Mel-RMu/DR9
AC CVCL_T021
SY MelRMu DR9; Mel-RMU-DR9
DR Cosmic; 1941947
RX PubMed=22437314;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S994 ! Mel-RMu
CA Cancer cell line
//
ID Mel-SOE
AC CVCL_C503
SY EST97
DR Cosmic; 1047659
DR Cosmic; 2163867
DR ESTDAB; ESTDAB-097
DR GEO; GSM156006
RX PubMed=17260012;
CC Omics: Array-based CGH.
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 7,12
ST FGA: 19,25
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel-SP
AC CVCL_T009
SY Mel SP
RX PubMed=10364001;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEL-STM
AC CVCL_9U70
RX PubMed=16142232;
CC Transfected with: HGNC; 7029; MET (activated TPR-MET).
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C854 ! MEL-STR
OI CVCL_9U71 ! MEL-STV
SX Male
CA Transformed cell line
//
ID MEL-STR
AC CVCL_C854
DR Cosmic; 1458969
RX PubMed=16142232;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9U70 ! MEL-STM
OI CVCL_9U71 ! MEL-STV
SX Male
CA Transformed cell line
//
ID MEL-STV
AC CVCL_9U71
DR Cosmic; 1458968
RX PubMed=16142232;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9U70 ! MEL-STM
OI CVCL_C854 ! MEL-STR
SX Male
CA Transformed cell line
//
ID Mel-Swift
AC CVCL_A650
SY Mel-SWIFT; Mel Swift; MEL-SWIFT
DR Cosmic; 692343
DR Cosmic; 702099
DR Cosmic; 706087
DR Cosmic; 888831
RX PubMed=10766161;
RX PubMed=15009714;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEL-TF19
AC CVCL_B268
RX PubMed=15250154;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Mel-WB
AC CVCL_T010
SY Mel WB
RX PubMed=7520026;
RX PubMed=9725211;
RX PubMed=10364001;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-WD
AC CVCL_GR45
RX PubMed=8980186;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-WL
AC CVCL_C504
DR Cosmic; 2163814
DR ESTDAB; ESTDAB-095
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,13
ST D3S1358: 14,15
ST D5S818: 10,13
ST D7S820: 9
ST FGA: 21,24
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel-WN
AC CVCL_GR34
RX PubMed=7520026;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEL1
AC CVCL_DG36
DR GEO; GSM202114
DR IGRhCellID; MEL1%20GEO
DI NCIt; C114828; Mucosal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel120
AC CVCL_D648
SY Mel 120
DR BTO; BTO:0005174
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel1617
AC CVCL_DG51
SY MEL1617
DR GEO; GSM1199180
RX PubMed=24055054;
CC Omics: Array-based CGH.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel1617-BR
AC CVCL_DG52
SY Mel1617BR; Mel1617-R
RX PubMed=21156289;
CC Selected for resistance to: ChEBI; CHEBI:131882; SB-590885.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DG51 ! Mel1617
CA Cancer cell line
//
ID Mel1617-MR
AC CVCL_DG53
DR GEO; GSM1199181
RX PubMed=24055054;
CC Selected for resistance to: ChEBI; CHEBI:75998; Trametinib (Mekinist; GSK1120212).
CC Omics: Array-based CGH.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DG51 ! Mel1617
CA Cancer cell line
//
ID MEL2-mCherry
AC CVCL_IR29
RX PubMed=22993664;
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B864 ! MEL-2
SX Female
CA Embryonic stem cell
//
ID Mel20-06-039
AC CVCL_8473
SY MEL20-06-039
DR Cosmic; 1665023
RX PubMed=21386926;
CC Omics: Transcriptome analysis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel20-06-045
AC CVCL_8474
SY MEL20-06-045
DR Cosmic; 1665024
RX PubMed=21386926;
CC Omics: Transcriptome analysis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel20-07-070
AC CVCL_8475
SY MEL20-07-070
DR Cosmic; 1665025
RX PubMed=21386926;
CC Omics: Transcriptome analysis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel20-08-128
AC CVCL_D714
DR Cosmic; 1665026
RX PubMed=22515704;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel20-09-196
AC CVCL_D715
DR Cosmic; 1665027
RX PubMed=22515704;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel202
AC CVCL_C301
SY MEL202; Mel-202; Mel 202; mel-202; EST128
DR Cosmic; 848329
DR Cosmic; 899894
DR Cosmic; 916143
DR Cosmic; 1047643
DR Cosmic; 1320372
DR Cosmic; 1628395
DR Cosmic; 2036706
DR Cosmic; 2163830
DR ECACC; 13012457
DR ESTDAB; ESTDAB-128
DR GEO; GSM156005
RX PubMed=1748551;
RX PubMed=17260012;
RX PubMed=22236444;
RX PubMed=24994677;
WW https://www.kerafast.com/product/2230/uveal-melanoma-cell-line-mel202
CC Doubling time: 43 hours (PubMed=24994677).
CC Omics: Array-based CGH.
ST Source(s): ECACC; ESTDAB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 11,12
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 11,12
ST FGA: 23,24
ST TH01: 6 (ECACC)
ST TH01: 6,7 (ESTDAB)
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel249
AC CVCL_3974
SY MEL249
DR BTO; BTO:0002952
RX PubMed=16740750;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel270
AC CVCL_C302
SY MEL270; Mel-270; Mel 270
DR Cosmic; 848330
DR Cosmic; 899898
DR Cosmic; 916144
DR Cosmic; 986621
DR Cosmic; 1628396
DR Cosmic; 1669124
DR Cosmic; 2036707
RX PubMed=9247253;
RX PubMed=16772116;
RX PubMed=22236444;
CC From: Ksander B.; Schepens Eye Research Institute; Boston; USA.
CC Misspelling: 'Mel207' in Cosmic 848330.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C305 ! OMM2.2
OI CVCL_C306 ! OMM2.3
OI CVCL_C307 ! OMM2.5
OI CVCL_C308 ! OMM2.6
SX Male
CA Cancer cell line
//
ID Mel285
AC CVCL_C303
SY MEL285; Mel-285; Mel 285
DR Cosmic; 916140
DR Cosmic; 1628405
DR Cosmic; 2036708
RX PubMed=16772116;
RX PubMed=22236444;
CC From: Ksander B.; Schepens Eye Research Institute; Boston; USA.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel290
AC CVCL_C304
SY MEL290; Mel-290; Mel 290; MEL 290
DR CLDB; cl7222
DR Cosmic; 916141
DR Cosmic; 1628406
DR Cosmic; 1669125
DR ICLC; HTL12001
RX PubMed=16772116;
RX PubMed=22236444;
CC From: Ksander B.; Schepens Eye Research Institute; Boston; USA.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel499
AC CVCL_3975
DR BTO; BTO:0002953
RX PubMed=16740750;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mel501A
AC CVCL_0V14
SY MEL501A; 501A; 501 A
DR EFO; EFO_0006356
DR BioSample; SAMN03473285
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Not specified.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,13
ST D16S539: 14
ST D18S51: 16
ST D21S11: 29
ST D3S1358: 14,16
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 12
ST FGA: 24
ST Penta D: 9
ST Penta E: 7,13
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8054 ! 624-mel
SX Male
CA Cancer cell line
//
ID Mel505
AC CVCL_3976
DR BTO; BTO:0002954
RX PubMed=16740750;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mel592
AC CVCL_3977
DR BTO; BTO:0002955
RX PubMed=16740750;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Melan-a
AC CVCL_4624
SY melan-a
DR BTO; BTO:0003216
DR Lonza; 161
RX PubMed=3102392;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID Melan-a Hm
AC CVCL_W079
SY melan-a Hm
DR BTO; BTO:0005424
RX PubMed=11734563;
CC Characteristics: Transfected with a chimeric tyrosine-protein kinase receptor composed of extracellular part of human EGFR and the intracellular part of Xmrk. Stimulation of the chimera with EGF induces activation of the xmrk kinase domain.
CC Transfected with: HGNC; 3236; EGFR (extracellular domain).
CC Transfected with: UniProtKB; P13388; Xiphophorus maculatus xmrk (intracellular domain).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4624 ! Melan-a
CA Spontaneously immortalized cell line
//
ID Melan-a2
AC CVCL_C692
SY melan-a2; melan a2
RX PubMed=7540532;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C693 ! Melb-a
CA Spontaneously immortalized cell line
//
ID Melb-a
AC CVCL_C693
SY melb-a
RX PubMed=7540532;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MELBA
AC CVCL_6G44
RX PubMed=3761468;
CC Derived from metastatic site: Urinary bladder.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Melligen
AC CVCL_HA63
RX Patent=US9365829;
RX PubMed=26029722;
WW http://www.diabetes.co.uk/forum/threads/potential-type-1-diabetes-treatment-receives-us-patent-approval.102547/
CC Characteristics: Produces insulin in response to extracellular glucose levels that are equivalent to physiological glucose levels.
CC Characteristics: When transplanted into diabetic immunoincompetent mice, Melligen cells restore normoglycemia.
CC Transfected with: HGNC; 4195; GCK.
CC Transfected with: HGNC; 6081; INS.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_HA62 ! HUH7-ins
SX Male
CA Cancer cell line
//
ID MEMO
AC CVCL_L300
RX PubMed=23249835;
DI NCIt; C5915; Oral cavity mucosal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MeMo 05
AC CVCL_F330
SY MEMO
DR CLDB; cl7211
DR ICLC; HTL07002
RX PubMed=23634660;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MEMOR 06
AC CVCL_F331
DR CLDB; cl7212
DR ICLC; HTL07004
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID mEMS88
AC CVCL_0J51
SY SXRA-ES
RX PubMed=12112873;
WW http://www.flintbox.com/public/project/512/
CC Breed/subspecies: C57BL/6J-Sxra x 129P3/JEms.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MEN1RGB
AC CVCL_H212
DR CLO; CLO_0051606
DR BioSample; SAMN03472306
DR RCB; RCB0410
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 10
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 9
ST TPOX: 8
ST vWA: 14,15
DI NCIt; C6432; Multiple endocrine neoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID MEN2RGB
AC CVCL_H213
DR CLO; CLO_0051607
DR BioSample; SAMN03472307
DR RCB; RCB0421
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8,9
ST D16S539: 9,10
ST D5S818: 9,12
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 9
ST vWA: 19,20
DI NCIt; C6432; Multiple endocrine neoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID MENII-1
AC CVCL_M431
SY SF6717
RX PubMed=18953429;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID MEQC1
AC CVCL_J504
SY MEQC 1; Myc Embryonic Quail Cardiomyocytes-1
RX PubMed=1846337;
CC Group: Bird cell line.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Cancer cell line
//
ID MEQC2
AC CVCL_J505
SY MEQC 2; Myc Embryonic Quail Cardiomyocytes-2
RX PubMed=1846337;
CC Group: Bird cell line.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Cancer cell line
//
ID MER,P
AC CVCL_E774
SY MER, P
DR dbMHC; 48969
DR ECACC; 94082226
DR IHW; IHW9127
DR IMGT/HLA; 11670
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl127.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Mero-14
AC CVCL_2590
DR ECACC; 09100101
RX PubMed=2474517;
RX PubMed=2790740;
CC Doubling time: ~24 hours (ECACC).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 9
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 9,11
ST vWA: 15,18
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mero-25
AC CVCL_2591
DR ECACC; 09100102
RX PubMed=2474517;
RX PubMed=2790740;
CC Doubling time: ~48 hours (ECACC; PubMed=2474517).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 9
ST TH01: 8
ST TPOX: 9
ST vWA: 16,17
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mero-41
AC CVCL_2592
DR ECACC; 09100103
RX PubMed=2474517;
RX PubMed=2790740;
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 12
ST D5S818: 13
ST D7S820: 9
ST TH01: 6,8
ST TPOX: 8
ST vWA: 17
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mero-48a
AC CVCL_2593
DR ECACC; 09100104
RX PubMed=2474517;
CC Doubling time: ~24 hours (ECACC).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W102 ! Mero-48b
OI CVCL_W103 ! Mero-48c
OI CVCL_W104 ! Mero-48d
SX Male
CA Cancer cell line
//
ID Mero-48b
AC CVCL_W102
RX PubMed=2474517;
CC Derived from metastatic site: Visceral (omental).
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2593 ! Mero-48a
OI CVCL_W103 ! Mero-48c
OI CVCL_W104 ! Mero-48d
SX Male
CA Cancer cell line
//
ID Mero-48c
AC CVCL_W103
RX PubMed=2474517;
CC Derived from metastatic site: Liver.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2593 ! Mero-48a
OI CVCL_W102 ! Mero-48b
OI CVCL_W104 ! Mero-48d
SX Male
CA Cancer cell line
//
ID Mero-48d
AC CVCL_W104
RX PubMed=2474517;
CC Derived from metastatic site: Pericardium.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2593 ! Mero-48a
OI CVCL_W102 ! Mero-48b
OI CVCL_W103 ! Mero-48c
SX Male
CA Cancer cell line
//
ID Mero-72
AC CVCL_W105
RX PubMed=2474517;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mero-82
AC CVCL_2594
DR ECACC; 09100105
RX PubMed=2474517;
CC Doubling time: ~24 hours (ECACC; PubMed=2474517).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mero-83
AC CVCL_2595
DR ECACC; 09100106
RX PubMed=2474517;
CC Doubling time: ~40 hours (ECACC).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 9
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mero-84
AC CVCL_2596
DR ECACC; 09100107
RX PubMed=2474517;
CC Doubling time: ~48 hours (ECACC).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 9
ST D5S818: 11
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 14,17
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mero-91
AC CVCL_W106
RX PubMed=2474517;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mero-95
AC CVCL_2597
DR ECACC; 09100108
RX PubMed=2474517;
CC Doubling time: ~30 hours (ECACC).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 11,14
ST D7S820: 7,9
ST TH01: 6
ST TPOX: 8,12
ST vWA: 18,19
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mero-96
AC CVCL_W107
RX PubMed=2474517;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-1
AC CVCL_H665
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-10
AC CVCL_H657
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-11
AC CVCL_H661
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-15
AC CVCL_H662
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-17
AC CVCL_H647
SY Meso 17; Meso-17; Meso17
DR Lonza; 325
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-19
AC CVCL_H656
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-2
AC CVCL_H666
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-20
AC CVCL_H663
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-29
AC CVCL_H651
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-30
AC CVCL_H650
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-35
AC CVCL_H648
SY Meso 35; Meso-35
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-36
AC CVCL_H652
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-37
AC CVCL_H649
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-45
AC CVCL_H653
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-49
AC CVCL_H654
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-5
AC CVCL_H667
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-50
AC CVCL_H655
SY 6-53
RX PubMed=7479897;
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-54
AC CVCL_H664
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-7
AC CVCL_H660
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-8
AC CVCL_H659
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mes-9
AC CVCL_H658
SY 1-53
RX PubMed=7479897;
RX PubMed=10451704;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MES-OV
AC CVCL_CZ92
SY MESOV
DR ATCC; CRL-3272
DR GEO; GSM95445
RX PubMed=12960427;
RX PubMed=16382445;
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 13
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MES-OV/T40
AC CVCL_CZ97
SY MESOV T40; MESOVT40
DR GEO; GSM95447
RX PubMed=16382445;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_CZ92 ! MES-OV
SX Female
CA Cancer cell line
//
ID MES-OV/TxT50
AC CVCL_CZ96
SY MESOV TxT50; MESOVTxT50
DR GEO; GSM95468
RX PubMed=16382445;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_CZ92 ! MES-OV
SX Female
CA Cancer cell line
//
ID MES-SA
AC CVCL_1404
SY MESSA
DR CLO; CLO_0007677
DR EFO; EFO_0002233
DR CLDB; cl3447
DR CLDB; cl3448
DR ATCC; CRL-1976
DR BCRC; 60333
DR BioSample; SAMN03470984
DR CCLE; MESSA_SOFT_TISSUE
DR ChEMBL-Cells; CHEMBL3307599
DR ChEMBL-Targets; CHEMBL614343
DR Cosmic; 687553
DR Cosmic; 848889
DR Cosmic; 908127
DR Cosmic; 2008739
DR Cosmic-CLP; 908127
DR ECACC; 95051030
DR GDSC; 908127
DR GEO; GSM827389
DR GEO; GSM1670096
DR GEO; GSM1676304
DR GEO; GSM1701639
DR ICLC; HTL96008
DR IGRhCellID; MESSA
RX PubMed=6883344;
RX PubMed=22889595;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-490.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 22-24 hours (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 12,15
ST D19S433: 14.2,15
ST D21S11: 29,30.2
ST D2S1338: 17
ST D3S1358: 14,17
ST D5S818: 13
ST D7S820: 7,11
ST D8S1179: 14,15
ST FGA: 20,25
ST Penta D: 13,15
ST Penta E: 7,10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C6339; Uterine corpus sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MES-SA/Dx1
AC CVCL_4T93
SY Mes-SA Dx1; MESSA-DX1; Dx1
RX PubMed=4028002;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C6339; Uterine corpus sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1404 ! MES-SA
SX Female
CA Cancer cell line
//
ID MES-SA/Dx5
AC CVCL_2598
SY MES-SA/Dx-5; MES-SA-Dx5; MES-SA Dx5; MESSA/Dx5; MESSA-DX5; MESSA Dx5; MESSADX5; Dx5
DR CLO; CLO_0007678
DR CLDB; cl3449
DR ATCC; CRL-1977
DR BCRC; 60331
DR BioSample; SAMN03470985
DR BioSample; SAMN03471267
DR ChEMBL-Cells; CHEMBL3308373
DR ChEMBL-Targets; CHEMBL613827
DR ECACC; 95051031
DR GEO; GSM827348
DR GEO; GSM1676305
DR GEO; GSM1701640
DR IGRhCellID; MESSADX5
RX PubMed=4028002;
RX PubMed=22889595;
RX PubMed=26351324;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 30 hours (ECACC).
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Misspelling: 'MES-SA/DxS' in ChEMBL CHEMBL613827 and CHEMBL3308373.
CC Discontinued: ATCC; CRL-1977; probable.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 11,12
ST D18S51: 15
ST D19S433: 14.2,15
ST D21S11: 29,30.2
ST D2S1338: 17
ST D3S1358: 14,17
ST D5S818: 13
ST D7S820: 7,11 (ATCC)
ST D7S820: 11 (PubMed=25877200)
ST D8S1179: 14,15
ST FGA: 20,25
ST Penta D: 13,15
ST Penta E: 7,10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C6339; Uterine corpus sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1404 ! MES-SA
SX Female
CA Cancer cell line
//
ID MES-SA/DxP5002
AC CVCL_4T94
SY DxP
RX PubMed=9038218;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C6339; Uterine corpus sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2598 ! MES-SA/Dx5
SX Female
CA Cancer cell line
//
ID MES-SA/MX2
AC CVCL_2599
SY MES-SA/Mx2; MESSA/MX2
DR CLO; CLO_0007679
DR ATCC; CRL-2274
DR BioSample; SAMN03471858
DR IGRhCellID; MESSAMX2
CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 11,12
ST D5S818: 13
ST D7S820: 7,11
ST TH01: 6
ST TPOX: 8,12
ST vWA: 18
DI NCIt; C6339; Uterine corpus sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1404 ! MES-SA
SX Female
CA Cancer cell line
//
ID MES1
AC CVCL_Z508
SY Mes1; Medaka ES-like line 1
RX PubMed=9025059;
RX PubMed=9520425;
CC Group: Fish cell line.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Embryonic stem cell
//
ID MES23.5
AC CVCL_J351
SY MES-23.5; MES 23.5
DR BTO; BTO:0004476
RX PubMed=1356145;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID MESC 16
AC CVCL_M012
DR ECACC; 11120811
RX PubMed=1483967;
CC Breed/subspecies: 129/Olac.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID MESC 17
AC CVCL_M013
DR ECACC; 11120817
RX PubMed=1483967;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID MESC 18
AC CVCL_M014
DR ECACC; 11120816
RX PubMed=1483967;
CC Breed/subspecies: 129/Olac.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MESC 19
AC CVCL_M015
DR ECACC; 11120813
RX PubMed=1483967;
CC Breed/subspecies: 129/Olac.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MESC 20
AC CVCL_M016
DR ECACC; 11120814
RX PubMed=1483967;
CC Breed/subspecies: 129/Olac.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MESC 21
AC CVCL_M017
DR ECACC; 11120815
RX PubMed=1483967;
CC Breed/subspecies: 129/Olac.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID MESC 23
AC CVCL_M018
DR ECACC; 11120818
CC Breed/subspecies: 129/Olac.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID MESC2.10
AC CVCL_B061
RX PubMed=12145295;
RX PubMed=17222562;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Conditionally immortalized cell line
//
ID Meso-10
AC CVCL_H668
SY Meso 10; Meso10; MESO10
DR Cosmic; 1522770
DR Cosmic; 1541216
DR GEO; GSM726275
RX PubMed=16475242;
RX PubMed=21642991;
RX PubMed=21774103;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso-9
AC CVCL_H669
SY Meso9; Meso09; MESO09
DR Cosmic; 1522775
DR Cosmic; 1541214
DR GEO; GSM726274
RX PubMed=16475242;
RX PubMed=21642991;
RX PubMed=21774103;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso11
AC CVCL_H670
SY Meso 11
RX PubMed=15070823;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso122
AC CVCL_H671
RX PubMed=21540305;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso13
AC CVCL_H672
RX PubMed=15070823;
RX PubMed=21540305;
RX PubMed=22144115;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso144
AC CVCL_H673
SY Meso 144
RX PubMed=21540305;
RX PubMed=22144115;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso148
AC CVCL_H674
RX PubMed=21540305;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso34
AC CVCL_H675
SY Meso 34
DR Cosmic; 1541207
RX PubMed=21540305;
RX PubMed=21774103;
RX PubMed=22144115;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso35
AC CVCL_H676
SY Meso 35
RX PubMed=21540305;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso37
AC CVCL_H677
SY MESO37; Meso 37
DR Cosmic; 1522761
DR Cosmic; 1541204
DR GEO; GSM726276
RX PubMed=21642991;
RX PubMed=21774103;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso4
AC CVCL_H678
RX PubMed=21540305;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso45
AC CVCL_H679
RX PubMed=21540305;
RX PubMed=22144115;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso47
AC CVCL_H680
SY Meso 47
RX PubMed=21540305;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso56
AC CVCL_H681
SY MESO56; Meso 56
DR Cosmic; 1522782
DR Cosmic; 1541206
DR GEO; GSM726277
RX PubMed=21540305;
RX PubMed=21642991;
RX PubMed=21774103;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso62
AC CVCL_H682
RX PubMed=21540305;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Meso96
AC CVCL_H683
RX PubMed=21540305;
RX PubMed=22144115;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MESV
AC CVCL_D804
SY Middle Ear cells derived by SV40 infection
RX PubMed=8382213;
RX PubMed=12382283;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10047; ! Meriones unguiculatus
CA Transformed cell line
//
ID Met-1(fvb2)
AC CVCL_U373
SY Met-1fvb2
DR Lonza; 1227
RX PubMed=16132578;
CC Breed/subspecies: FVB/N-Tg(MMTV-PyVmT).
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MeT-4A
AC CVCL_H531
SY MeT 4A; Met4A; Mesothelial cells transfected with pRSV-T 4A
RX PubMed=9175740;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID MeT-5A
AC CVCL_3749
SY MeT 5A; MeT5A; Met5A; MET5A; Mesothelial cells transfected with pRSV-T 5A
DR CLO; CLO_0007680
DR EFO; EFO_0001218
DR ATCC; CRL-9444
DR BCRC; 60352
DR BioSample; SAMN03471216
DR IZSLER; BS CL 214
RX Patent=US4885238;
RX PubMed=2541616;
RX PubMed=9533946;
RX PubMed=15920167;
RX PubMed=22576795;
RX PubMed=24926545;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Meta 1
AC CVCL_4559
SY Meta-1; META-1
DR CLO; CLO_0007684
DR CLDB; cl3451
RX PubMed=3455746;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F736 ! TS/A
SX Female
CA Cancer cell line
//
ID Meta 10
AC CVCL_3851
SY Meta-10; META-10
DR CLO; CLO_0007681
DR CLO; CLO_0007685
DR CLDB; cl3452
DR CLDB; cl3453
DR ECACC; 90062271
RX PubMed=3455746;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3853 ! Meta 7
SX Female
CA Cancer cell line
//
ID Meta 15
AC CVCL_3852
SY Meta-15; META-15
DR CLO; CLO_0007682
DR CLDB; cl3450
DR ECACC; 90062270
RX PubMed=3455746;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3851 ! Meta 10
SX Female
CA Cancer cell line
//
ID Meta 7
AC CVCL_3853
SY Meta-7; META-7
DR CLO; CLO_0007683
DR CLO; CLO_0007686
DR CLDB; cl3454
DR CLDB; cl3455
DR ECACC; 90062272
RX PubMed=3455746;
CC Breed/subspecies: BALB/cAnNCrlBR.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4559 ! Meta 1
SX Female
CA Cancer cell line
//
ID Meth A Sarcoma
AC CVCL_5798
SY Meth A; Meth-A; Meth-A-sarkom
DR CLS; 400284/p12831_Meth_A_sarcoma
DR TKG; TKG 0158
RX PubMed=2529426;
RX PubMed=11529879;
RX PubMed=12680876;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID METON
AC CVCL_T055
RX PubMed=23761224;
DI NCIt; C5978; Benign salivary gland myoepithelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MeWo
AC CVCL_0445
SY MEWO; Mewo; Me Wo; Me-Wo; Mevo; SK-MEL-MeWo; BI-Mel; EST50
DR BTO; BTO:0003301
DR CLO; CLO_0007687
DR CLO; CLO_0007688
DR EFO; EFO_0006648
DR MCCL; MCC:0000341
DR CLDB; cl3456
DR CLDB; cl3458
DR ATCC; HTB-65
DR BCRC; 60540
DR BCRJ; 0358
DR BioSample; SAMN01821578
DR BioSample; SAMN01821699
DR BioSample; SAMN03470821
DR CCLE; MEWO_SKIN
DR ChEMBL-Cells; CHEMBL3308024
DR ChEMBL-Targets; CHEMBL613300
DR CLS; 300285/p1765_MEWO
DR Cosmic; 721835
DR Cosmic; 886829
DR Cosmic; 908128
DR Cosmic; 928689
DR Cosmic; 932713
DR Cosmic; 933141
DR Cosmic; 972284
DR Cosmic; 1047647
DR Cosmic; 1060422
DR Cosmic; 1132584
DR Cosmic; 1238113
DR Cosmic; 1303046
DR Cosmic; 1995506
DR Cosmic; 2036702
DR Cosmic; 2159442
DR Cosmic; 2163794
DR Cosmic-CLP; 908128
DR ECACC; 93082609
DR ESTDAB; ESTDAB-050
DR GDSC; 908128
DR GEO; GSM156016
DR GEO; GSM188224
DR GEO; GSM188254
DR GEO; GSM188313
DR GEO; GSM206525
DR GEO; GSM827470
DR GEO; GSM887310
DR GEO; GSM888386
DR GEO; GSM1670097
DR ICLC; HTL97019
DR JCRB; JCRB0066
DR Lonza; 437
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1383272;
RX PubMed=2068080;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=7908310;
RX PubMed=9290701;
RX PubMed=17260012;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-532.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; CLS; Cosmic-CLP; ESTDAB; JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12 (ATCC; CLS; Cosmic-CLP; JCRB; PubMed=25877200)
ST CSF1PO: 10,12 (ESTDAB)
ST D13S317: 8 (Cosmic-CLP; ESTDAB)
ST D13S317: 8,9 (ATCC; CLS; JCRB; PubMed=25877200)
ST D16S539: 10,12
ST D18S51: 14,17
ST D21S11: 30,32.2
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 10
ST Penta E: 5 (CLS)
ST Penta E: 5,15 (PubMed=25877200)
ST TH01: 7,9
ST TPOX: 8,10 (ATCC; CLS; Cosmic-CLP; JCRB; PubMed=25877200)
ST TPOX: 9,11 (ESTDAB)
ST vWA: 15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MeWo CIS 0.01
AC CVCL_AZ60
SY MeWo-cisplatin 0.01
RX PubMed=11001322;
RX PubMed=11058868;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Proteome analysis by 2D-DE.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MeWo CIS 1
AC CVCL_AZ74
SY MeWo CIS 1.0; MeWo CIS; MeWo-cisplatin 1
RX PubMed=11001322;
RX PubMed=11058868;
RX PubMed=21475863;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Proteome analysis by 2D-DE.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MeWo ETO 0.1
AC CVCL_AZ61
SY MeWo-etoposide 0.1
RX PubMed=11001322;
RX PubMed=11058868;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC Omics: Proteome analysis by 2D-DE.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MeWo ETO 1
AC CVCL_AZ62
SY MeWo ETO 1.0; MeWo ETO; MeWo-etoposide 1
RX PubMed=11001322;
RX PubMed=11058868;
RX PubMed=21475863;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC Omics: Proteome analysis by 2D-DE.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MeWo FOTE 4
AC CVCL_AZ75
SY MeWo FOTE 4.0; MeWo-fotemustine 4
RX PubMed=11058868;
RX PubMed=21475863;
CC Selected for resistance to: ChEBI; CHEBI:131848; Fotemustine.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MeWo FOTE 40
AC CVCL_AZ76
SY MeWo FOTE; MeWo-fotemustine 40
RX PubMed=11001322;
RX PubMed=11058868;
RX PubMed=21475863;
CC Selected for resistance to: ChEBI; CHEBI:131848; Fotemustine.
CC Omics: Proteome analysis by 2D-DE.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MeWo LNI 6I
AC CVCL_Y663
RX PubMed=1383272;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MeWo VIN 0.5
AC CVCL_AZ63
SY MeWo-vindesine 0.5
RX PubMed=11001322;
RX PubMed=11058868;
CC Selected for resistance to: ChEBI; CHEBI:36373; Vindesine.
CC Omics: Proteome analysis by 2D-DE.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MeWo VIN 5
AC CVCL_AZ77
SY MeWo VIN 5.0; MeWo VIN; MeWo-vindesine 5
RX PubMed=11001322;
RX PubMed=11058868;
RX PubMed=21475863;
CC Selected for resistance to: ChEBI; CHEBI:36373; Vindesine.
CC Omics: Proteome analysis by 2D-DE.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MeWo-LC1
AC CVCL_U937
RX PubMed=3000950;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID Mewo-Luc
AC CVCL_J260
DR JCRB; JCRB1396
DR JCRB; NIHS0643
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0643; true.
CC Derived from metastatic site: Lymph node.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 10,12
ST D5S818: 12,13
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,10
ST vWA: 15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0445 ! MeWo
SX Male
CA Cancer cell line
//
ID MEXF 276L
AC CVCL_D132
SY MEXF276L; MEXF 276
DR ChEMBL-Cells; CHEMBL3307542
DR ChEMBL-Targets; CHEMBL614130
DR Cosmic; 907392
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEXF 462NL
AC CVCL_D128
SY MEXF462NL; MEXF 462; MEXF462
DR Cosmic; 907393
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MEXF 514L
AC CVCL_D129
SY MEXF514L; MEXF 514; MEXF514
DR ChEMBL-Cells; CHEMBL3307728
DR ChEMBL-Targets; CHEMBL614873
DR Cosmic; 907394
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MF
AC CVCL_Y126
DR ATCC; CRL-1375
CC Discontinued: ATCC; CRL-1375; true.
DI NCIt; C85036; Pseudoxanthoma elasticum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID MF 116
AC CVCL_J762
SY MF116
DR CLO; CLO_0007689
DR ATCC; HB-8411
RX Patent=US4666845;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MF 61
AC CVCL_J843
SY MF61
DR ATCC; HB-8410
RX Patent=US4666845;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MF-1
AC CVCL_0C47
RX PubMed=18594539;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C42 ! BLC-1
OI CVCL_0C52 ! HCC-1.1
OI CVCL_0C53 ! HCC-1.2
SX Male
CA Cancer cell line
//
ID MF-2
AC CVCL_0C48
RX PubMed=18594539;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C43 ! BLC-2
OI CVCL_0C54 ! HCC-2
SX Male
CA Cancer cell line
//
ID MF-3
AC CVCL_0C49
RX PubMed=18594539;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C55 ! HCC-3
SX Male
CA Cancer cell line
//
ID MF-5
AC CVCL_0C50
RX PubMed=18594539;
CC Derived from metastatic site: Subcutis.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MF-6
AC CVCL_0C51
RX PubMed=18594539;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C45 ! BLC-6
SX Female
CA Cancer cell line
//
ID MF1-PI 30
AC CVCL_9W14
DR NCBI_Iran; C440
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MF14
AC CVCL_DI53
SY UCLA-SO-MF14
RX PubMed=954005;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1395 ! M14
OI CVCL_DI50 ! ML14
SX Male
CA Finite cell line
//
ID MF20
AC CVCL_DI54
SY UCLA-SO-MF20
RX PubMed=954005;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DI51 ! M20 [Human melanoma]
CA Finite cell line
//
ID Mf4/4
AC CVCL_U655
SY MF4/4
RX PubMed=9605128;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-535.html
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID MFA00335IN
AC CVCL_E166
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Transformed cell line
//
ID MFA00336IN
AC CVCL_E167
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Transformed cell line
//
ID MFA00337IN
AC CVCL_E168
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Transformed cell line
//
ID MFA00338IN
AC CVCL_E169
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Transformed cell line
//
ID MFA00340IN
AC CVCL_E170
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Transformed cell line
//
ID MFA00341IN
AC CVCL_E171
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Female
CA Transformed cell line
//
ID MFA00342IN
AC CVCL_E172
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Female
CA Transformed cell line
//
ID MFB-F11
AC CVCL_5333
RX PubMed=16549026;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MFB-F11
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MFBY2
AC CVCL_M082
DR BTO; BTO:0003526
RX PubMed=14623275;
RX PubMed=17760834;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID MFC
AC CVCL_5J48
SY Mouse Forestomach Carcinoma
DR CCRID; 3111C0001CCC000143
DR CCRID; 3131C0001000800023
DR KCB; KCB 92020YJ
RX PubMed=3678016;
DI NCIt; C24225; Mouse gastric carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MFC-GFP
AC CVCL_BT06
DR CCRID; 3111C0001CCC000226
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C24225; Mouse gastric carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5J48 ! MFC
CA Cancer cell line
//
ID MFE-280
AC CVCL_1405
SY MFE 280; MFE280
DR CLO; CLO_0007692
DR CLDB; cl5080
DR BioSample; SAMN03473586
DR CCLE; MFE280_ENDOMETRIUM
DR ChEMBL-Cells; CHEMBL3308455
DR ChEMBL-Targets; CHEMBL1075502
DR Cosmic; 908129
DR Cosmic; 1434185
DR Cosmic; 1576462
DR Cosmic; 2030478
DR Cosmic-CLP; 908129
DR DSMZ; ACC-410
DR ECACC; 98050131
DR GDSC; 908129
DR GEO; GSM374974
DR GEO; GSM375433
DR GEO; GSM844603
DR GEO; GSM887311
DR GEO; GSM888387
DR GEO; GSM1670098
RX PubMed=9615781;
RX PubMed=9620227;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~60-90 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 7
ST TPOX: 9,10
ST vWA: 17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MFE-294
AC CVCL_DI49
RX PubMed=9620227;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MFE-296
AC CVCL_1406
SY MFE 296; MFE296
DR CLO; CLO_0007693
DR CLDB; cl5081
DR BioSample; SAMN03473590
DR CCLE; MFE296_ENDOMETRIUM
DR ChEMBL-Cells; CHEMBL3308374
DR ChEMBL-Targets; CHEMBL1075503
DR Cosmic; 908130
DR Cosmic; 1105621
DR Cosmic; 1177684
DR Cosmic; 1434195
DR Cosmic; 1576463
DR Cosmic; 2030479
DR Cosmic-CLP; 908130
DR DSMZ; ACC-419
DR ECACC; 98031101
DR GDSC; 908130
DR GEO; GSM374975
DR GEO; GSM375434
DR GEO; GSM844604
DR GEO; GSM844605
DR GEO; GSM887312
DR GEO; GSM888388
DR GEO; GSM1670099
RX PubMed=8150529;
RX PubMed=9620227;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~50-60 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,13
ST D16S539: 11,14
ST D5S818: 11,12 (Cosmic-CLP; DSMZ)
ST D5S818: 11,13 (ECACC)
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MFE-319
AC CVCL_2112
SY MFE319
DR CLO; CLO_0007694
DR BioSample; SAMN03473593
DR CCLE; MFE319_ENDOMETRIUM
DR Cosmic; 1434187
DR Cosmic-CLP; 1240174
DR DSMZ; ACC-423
DR GDSC; 1240174
DR GEO; GSM374976
DR GEO; GSM375435
DR GEO; GSM887313
DR GEO; GSM888389
DR GEO; GSM1670100
RX PubMed=9620227;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~100 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10,13 (Cosmic-CLP)
ST CSF1PO: 10,14 (DSMZ)
ST D13S317: 13
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 8,12 (Cosmic-CLP)
ST D7S820: 8,8.1,12 (DSMZ)
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 18,20 (Cosmic-CLP)
ST vWA: 18,19,20 (DSMZ)
DI NCIt; C114656; Endometrial adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MFF-1
AC CVCL_R912
SY Mandarin Fish Fry-1
RX PubMed=18485510;
CC Group: Fish cell line.
OX NCBI_TaxID=119488; ! Siniperca chuatsi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID MFF-8C1
AC CVCL_1K31
RX PubMed=24101440;
RX PubMed=25903999;
CC Group: Fish cell line.
CC Group: Vaccine production cell line.
OX NCBI_TaxID=119488; ! Siniperca chuatsi
HI CVCL_R912 ! MFF-1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID MFH-3
AC CVCL_W489
RX PubMed=12237927;
CC Derived from metastatic site: Lung.
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MFH-H
AC CVCL_M824
RX PubMed=10470134;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MFH-I
AC CVCL_M790
RX PubMed=3025391;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MFH-II
AC CVCL_M791
RX PubMed=3025391;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MFH-ino
AC CVCL_1407
DR CLO; CLO_0050084
DR BioSample; SAMN03472224
DR ChEMBL-Cells; CHEMBL3308269
DR ChEMBL-Targets; CHEMBL2366262
DR Cosmic; 925343
DR Cosmic-CLP; 925343
DR GDSC; 925343
DR GEO; GSM1670101
DR RCB; RCB0749
RX PubMed=1653597;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MFH-ToE
AC CVCL_M825
RX PubMed=10536176;
CC Doubling time: 37 hours, at 20th passage (PubMed=10536176).
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MFH1NR
AC CVCL_M800
RX PubMed=6290021;
CC Transformant: ChEBI; CHEBI:28469; 4-(hydroxyamino)quinoline N-oxide (4-HAQO).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID MFHm-2
AC CVCL_W490
RX PubMed=12237927;
CC Derived from metastatic site: Retroperitoneal space.
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MFM-223
AC CVCL_1408
SY MFM223
DR BTO; BTO:0001961
DR CLO; CLO_0007695
DR EFO; EFO_0006649
DR BioSample; SAMN03473045
DR BioSample; SAMN03473592
DR ChEMBL-Cells; CHEMBL3308115
DR ChEMBL-Targets; CHEMBL1075504
DR Cosmic; 910948
DR Cosmic; 2165000
DR Cosmic-CLP; 910948
DR DSMZ; ACC-422
DR ECACC; 98050130
DR GDSC; 910948
DR GEO; GSM344380
DR GEO; GSM344430
DR GEO; GSM595616
DR GEO; GSM783967
DR GEO; GSM1670102
DR Lonza; 162
DR PRIDE; PXD000309
RX PubMed=1913690;
RX PubMed=22414580;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~5-7 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 11
ST D18S51: 21
ST D21S11: 29,30
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 8,10 (Cosmic-CLP; ECACC; PubMed=25877200)
ST D7S820: 8 (DSMZ)
ST D8S1179: 14
ST FGA: 19,23
ST Penta D: 8,9,12
ST Penta E: 15,17
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mfn1-null MEFs
AC CVCL_L691
DR ATCC; CRL-2992
RX PubMed=12527753;
CC Knockout cell: Method=KO mouse; MGI:1914664; Mfn1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Mfn1/Mfn2-null MEFs
AC CVCL_L692
DR ATCC; CRL-2994
RX PubMed=12527753;
CC Knockout cell: Method=KO mouse; MGI:1914664; Mfn1.
CC Knockout cell: Method=KO mouse; MGI:2442230; Mfn2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Mfn2-null MEFs
AC CVCL_L693
DR ATCC; CRL-2993
RX PubMed=12527753;
CC Knockout cell: Method=KO mouse; MGI:2442230; Mfn2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MFP-2
AC CVCL_9V34
DR ATCC; HB-12482
DR NCBI_Iran; C605
RX Patent=US6197582;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9V32 ! B6B11
CA Hybrid cell line
//
ID MFS5
AC CVCL_B868
SY MFS 5
DR ISCR; 1379
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=394
CC From: Stanford University; Stanford; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0052.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID mFS6
AC CVCL_L882
SY FS6
DR CLO; CLO_0007696
DR CLDB; cl3460
RX PubMed=7426348;
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MFS8
AC CVCL_0J40
SY MFS-8; MFS 8; Mouse FibroSarcoma No. 8
RX PubMed=5954138;
RX PubMed=9753870;
RX PubMed=13990732;
CC Breed/subspecies: Swiss.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MG-22A
AC CVCL_U248
SY MG22A; MG22a
DR ChEMBL-Cells; CHEMBL3307374
DR ChEMBL-Targets; CHEMBL614346
CC Caution: Erroneously indicated as originating from human in ChEMBL CHEMBL614346 and CHEMBL3307374.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MG-3
AC CVCL_J029
SY Mrigal Gill-3
RX CelloPub=CLPUB00080;
CC Group: Fish cell line.
OX NCBI_TaxID=683832; ! Cirrhinus mrigala
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID MG-63
AC CVCL_0426
SY M-G63; MG63
DR BTO; BTO:0001596
DR CLO; CLO_0007699
DR CLO; CLO_0007701
DR CLO; CLO_0050808
DR EFO; EFO_0002234
DR MCCL; MCC:0000323
DR CLDB; cl3462
DR CLDB; cl3463
DR CLDB; cl3464
DR CLDB; cl3465
DR CLDB; cl4934
DR ATCC; CRL-1427
DR BCRC; 60279
DR BCRJ; 0173
DR BioSample; SAMN03471910
DR BioSample; SAMN03472771
DR CCLE; MG63_BONE
DR CCRID; 3111C0001CCC000080
DR CCRID; 3131C0001000700124
DR CCRID; 3142C0001000000073
DR ChEMBL-Cells; CHEMBL3308498
DR ChEMBL-Targets; CHEMBL614347
DR CLS; 300441/p2938_MG-63
DR Cosmic; 755310
DR Cosmic; 908131
DR Cosmic; 931036
DR Cosmic; 931913
DR Cosmic; 1044085
DR Cosmic; 1070844
DR Cosmic; 1074394
DR Cosmic; 1082504
DR Cosmic; 1188475
DR Cosmic; 1529903
DR Cosmic-CLP; 908131
DR ECACC; 86051601
DR ENCODE; ENCBS091SUW
DR ENCODE; ENCBS462PMF
DR GDSC; 908131
DR GEO; GSM170251
DR GEO; GSM320828
DR GEO; GSM827317
DR GEO; GSM879217
DR GEO; GSM887314
DR GEO; GSM888390
DR GEO; GSM1670103
DR ICLC; HTL99003
DR IFO; IFO50108
DR IGRhCellID; MG63
DR IZSLER; BS TCL 40
DR KCB; KCB 200528YJ
DR KCLB; 21427
DR Lonza; 872
DR NCBI_Iran; C555
DR RCB; RCB1890
DR TKG; TKG 0294
DR TOKU-E; 2429
RX PubMed=2823272;
RX PubMed=7873286;
RX PubMed=8617485;
RX PubMed=12645653;
RX PubMed=15736406;
RX PubMed=19363654;
RX PubMed=19787792;
RX PubMed=21519327;
RX PubMed=22460905;
RX PubMed=25382592;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-91.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 28.3 hours (PubMed=19363654).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Metabolome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11 (ATCC; CLS; Cosmic-CLP; ECACC; PubMed=25877200; RCB; TKG)
ST D16S539: 11,12 (JCRB)
ST D18S51: 13 (CLS)
ST D18S51: 16 (PubMed=25877200)
ST D21S11: 28,29 (CLS)
ST D21S11: 30 (PubMed=25877200)
ST D3S1358: 15,17 (CLS)
ST D3S1358: 15 (KCLB; PubMed=25877200)
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 11,15 (CLS)
ST D8S1179: 13 (PubMed=25877200)
ST FGA: 20,21 (CLS)
ST FGA: 21,25 (KCLB; PubMed=25877200)
ST Penta D: 11,13 (CLS)
ST Penta D: 9,13 (PubMed=25877200)
ST Penta E: 12 (CLS)
ST Penta E: 11,12 (PubMed=25877200)
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MG-63.3A
AC CVCL_IR36
SY MG63.3A
RX PubMed=2533054;
RX PubMed=3068006;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0426 ! MG-63
SX Male
CA Cancer cell line
//
ID MG0001
AC CVCL_8Y19
DR ECACC; 00080908
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID MG1.19
AC CVCL_C314
DR BTO; BTO:0003561
CC Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C313 ! CCE
SX Male
CA Embryonic stem cell
//
ID MG1361
AC CVCL_3404
SY MG-1361
DR CLO; CLO_0007697
DR CLDB; cl3461
DR ICLC; ATL97003
RX PubMed=9497105;
CC Transfected with: RGD; 2561; Erbb2 (with E-661).
CC Transformant: Activated Erbb2/neu.
CC Breed/subspecies: (C57BL/6 x DBA)F1 x CD-1 MMTV-neu transgenic.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MG20
AC CVCL_5T82
RX PubMed=17121794;
CC Breed/subspecies: Tga20.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MG38
AC CVCL_J763
DR CLO; CLO_0007698
DR ATCC; CRL-2640
RX PubMed=10980384;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MG5
AC CVCL_5556
DR IFO; IFO50520
RX PubMed=9383038;
CC Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MG6
AC CVCL_8732
SY MG6-1
DR CLO; CLO_0050905
DR RCB; RCB2403
RX PubMed=16122875;
CC Transfected with: HGNC; 7553; MYC.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Transformed cell line
//
ID MG63/DXR1000
AC CVCL_9U34
RX PubMed=10854558;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0426 ! MG-63
SX Male
CA Cancer cell line
//
ID MG63.2
AC CVCL_R705
RX PubMed=19363654;
CC Doubling time: 36.1 hours (PubMed=19363654).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0426 ! MG-63
SX Male
CA Cancer cell line
//
ID MG87
AC CVCL_U510
SY MG-87
RX PubMed=7657612;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-122.html
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID MGAR
AC CVCL_E775
SY MGar
DR dbMHC; 48970
DR ECACC; 88022014
DR IHW; IHW9014
DR IMGT/HLA; 11069
RX PubMed=23619976;
WW http://bioinformatics.hsanmartino.it/ecbr/cl14.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MGC-803
AC CVCL_5334
SY MGC803
DR BTO; BTO:0004953
DR EFO; EFO_0006286
DR CCRID; 3111C0001CCC000227
DR CCRID; 3131C0001000700084
DR Cosmic; 2267321
DR GEO; GSM844588
DR GEO; GSM1374671
RX DOI=10.1007/BF02948354;
CC Omics: Transcriptome analysis.
CC Misspelling: 'MCG803' in GEO GSM844588.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID mGC11CEA
AC CVCL_X065
RX PubMed=16536871;
DI NCIt; C24227; Mouse gastric adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID mGC2CEA
AC CVCL_X066
RX PubMed=16536871;
DI NCIt; C24227; Mouse gastric adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID mGC3
AC CVCL_X067
RX PubMed=16536871;
DI NCIt; C24227; Mouse gastric adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID mGC4CEA
AC CVCL_X068
RX PubMed=16536871;
DI NCIt; C24227; Mouse gastric adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID mGC5
AC CVCL_X069
RX PubMed=16536871;
DI NCIt; C24227; Mouse gastric adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID mGC8
AC CVCL_X070
RX PubMed=16536871;
DI NCIt; C24227; Mouse gastric adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MGE02
AC CVCL_6B98
RX PubMed=12743444;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MGE12-1
AC CVCL_6B99
RX PubMed=12743444;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MGE3-2
AC CVCL_6C00
RX PubMed=12743444;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MGE503
AC CVCL_6C01
RX PubMed=12743444;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MGE507
AC CVCL_6C02
RX PubMed=12743444;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MGE509
AC CVCL_6C03
RX PubMed=12743444;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MGE511
AC CVCL_6C04
RX PubMed=12743444;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MGE727
AC CVCL_6C05
RX PubMed=12743444;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MGH-13
AC CVCL_W788
SY MGH13
RX PubMed=8382008;
RX PubMed=9649128;
RX PubMed=11369051;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-14
AC CVCL_W789
SY MGH14
RX PubMed=8382008;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-24
AC CVCL_W790
SY MGH24
RX PubMed=8382008;
RX PubMed=9649128;
RX PubMed=11369051;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-26
AC CVCL_W791
SY MGH26
RX PubMed=8382008;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-30
AC CVCL_W792
SY MGH30
RX PubMed=8382008;
RX PubMed=9649128;
RX PubMed=11369051;
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-4
AC CVCL_W785
SY MGH4
RX PubMed=8382008;
RX PubMed=9649128;
RX PubMed=11369051;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-7
AC CVCL_W786
SY MGH7
RX PubMed=8382008;
RX PubMed=9649128;
RX PubMed=11369051;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MGH-8
AC CVCL_W787
SY MGH8
RX PubMed=8382008;
RX PubMed=9649128;
RX PubMed=11369051;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-BA-1
AC CVCL_A651
SY BA-1
DR Cosmic; 706099
DR Cosmic; 897492
RX PubMed=9692547;
RX PubMed=10766161;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-BO-1
AC CVCL_A652
SY BO-1
DR Cosmic; 706100
DR Cosmic; 888841
DR Cosmic; 897488
RX PubMed=9692547;
RX PubMed=10766161;
RX PubMed=15009714;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-GO-1
AC CVCL_W794
DR Cosmic; 706094
RX PubMed=10766161;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-LA-1
AC CVCL_W795
DR Cosmic; 706109
RX PubMed=10766161;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-MC-1
AC CVCL_9878
DR Cosmic; 888854
DR Cosmic; 897485
RX PubMed=15009714;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-MC-2
AC CVCL_9879
DR Cosmic; 706085
DR Cosmic; 888830
DR Cosmic; 897470
RX PubMed=10766161;
RX PubMed=15009714;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-mcc1
AC CVCL_D781
DR Cosmic; 1693012
RX PubMed=22261808;
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MGH-PO-1
AC CVCL_A653
DR Cosmic; 706088
DR Cosmic; 888832
DR Cosmic; 897472
RX PubMed=10766161;
RX PubMed=15009714;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH-U2
AC CVCL_9826
SY MGHU2; MGH-U2 (HM); HM
DR BioSample; SAMN03151950
DR Cosmic; 925831
RX PubMed=3708594;
RX PubMed=4027986;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594, PubMed=20143388).
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 16,18
ST D21S11: 29
ST D8S1179: 14
ST FGA: 17,22
ST TH01: 6
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID MGH-U3
AC CVCL_9827
SY MGHU3; MG-HU-3; MGH-U3 (RN); RN
DR Cosmic; 928825
DR Cosmic; 1016886
DR Cosmic; 1068090
DR Cosmic; 1285123
DR Cosmic; 1286013
DR Cosmic; 1302361
DR Cosmic; 1927290
DR Cosmic; 1938479
DR Cosmic; 2037951
DR Cosmic; 2050458
DR GEO; GSM1374672
DR GEO; GSM1374673
DR GEO; GSM1574573
RX PubMed=4027986;
RX PubMed=8873383;
RX PubMed=16885334;
RX PubMed=23401075;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25997541;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MGH-U4
AC CVCL_9828
SY MGHU4; MG-HU-4; MGH-U4 (RB); RB
DR Cosmic; 928826
DR Cosmic; 1016879
DR Cosmic; 1927291
DR Cosmic; 2037952
DR GEO; GSM1574549
RX PubMed=4027986;
RX PubMed=8873383;
RX PubMed=16885334;
RX PubMed=23401075;
RX PubMed=24018021;
RX PubMed=25997541;
RX PubMed=26621286;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MGH021-4
AC CVCL_AY54
DR Cosmic; 2275266
RX PubMed=24675041;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH045
AC CVCL_AY55
DR Cosmic; 2275265
RX PubMed=24675041;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH051
AC CVCL_AY56
DR Cosmic; 2275267
RX PubMed=24675041;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH056-1
AC CVCL_EI95
DR Cosmic; 2245570
RX PubMed=25228534;
CC Derived from metastatic site: Liver.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH119
AC CVCL_DH47
DR GEO; GSM1568545
RX PubMed=25758528;
CC Omics: Transcriptome analysis.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH119-R
AC CVCL_DH48
SY MGH119-GR
DR GEO; GSM1568546
RX PubMed=25758528;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Omics: Transcriptome analysis.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH47 ! MGH119
CA Cancer cell line
//
ID MGH121
AC CVCL_DH49
DR GEO; GSM1568547
RX PubMed=25758528;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH125
AC CVCL_DH50
DR GEO; GSM1568548
DR GEO; GSM1579487
RX PubMed=25758528;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MGH126
AC CVCL_DH51
DR GEO; GSM1568549
RX PubMed=25758528;
CC Omics: Transcriptome analysis.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH131-1
AC CVCL_DH52
DR GEO; GSM1568553
DR GEO; GSM1579486
RX PubMed=25758528;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DH53 ! MGH131-2
SX Male
CA Cancer cell line
//
ID MGH131-2
AC CVCL_DH53
DR GEO; GSM1568554
RX PubMed=25758528;
CC Omics: Transcriptome analysis.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DH52 ! MGH131-1
SX Male
CA Cancer cell line
//
ID MGH134
AC CVCL_DH54
DR GEO; GSM1568550
RX PubMed=25758528;
CC Omics: Transcriptome analysis.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH141
AC CVCL_DH55
DR GEO; GSM1568551
RX PubMed=25758528;
CC Omics: Transcriptome analysis.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH156
AC CVCL_DH56
RX PubMed=25758528;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGH157
AC CVCL_DH57
DR GEO; GSM1568552
RX PubMed=25758528;
CC Omics: Transcriptome analysis.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGL8
AC CVCL_D892
SY MGL-8
DR BTO; BTO:0005260
RX PubMed=605378;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MGM-1
AC CVCL_W447
RX PubMed=7556648;
RX PubMed=9234071;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MGM-2
AC CVCL_W448
RX PubMed=7556648;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MGM-3
AC CVCL_W449
RX PubMed=7556648;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MGM-A
AC CVCL_X197
RX PubMed=8513002;
RX PubMed=8519890;
OX NCBI_TaxID=10047; ! Meriones unguiculatus
OI CVCL_X198 ! MGM-S
SX Male
CA Cancer cell line
//
ID MGM-S
AC CVCL_X198
RX PubMed=8519890;
OX NCBI_TaxID=10047; ! Meriones unguiculatus
OI CVCL_X197 ! MGM-A
SX Male
CA Cancer cell line
//
ID MGR1
AC CVCL_8563
SY MGR 1; MGR-1; UWR1; UWR-1
RX PubMed=2208164;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGR2
AC CVCL_8564
SY MGR 2; UWR2; UWR-2
RX PubMed=2208164;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGR3
AC CVCL_8565
SY MGR 3; UWR3; UWR-3
DR Lonza; 710
RX PubMed=2208164;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MGS
AC CVCL_6A84
SY Mongolian gerbil Gastric epithelial cells with SV-40
RX DOI=10.1016/S0016-5085(08)83714-6;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10047; ! Meriones unguiculatus
CA Transformed cell line
//
ID mGS-DBA1
AC CVCL_1T53
DR RCB; AES0004
DR RCB; RCB2003
RX PubMed=15620358;
CC Characteristics: Germ stem cell line.
CC Discontinued: RCB; RCB2003; true.
CC Breed/subspecies: DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MGSO-3
AC CVCL_6847
DR BTO; BTO:0005047
RX PubMed=19725227;
RX PubMed=23404580;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID mh
AC CVCL_6780
AS CVCL_4242
SY mocha; Mocha; MOCHA
DR CLO; CLO_0007706
DR ATCC; CRL-2709
DR ECACC; 02111901
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MH [Human mesothelioma]
AC CVCL_W085
DR Cosmic; 1522783
DR GEO; GSM726278
RX PubMed=21642991;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MH [Human ovarian carcinoma]
AC CVCL_F845
DR CGH-DB; 339-2
DR Cosmic; 931365
RX PubMed=7844449;
RX PubMed=8217948;
RX PubMed=17671176;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MH 55
AC CVCL_J224
SY MH55
DR CLO; CLO_0007712
DR ATCC; HB-8412
RX Patent=US4666845;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MH 94
AC CVCL_J844
DR ATCC; HB-8413
RX Patent=US4666845;
CC Discontinued: ATCC; HB-8413; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MH-1
AC CVCL_H639
DR Cosmic; 1086351
RX CelloPub=CLPUB00081;
RX PubMed=2456698;
RX PubMed=15356658;
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MH-12
AC CVCL_AT87
DR Cosmic; 888858
RX PubMed=15009714;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MH-17
AC CVCL_AT88
DR Cosmic; 888863
RX PubMed=15009714;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MH-2
AC CVCL_AT89
DR Cosmic; 888859
RX PubMed=15009714;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MH-22a
AC CVCL_3854
SY MH-22A
DR CLO; CLO_0007710
DR CLO; CLO_0007711
DR CLDB; cl3472
DR CLDB; cl5082
DR ECACC; 96121721
CC Breed/subspecies: C3HA.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MH-3924A
AC CVCL_5799
SY MH 3924A; MH3924A; MH-3924 A; MH 3924 A; 3924A; Morris hepatoma 3924A; MH-3924; MH3924; MH 3924
DR BTO; BTO:0000577
DR ChEMBL-Cells; CHEMBL3307989
DR ChEMBL-Targets; CHEMBL612581
DR CLS; 500286/p2646_MH-3924A
CC Breed/subspecies: ACI.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID MH-7777A
AC CVCL_2113
SY MH 7777A; MH7777A
DR BTO; BTO:0000217
DR CLO; CLO_0007713
DR DSMZ; ACC-345
RX PubMed=7498532;
CC Doubling time: ~48 hours (DSMZ).
CC Breed/subspecies: Buffalo.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_0444 ! McA-RH7777
OI CVCL_0F78 ! 7777-14b-aza
SX Female
CA Cancer cell line
//
ID MH-S
AC CVCL_3855
DR CLO; CLO_0007721
DR CLDB; cl3473
DR CLDB; cl5231
DR ATCC; CRL-2019
DR BCRC; 60419
DR CCRID; 3131C0001001200005
DR ECACC; 95090612
DR IZSLER; BS CL 141
RX PubMed=2787372;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/cJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID MH-SVM16
AC CVCL_J764
SY SVM-16
DR ATCC; HB-8880
RX Patent=US4843011;
CC Discontinued: ATCC; HB-8880; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MH-SVM23
AC CVCL_J765
SY SVM-23
DR CLO; CLO_0007722
DR ATCC; HB-8870
RX Patent=US4843011;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MH-SVM25
AC CVCL_J766
SY SVM-25
DR CLO; CLO_0007723
DR ATCC; HB-8871
RX Patent=US4843011;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MH-SVM26
AC CVCL_J767
SY SVM-26
DR CLO; CLO_0007724
DR ATCC; HB-8872
RX Patent=US4843011;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MH-SVM33C9
AC CVCL_J768
SY MH-SVM33; SVM-33
DR CLO; CLO_0007725
DR ATCC; HB-8975
RX Patent=US4843011;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MH-TC-5123
AC CVCL_5800
DR CLS; 500287/p592_MH-TC-5123
CC Breed/subspecies: Buffalo.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID MH/Nike
AC CVCL_DN29
SY Nike
DR GEO; GSM1974795
RX PubMed=26842912;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
DI NCIt; C128125; Canine histiocytic sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID MH01
AC CVCL_J222
DR ECACC; 93062401
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID MH1
AC CVCL_J223
DR CLO; CLO_0007708
DR ATCC; HB-9739
RX Patent=US5091512;
RX Patent=US5120834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MH1-BS
AC CVCL_M227
RX PubMed=3030788;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV7].
DI NCIt; C2903; Bloom syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J657 ! GM02548
SX Male
CA Transformed cell line
//
ID MH11
AC CVCL_8893
RX PubMed=1283157;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MH11
CC Characteristics: Requires feeder cells. Maintenance of MH11 depends on the presence of cell line ST-2 (CVCL_2205).
CC Characteristics: IL7 dependent.
CC Breed/subspecies: C57BL/6 x BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID MH129
AC CVCL_8110
SY MH-129; MH 129
CC Breed/subspecies: C3H/He.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MH129F-TC
AC CVCL_8Z12
SY MH129F
DR TKG; TKG 0159
DR TKG; TKG 0569
CC Breed/subspecies: C3H/He.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_8110 ! MH129
CA Cancer cell line
//
ID MH129P-TC
AC CVCL_8Z13
SY MH129P
DR TKG; TKG 0160
DR TKG; TKG 0570
CC Breed/subspecies: C3H/He.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_8110 ! MH129
CA Cancer cell line
//
ID MH134-TC
AC CVCL_8111
SY MH-134; MH 134; MH134
DR BTO; BTO:0001083
DR TKG; TKG 0161
DR TKG; TKG 0568
CC Breed/subspecies: C3H/He.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MH1C1
AC CVCL_2114
SY MH 1 C 1
DR BTO; BTO:0000220
DR CLO; CLO_0007707
DR CLO; CLO_0007709
DR CLDB; cl3474
DR CLDB; cl3475
DR CLDB; cl3476
DR CLDB; cl3477
DR CLDB; cl4918
DR ATCC; CCL-144
DR BCRC; 60143
DR ChEMBL-Cells; CHEMBL3307375
DR ChEMBL-Targets; CHEMBL614349
DR DSMZ; ACC-106
DR ECACC; 85112702
DR GEO; GSM1240490
DR GEO; GSM1240491
DR GEO; GSM1240492
DR GEO; GSM1240493
DR GEO; GSM1240494
DR GEO; GSM1240495
DR GEO; GSM1240496
DR GEO; GSM1240497
DR GEO; GSM1240498
DR GEO; GSM1240499
DR GEO; GSM1240500
DR GEO; GSM1240501
DR ICLC; ATL98014
DR IZSLER; BS TCL 41
RX PubMed=4177659;
RX PubMed=24386269;
CC Doubling time: ~33-60 hours (DSMZ).
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 85112702; probable.
CC Breed/subspecies: Buffalo.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID MH2-FA
AC CVCL_M228
RX PubMed=3030788;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV7].
DI NCIt; C62505; Fanconi anemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F593 ! GM02053
SX Female
CA Transformed cell line
//
ID MH3-XPD
AC CVCL_M229
RX PubMed=3030788;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV7].
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L754 ! GM00434
SX Male
CA Transformed cell line
//
ID MH60.BSF2
AC CVCL_7201
SY MH60.BSF-2; MH60-BSF-2
DR TKG; TKG 0226
RX PubMed=3260187;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MH60-BSF-2
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID MH7A
AC CVCL_0427
DR BTO; BTO:0003437
DR CLO; CLO_0050142
DR BioSample; SAMN03472146
DR MCCL; MCC:0000324
DR RCB; RCB1512
RX PubMed=9832620;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 8
ST D16S539: 10,11
ST D5S818: 12
ST D7S820: 10
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MHCC97
AC CVCL_4971
SY MHCC-97; MHCC 97
DR BTO; BTO:0004168
DR GEO; GSM1374674
RX PubMed=10555751;
CC Characteristics: Has lost chromosome Y.
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Transcriptome analysis.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MHCC97-H
AC CVCL_4972
SY MHCC 97-H; MHCC97H
DR BTO; BTO:0004169
DR GEO; GSM936771
DR GEO; GSM1374675
DR PRIDE; PXD000529
DR PRIDE; PXD000533
DR PRIDE; PXD000535
RX PubMed=11819844;
RX PubMed=15048980;
RX PubMed=15146329;
RX PubMed=23505090;
CC Characteristics: Has lost chromosome Y.
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4971 ! MHCC97
SX Male
CA Cancer cell line
//
ID MHCC97-L
AC CVCL_4973
SY MHCC 97-L; MHCC97L
DR BTO; BTO:0004170
DR GEO; GSM936772
DR GEO; GSM1374676
RX PubMed=11819844;
RX PubMed=15048980;
RX PubMed=15146329;
RX PubMed=23505090;
CC Characteristics: Has lost chromosome Y.
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4971 ! MHCC97
SX Male
CA Cancer cell line
//
ID MHEC5-T
AC CVCL_2115
SY Mouse Heart Endothelial Cell clone 5-Transformed
DR CLO; CLO_0007714
DR DSMZ; ACC-336
RX PubMed=7655744;
CC Doubling time: ~30 hours (DSMZ).
CC Breed/subspecies: NMRI.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MHH-CALL-2
AC CVCL_1409
SY Mhh-Call 2; MHH-CALL2; MHHCALL2
DR CLO; CLO_0007715
DR BioSample; SAMN03473355
DR CCLE; MHHCALL2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308333
DR ChEMBL-Targets; CHEMBL2366286
DR Cosmic; 908132
DR Cosmic; 1012089
DR Cosmic; 1130251
DR Cosmic; 1524803
DR Cosmic; 1943387
DR Cosmic; 2491071
DR Cosmic-CLP; 908132
DR DSMZ; ACC-341
DR GDSC; 908132
DR GEO; GSM236789
DR GEO; GSM236825
DR GEO; GSM887315
DR GEO; GSM888391
DR GEO; GSM931335
DR GEO; GSM1670104
RX PubMed=9067587;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 14
ST D13S317: 8
ST D16S539: 14
ST D5S818: 12
ST D7S820: 9
ST TH01: 8
ST TPOX: 11
ST vWA: 18
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MHH-CALL-3
AC CVCL_0089
SY Mhh-Call 3; MHH cALL 3; MHH-CALL3; MHH-cALL3; MHHCALL3
DR CLO; CLO_0007716
DR BioSample; SAMN03473353
DR CCLE; MHHCALL3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1281374
DR Cosmic; 1524844
DR Cosmic; 2491072
DR DSMZ; ACC-339
DR GEO; GSM236790
DR GEO; GSM236826
DR GEO; GSM887316
DR GEO; GSM888392
RX PubMed=9067587;
RX PubMed=15843827;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~120 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,8
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MHH-CALL-4
AC CVCL_1410
SY MHH-CALL4; MHHCALL4
DR CLO; CLO_0007717
DR BioSample; SAMN03473351
DR CCLE; MHHCALL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 908133
DR Cosmic; 1012090
DR Cosmic; 1278370
DR Cosmic; 1524804
DR Cosmic-CLP; 908133
DR DSMZ; ACC-337
DR GEO; GSM887317
DR GEO; GSM888393
DR GEO; GSM1670105
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~80-100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,10
ST D16S539: 11
ST D5S818: 13
ST D7S820: 9,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MHH-ES-1
AC CVCL_1411
SY MHH-ES1
DR CLO; CLO_0007718
DR EFO; EFO_0006650
DR CLDB; cl3478
DR BioSample; SAMN03471911
DR BioSample; SAMN03473362
DR CCLE; MHHES1_BONE
DR ChEMBL-Cells; CHEMBL3308762
DR ChEMBL-Targets; CHEMBL1075505
DR CLS; 300136/p724_MHH-ES1
DR Cosmic; 908134
DR Cosmic; 1718436
DR Cosmic; 2250463
DR Cosmic-CLP; 908134
DR DSMZ; ACC-167
DR GDSC; 908134
DR GEO; GSM887318
DR GEO; GSM888394
DR GEO; GSM1670106
RX DOI=10.1016/0165-4608(89)90568-2;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25223734;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~28 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): CLS; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8 (CLS; PubMed=25877200)
ST D13S317: 8,13 (Cosmic-CLP; DSMZ)
ST D16S539: 11
ST D18S51: 14,16
ST D21S11: 28,32.2
ST D3S1358: 15,16
ST D5S818: 13
ST D7S820: 9,11
ST D8S1179: 11,13
ST FGA: 22
ST Penta D: 11,12
ST Penta E: 11,15
ST TH01: 8,9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MHH-MED-1
AC CVCL_7988
SY MHH-Med-1; MED1
DR Cosmic; 975026
DR Cosmic; 2362654
DR GEO; GSM919362
RX PubMed=8205550;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MHH-MED-2
AC CVCL_7989
DR Cosmic; 2362655
RX PubMed=8205550;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MHH-MED-3
AC CVCL_7990
DR Cosmic; 2362656
RX PubMed=8205550;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MHH-MED-4
AC CVCL_7991
RX PubMed=8205550;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MHH-NB-11
AC CVCL_1412
SY MHH-NB11; MHHNB11
DR CLO; CLO_0007719
DR EFO; EFO_0006651
DR CLDB; cl3479
DR BioSample; SAMN03473088
DR CCLE; MHHNB11_AUTONOMIC_GANGLIA
DR ChEMBL-Cells; CHEMBL3308310
DR ChEMBL-Targets; CHEMBL2366185
DR Cosmic; 908135
DR Cosmic; 2485948
DR Cosmic-CLP; 908135
DR DSMZ; ACC-157
DR GDSC; 908135
DR GEO; GSM887319
DR GEO; GSM888395
DR GEO; GSM1366409
DR GEO; GSM1670107
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=3218965;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Adrenal gland.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9,13
ST D18S51: 16,17
ST D21S11: 30,31.2
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 13,14
ST FGA: 20,21
ST Penta D: 11,12
ST Penta E: 5,12
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MHH-PNET-5
AC CVCL_7992
RX PubMed=8205550;
DI NCIt; C5406; Spinal cord primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MHH-PREB-1
AC CVCL_1413
SY MHHPREB1
DR CLO; CLO_0007720
DR EFO; EFO_0002235
DR BioSample; SAMN03471645
DR BioSample; SAMN03473315
DR ChEMBL-Cells; CHEMBL3308334
DR ChEMBL-Targets; CHEMBL2366127
DR Cosmic; 908136
DR Cosmic; 2276316
DR Cosmic; 2491097
DR Cosmic-CLP; 908136
DR DSMZ; ACC-354
DR GDSC; 908136
DR GEO; GSM1670108
DR IGRhCellID; MHHPREB1
RX PubMed=9067587;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~20-40 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,12
ST D16S539: 8,13
ST D18S51: 11,18
ST D21S11: 29,30
ST D3S1358: 17,19
ST D5S818: 11,13,14 (Cosmic-CLP)
ST D5S818: 11,13 (DSMZ; PubMed=25877200)
ST D7S820: 11,12 (Cosmic-CLP; DSMZ)
ST D7S820: 11,12.3 (PubMed=25877200)
ST D8S1179: 10,16
ST FGA: 21,23
ST Penta D: 9,13
ST Penta E: 7,16
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 15,20
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MHH-TALL-1
AC CVCL_9824
SY MHH-TALL1
DR Cosmic; 1281375
DR Cosmic; 1498421
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MHH-TALL-2
AC CVCL_9825
SY MHH-TALL2
DR Cosmic; 1281376
DR DSMZ; ACC-728
CC Doubling time: ~60-72 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 11,12
ST D5S818: 10,12
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MHH225
AC CVCL_8894
SY MHH-225; MHH 225
DR BioSample; SAMN03151807
RX PubMed=7548328;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Jurkat derivative (PubMed=12592342, PubMed=20143388). Was originally thought to originate from an acute myeloid leukemia.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID MHHZ-00020533
AC CVCL_V376
DR IMGT/HLA; 14464
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID mHippoE-14
AC CVCL_D375
RX PubMed=20619320;
WW https://www.cedarlanelabs.com/Products/Detail/CLU198?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Swiss Webster.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHippoE-18
AC CVCL_D376
RX PubMed=20619320;
WW https://www.cedarlanelabs.com/Products/Detail/CLU199?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Swiss Webster.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHippoE-2
AC CVCL_D377
RX PubMed=20619320;
WW https://www.cedarlanelabs.com/Products/Detail/CLU196?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Swiss Webster.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHippoE-5
AC CVCL_D378
RX PubMed=20619320;
WW https://www.cedarlanelabs.com/Products/Detail/CLU197?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Swiss Webster.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MHM
AC CVCL_B426
SY MHMX
DR Cosmic; 1529904
DR GEO; GSM879218
RX PubMed=8198963;
RX PubMed=19787792;
RX PubMed=21519327;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MHM-25
AC CVCL_GZ63
DR GEO; GSM1676342
DR GEO; GSM1701673
RX PubMed=26351324;
DI NCIt; C9118; Sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MHM-8
AC CVCL_GZ64
DR GEO; GSM1676307
DR GEO; GSM1701641
RX PubMed=26351324;
DI NCIt; C9118; Sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MHP36
AC CVCL_U372
DR Lonza; 705
RX PubMed=9316014;
RX PubMed=11447341;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MHR14
AC CVCL_DE45
SY GM11535
DR CLO; CLO_0021002
DR Coriell; GM11535
RX PubMed=1765380;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DE39 ! HHW890
CA Hybrid cell line
//
ID mHypoA-1/1
AC CVCL_D379
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU178?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-1/2
AC CVCL_D380
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU172?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-1/3
AC CVCL_D381
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU173?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-1/6
AC CVCL_D382
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU179?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-1/9
AC CVCL_D383
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU180?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/10
AC CVCL_D384
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU176?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/12
AC CVCL_D385
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU177?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/21
AC CVCL_D386
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU181?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/22
AC CVCL_D387
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU182?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/23
AC CVCL_D388
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU183?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/24
AC CVCL_D389
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU184?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/25
AC CVCL_D390
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU185?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/26
AC CVCL_D391
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU186?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/27
AC CVCL_D392
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU187?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/28
AC CVCL_D393
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU188?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/29
AC CVCL_D394
DR BCRJ; 0296
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU189?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Misspelling: 'CLU-189' in BCRJ (based on the Cellutions Biosystems catalog number).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/30
AC CVCL_D395
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU190?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/31
AC CVCL_D396
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU191?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/32
AC CVCL_D397
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU192?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/33
AC CVCL_D398
RX PubMed=19703933;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: Cedarlane Cellutions Systems; Catalog number CLU193.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/34
AC CVCL_D399
RX PubMed=19703933;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: Cedarlane Cellutions Systems; Catalog number CLU194.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/4
AC CVCL_D400
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU174?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-2/6
AC CVCL_D401
RX PubMed=19703933;
WW https://www.cedarlanelabs.com/Products/Detail/CLU175?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-41
AC CVCL_D402
WW https://www.cedarlanelabs.com/Products/Detail/CLU450?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-42
AC CVCL_D403
WW https://www.cedarlanelabs.com/Products/Detail/CLU451?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-43
AC CVCL_D404
WW https://www.cedarlanelabs.com/Products/Detail/CLU452?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-44
AC CVCL_D405
WW https://www.cedarlanelabs.com/Products/Detail/CLU453?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-45
AC CVCL_D406
WW https://www.cedarlanelabs.com/Products/Detail/CLU454?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-46
AC CVCL_D407
WW https://www.cedarlanelabs.com/Products/Detail/CLU455?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-47
AC CVCL_D408
WW https://www.cedarlanelabs.com/Products/Detail/CLU456?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-48
AC CVCL_D409
WW https://www.cedarlanelabs.com/Products/Detail/CLU457?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-49
AC CVCL_D410
WW https://www.cedarlanelabs.com/Products/Detail/CLU458?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-50
AC CVCL_D411
WW https://www.cedarlanelabs.com/Products/Detail/CLU459?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-51
AC CVCL_D412
WW https://www.cedarlanelabs.com/Products/Detail/CLU460?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-52
AC CVCL_D413
WW https://www.cedarlanelabs.com/Products/Detail/CLU461?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-53
AC CVCL_D414
WW https://www.cedarlanelabs.com/Products/Detail/CLU462?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-54
AC CVCL_D415
WW https://www.cedarlanelabs.com/Products/Detail/CLU463?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-55
AC CVCL_D416
WW https://www.cedarlanelabs.com/Products/Detail/CLU464?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-56
AC CVCL_D417
WW https://www.cedarlanelabs.com/Products/Detail/CLU465?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-57
AC CVCL_D418
WW https://www.cedarlanelabs.com/Products/Detail/CLU466?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-58
AC CVCL_D419
WW https://www.cedarlanelabs.com/Products/Detail/CLU467?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-59
AC CVCL_D420
RX PubMed=21914774;
WW https://www.cedarlanelabs.com/Products/Detail/CLU468?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-60
AC CVCL_D421
WW https://www.cedarlanelabs.com/Products/Detail/CLU469?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-61
AC CVCL_D422
WW https://www.cedarlanelabs.com/Products/Detail/CLU470?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-62
AC CVCL_D423
WW https://www.cedarlanelabs.com/Products/Detail/CLU471?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-63
AC CVCL_D424
WW https://www.cedarlanelabs.com/Products/Detail/CLU472?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-GnRH/GFP
AC CVCL_DP31
WW https://www.cedarlanelabs.com/Products/Detail/CLU498?lob=Cellutions
CC Transfected with: UniProtKB; Q963I9; Renilla GFP.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-NPY/GFP
AC CVCL_Y000
RX PubMed=21914774;
WW https://www.cedarlanelabs.com/Products/Detail/CLU499?lob=Cellutions
CC Transfected with: UniProtKB; Q963I9; Renilla GFP.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: B6.FVB-Tg(Npy-hrGFP)1Lowl/J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoA-POMC/GFP-1
AC CVCL_EP66
RX PubMed=24134870;
WW https://www.cedarlanelabs.com/Products/Detail/CLU500?lob=Cellutions
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-POMC/GFP-2
AC CVCL_EP67
RX PubMed=24134870;
WW https://www.cedarlanelabs.com/Products/Detail/CLU501?lob=Cellutions
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-POMC/GFP-3
AC CVCL_EP68
RX PubMed=24134870;
WW https://www.cedarlanelabs.com/Products/Detail/CLU502?lob=Cellutions
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-POMC/GFP-4
AC CVCL_EP69
RX PubMed=24134870;
WW https://www.cedarlanelabs.com/Products/Detail/CLU503?lob=Cellutions
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID mHypoA-SCN
AC CVCL_5I56
WW https://www.cedarlanelabs.com/Products/Detail/CLU497?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mHypoE-N1
AC CVCL_D425
SY N1
WW https://www.cedarlanelabs.com/Products/Detail/CLU101?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N11
AC CVCL_D426
SY N11
WW https://www.cedarlanelabs.com/Products/Detail/CLU107?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N20/1
AC CVCL_D427
SY N20/1
WW https://www.cedarlanelabs.com/Products/Detail/CLU108?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N20/2
AC CVCL_D428
SY N20/2
WW https://www.cedarlanelabs.com/Products/Detail/CLU109?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N25/2
AC CVCL_D429
SY N25/2
WW https://www.cedarlanelabs.com/Products/Detail/CLU110?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N25/3
AC CVCL_D430
SY N25/3
WW https://www.cedarlanelabs.com/Products/Detail/CLU111?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N29/1
AC CVCL_D431
SY N29/1
WW https://www.cedarlanelabs.com/Products/Detail/CLU112?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N29/2
AC CVCL_D432
SY N29/2
WW https://www.cedarlanelabs.com/Products/Detail/CLU113?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N29/3
AC CVCL_D433
SY N29/3
WW https://www.cedarlanelabs.com/Products/Detail/CLU114?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N29/4
AC CVCL_D434
SY N29/4
WW https://www.cedarlanelabs.com/Products/Detail/CLU115?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N3
AC CVCL_D435
SY N3
WW https://www.cedarlanelabs.com/Products/Detail/CLU102?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N36/1
AC CVCL_D436
AS CVCL_0446
SY N36/1; N-36/1
DR MCCL; MCC:0000343
WW https://www.cedarlanelabs.com/Products/Detail/CLU116?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N37
AC CVCL_D437
SY N37
WW https://www.cedarlanelabs.com/Products/Detail/CLU117?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N38
AC CVCL_D438
AS CVCL_0447
SY N38; N-38
DR BTO; BTO:0003956
DR MCCL; MCC:0000344
WW https://www.cedarlanelabs.com/Products/Detail/CLU118?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N39
AC CVCL_D439
AS CVCL_0448
SY N39; N-39
DR MCCL; MCC:0000345
WW https://www.cedarlanelabs.com/Products/Detail/CLU119?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N4
AC CVCL_D440
SY N4
WW https://www.cedarlanelabs.com/Products/Detail/CLU103?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N40
AC CVCL_D441
SY N40
WW https://www.cedarlanelabs.com/Products/Detail/CLU120?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N41
AC CVCL_D442
SY N41
WW https://www.cedarlanelabs.com/Products/Detail/CLU121?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N42
AC CVCL_D443
AS CVCL_0449
SY N42; N-42
DR MCCL; MCC:0000346
WW https://www.cedarlanelabs.com/Products/Detail/CLU122?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/1
AC CVCL_D444
SY N43/1
WW https://www.cedarlanelabs.com/Products/Detail/CLU123?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/10
AC CVCL_D445
SY N43/10
WW https://www.cedarlanelabs.com/Products/Detail/CLU132?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/13
AC CVCL_D446
SY N43/13
WW https://www.cedarlanelabs.com/Products/Detail/CLU133?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/14
AC CVCL_D447
SY N43/14
WW https://www.cedarlanelabs.com/Products/Detail/CLU134?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/15
AC CVCL_D448
SY N43/15
WW https://www.cedarlanelabs.com/Products/Detail/CLU135?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/2
AC CVCL_D449
SY N43/2
WW https://www.cedarlanelabs.com/Products/Detail/CLU124?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/3
AC CVCL_D450
SY N43/3
WW https://www.cedarlanelabs.com/Products/Detail/CLU125?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/4
AC CVCL_D451
SY N43/4
WW https://www.cedarlanelabs.com/Products/Detail/CLU126?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/5
AC CVCL_D452
SY N43/5
WW https://www.cedarlanelabs.com/Products/Detail/CLU127?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/6
AC CVCL_D453
SY N43/6
WW https://www.cedarlanelabs.com/Products/Detail/CLU128?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/7
AC CVCL_D454
SY N43/7
WW https://www.cedarlanelabs.com/Products/Detail/CLU129?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/8
AC CVCL_D455
SY N43/8
WW https://www.cedarlanelabs.com/Products/Detail/CLU130?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N43/9
AC CVCL_D456
SY N43/9
WW https://www.cedarlanelabs.com/Products/Detail/CLU131?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N44
AC CVCL_D457
SY N44
WW https://www.cedarlanelabs.com/Products/Detail/CLU136?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N45
AC CVCL_D458
SY N45
WW https://www.cedarlanelabs.com/Products/Detail/CLU137?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N46
AC CVCL_D459
SY N46
WW https://www.cedarlanelabs.com/Products/Detail/CLU138?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N47
AC CVCL_D460
SY N47
WW https://www.cedarlanelabs.com/Products/Detail/CLU139?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N6
AC CVCL_D461
SY N6
WW https://www.cedarlanelabs.com/Products/Detail/CLU104?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N7
AC CVCL_D462
SY N7
WW https://www.cedarlanelabs.com/Products/Detail/CLU105?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mHypoE-N8
AC CVCL_D463
SY N8
WW https://www.cedarlanelabs.com/Products/Detail/CLU106?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MI #1
AC CVCL_1E43
SY MI 1
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=994214;
CC Doubling time: 48 hours, at 46th passage (PubMed=994214).
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mi Ten
AC CVCL_3024
AS CVCL_V561
SY Mi-Ten; MiTen
DR ATCC; CRL-1113
DR BioSample; SAMN03471061
DR JCRB; JCRB0072
RX PubMed=7471105;
CC Discontinued: ATCC; CRL-1113; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 12,14
ST D7S820: 8,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID MI-4 [Human glioblastoma]
AC CVCL_N722
RX PubMed=8055485;
RX PubMed=16102584;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MI-4 [Human lung adenocarcinoma]
AC CVCL_6294
RX PubMed=12079515;
RX PubMed=16820947;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MI-4
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MIA PaCa-2
AC CVCL_0428
SY MIA-PaCa-2; MIA-PACA-2; MIA-Pa-Ca-2; MIA Paca2; MIA PaCa2; MiaPaCa-2; MiaPaca.2; MiaPaCa2; Miapaca2; MIAPaCa2; MIAPACA2; Mia PACA 2; MIAPaCa-2; PaCa2
DR BTO; BTO:0002137
DR BTO; BTO:0002138
DR CLO; CLO_0007726
DR CLO; CLO_0050101
DR EFO; EFO_0002236
DR MCCL; MCC:0000325
DR CLDB; cl3480
DR CLDB; cl3481
DR CLDB; cl3482
DR ATCC; CRL-1420
DR ATCC; CRM-CRL-1420
DR BCRC; 60139
DR BCRJ; 0174
DR BioSample; SAMN01821579
DR BioSample; SAMN01821700
DR BioSample; SAMN03472131
DR CCLE; MIAPACA2_PANCREAS
DR CGH-DB; 321-1
DR CGH-DB; 9374-4
DR ChEMBL-Cells; CHEMBL3307341
DR ChEMBL-Cells; CHEMBL3308500
DR ChEMBL-Targets; CHEMBL614228
DR ChEMBL-Targets; CHEMBL614725
DR Cosmic; 707249
DR Cosmic; 710861
DR Cosmic; 719677
DR Cosmic; 724644
DR Cosmic; 724870
DR Cosmic; 730532
DR Cosmic; 808172
DR Cosmic; 868243
DR Cosmic; 872996
DR Cosmic; 913313
DR Cosmic; 918056
DR Cosmic; 922249
DR Cosmic; 923170
DR Cosmic; 932520
DR Cosmic; 947399
DR Cosmic; 948373
DR Cosmic; 948731
DR Cosmic; 949234
DR Cosmic; 968107
DR Cosmic; 1006368
DR Cosmic; 1066202
DR Cosmic; 1108337
DR Cosmic; 1198208
DR Cosmic; 1299302
DR Cosmic; 1320461
DR Cosmic; 1366278
DR Cosmic; 1477431
DR Cosmic; 1571779
DR Cosmic; 1534318
DR Cosmic; 1609545
DR Cosmic; 1644314
DR Cosmic; 1995507
DR Cosmic; 2434084
DR Cosmic-CLP; 724870
DR DSMZ; ACC-733
DR ECACC; 85062806
DR GDSC; 724870
DR GEO; GSM206526
DR GEO; GSM244425
DR GEO; GSM621895
DR GEO; GSM784703
DR GEO; GSM887320
DR GEO; GSM888396
DR GEO; GSM1024404
DR GEO; GSM1374677
DR GEO; GSM1374678
DR GEO; GSM1374679
DR GEO; GSM1588612
DR GEO; GSM1670109
DR IGRhCellID; MIAPaCa
DR IZSLER; BS TCL 42
DR JCRB; JCRB0070
DR KCLB; 21420
DR NCBI_Iran; C459
DR PRIDE; PXD001260
DR PRIDE; PXD003198
DR RCB; RCB2094
DR SKY/M-FISH/CGH; 1996
DR TKG; TKG 0227
RX PubMed=9290701;
RX PubMed=10027410;
RX PubMed=11169957;
RX PubMed=11169959;
RX PubMed=11787853;
RX PubMed=12692724;
RX PubMed=14695172;
RX PubMed=17254797;
RX PubMed=18380791;
RX PubMed=20418756;
RX PubMed=22460905;
RX PubMed=23386380;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/MIA%20PaCA-2.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=MIA%20PaCa-2
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=64
WW http://www.addexbio.com/productdetail?pid=59
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 26 hours (PubMed=25984343); 25.7 +- 4.3 hours (PubMed=27067801); 40 hours, 18 hours, in serum-free medium (PubMed=23386380); ~40 hours (ATCC); ~30-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): AddexBio; ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=17254797; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 10,13 (AddexBio; ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=25877200; RCB; TKG)
ST D16S539: 11,13 (PubMed=17254797)
ST D18S51: 12
ST D21S11: 29,31 (PubMed=17254797)
ST D21S11: 29,31.2 (PubMed=25877200)
ST D3S1358: 16
ST D5S818: 12,13 (AddexBio; ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=25877200; RCB; TKG)
ST D5S818: 13 (PubMed=17254797)
ST D7S820: 12,13 (AddexBio; ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=17254797; PubMed=25877200; RCB; TKG)
ST D7S820: 12 (KCLB)
ST D8S1179: 16
ST FGA: 22
ST Penta D: 12,16
ST Penta E: 13,18
ST TH01: 9,10
ST TPOX: 9
ST vWA: 15
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MIA PaCa-3
AC CVCL_4011
SY Mia-Paca 3; PaCa3; PaCa-3; Paca-3; PACA3; Pc3
DR Cosmic; 710862
DR Cosmic; 1108336
DR Cosmic; 1320460
RX PubMed=11169959;
RX PubMed=12800145;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/PaCa-3.html
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MI5-4
AC CVCL_IP24
RX PubMed=9753618;
RX PubMed=20331963;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID MI8-5
AC CVCL_IP25
DR BTO; BTO:0005972
RX PubMed=9753618;
RX PubMed=9884408;
RX PubMed=20331963;
CC Characteristics: Lacks glucosyltransferase I (ALG6) activity.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID MIC
AC CVCL_EI96
DR Cosmic; 2250464
RX PubMed=25223734;
CC From: Delattre O.; Institut Curie; Paris; France.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MiCl1 (S+L-)
AC CVCL_3405
SY S+L- MiCl1; MiCl1; S+L-Mink
DR CLO; CLO_0007727
DR CLO; CLO_0007728
DR CLO; CLO_0051611
DR CLDB; cl3483
DR CLDB; cl3484
DR CLDB; cl3485
DR ATCC; CCL-64.1
DR ECACC; 86020603
DR ICLC; ATL97001
DR IZSLER; BS CL 66
DR RCB; RCB1834
RX PubMed=52940;
RX PubMed=170737;
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
OX NCBI_TaxID=452646; ! Neovison vison
HI CVCL_0593 ! Mv1Lu
SX Mixed sex
CA Transformed cell line
//
ID Middle91
AC CVCL_W860
SY Middle 91
RX PubMed=8704258;
RX PubMed=8847894;
RX PubMed=9454894;
RX PubMed=12967475;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MIEU
AC CVCL_H208
SY Mieu
CC From: Al Saati T.; Purpan Hospital; Toulouse; France.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MiF-6
AC CVCL_3750
SY MiF-6 [Mutatect]
DR CLO; CLO_0007729
DR ATCC; CRL-2802
RX PubMed=14732341;
CC Breed/subspecies: C57BL/10.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4982 ! MC-TGS17-51
SX Male
CA Cancer cell line
//
ID MIH5
AC CVCL_CW88
RX PubMed=14515261;
CC Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID MIH5(GIT)
AC CVCL_C663
DR CLO; CLO_0050519
DR RCB; RCB2305
CC Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_CW88 ! MIH5
CA Hybridoma
//
ID MIH5(RPMI)
AC CVCL_C664
DR CLO; CLO_0050520
DR RCB; RCB2324
CC Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_CW88 ! MIH5
CA Hybridoma
//
ID MIH6
AC CVCL_CW89
RX PubMed=12421930;
RX PubMed=14515261;
CC Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID MIKA
AC CVCL_E776
SY 5194
DR dbMHC; 48971
DR ECACC; 94071407
DR IHW; IHW9274
DR IMGT/HLA; 11075
WW http://bioinformatics.hsanmartino.it/ecbr/cl274.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Mil Kin
AC CVCL_0F66
DR ATCC; CRL-1123
CC Discontinued: ATCC; CRL-1123; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID Mili-KO GS
AC CVCL_1T54
DR RCB; AES0197
RX PubMed=23611983;
CC Characteristics: Germ stem cell line.
CC Breed/subspecies: DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MIM/8
AC CVCL_Y662
RX PubMed=1383272;
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID mIMCD-3
AC CVCL_0429
SY mIMCD3; IMCD-3; IMCD3; mouse Inner Medullary Collecting Duct-3
DR BTO; BTO:0003913
DR CLO; CLO_0007730
DR EFO; EFO_0002073
DR MCCL; MCC:0000500
DR ATCC; CRL-2123
DR Wikidata; Q28472922
RX PubMed=8214101;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mIMCD-K2
AC CVCL_0430
SY mouse Inner Medullary Collecting Duct-K2
DR MCCL; MCC:0000501
RX PubMed=7864176;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Tg(SV40E)Bri/7 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID MIN
AC CVCL_E777
DR dbMHC; 48972
DR ECACC; 940822102
DR IHW; IHW9198
DR IMGT/HLA; 11739
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl198.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID MIN01i-32517.A
AC CVCL_AS51
SY MIN32517 A; 32517-A
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min01i-32517-a.cmsx
DI NCIt; C126330; X-linked dystonia parkinsonism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS52 ! MIN02i-32517.B
SX Male
CA Induced pluripotent stem cell
//
ID MIN02i-32517.B
AC CVCL_AS52
SY MIN32517 B; 32517-B
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min02i-32517-b.cmsx
DI NCIt; C126330; X-linked dystonia parkinsonism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS51 ! MIN01i-32517.A
SX Male
CA Induced pluripotent stem cell
//
ID MIN03i-32642.B
AC CVCL_AS53
SY MIN32642 B; 32642-B
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min03i-32642-b.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID MIN04i-33109.2B
AC CVCL_AS54
SY MIN33109 2B; 33109-2B
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min04i-33109-2b.cmsx
DI NCIt; C126330; X-linked dystonia parkinsonism
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID MIN05i-33110.2F
AC CVCL_AS55
SY MIN33110 2F; 33110-2F
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min05i-33110-2f.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS56 ! MIN06i-33110.2H
SX Female
CA Induced pluripotent stem cell
//
ID MIN06i-33110.2H
AC CVCL_AS56
SY MIN33110 2H; 33110-2H
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min06i-33110-2h.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS55 ! MIN05i-33110.2F
SX Female
CA Induced pluripotent stem cell
//
ID MIN07i-33113.2D
AC CVCL_AS57
SY MIN33113 2D; 33113-2D
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min07i-33113-2d.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS72 ! MIN22i-33113.2I
SX Male
CA Induced pluripotent stem cell
//
ID MIN08i-33114.B
AC CVCL_AS58
SY MIN33114 B; 33114-B
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min08i-33114-b.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS59 ! MIN09i-33114.C
SX Male
CA Induced pluripotent stem cell
//
ID MIN09i-33114.C
AC CVCL_AS59
SY MIN33114 C; 33114-C
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min09i-33114-c.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS58 ! MIN08i-33114.B
SX Male
CA Induced pluripotent stem cell
//
ID MIN10i-33360.A
AC CVCL_AS60
SY MIN33360 A; 33360-A
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min10i-33360-a.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS61 ! MIN11i-33360.B
SX Female
CA Induced pluripotent stem cell
//
ID MIN11i-33360.B
AC CVCL_AS61
SY MIN33360 B; 33360-B
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min11i-33360-b.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS60 ! MIN10i-33360.A
SX Female
CA Induced pluripotent stem cell
//
ID MIN12i-33362.C
AC CVCL_AS62
SY MIN33362 C; 33362-C
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min12i-33362-c.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS63 ! MIN13i-33362.D
SX Male
CA Induced pluripotent stem cell
//
ID MIN13i-33362.D
AC CVCL_AS63
SY MIN33362 D; 33362-D
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min13i-33362-d.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS62 ! MIN12i-33362.C
SX Male
CA Induced pluripotent stem cell
//
ID MIN14i-33363.C
AC CVCL_AS64
SY MIN33363 C; 33363-C
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min14i-33363-c.cmsx
DI NCIt; C126330; X-linked dystonia parkinsonism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS65 ! MIN15i-33363.D
SX Male
CA Induced pluripotent stem cell
//
ID MIN15i-33363.D
AC CVCL_AS65
SY MIN33363 D; 33363-D
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min15i-33363-d.cmsx
DI NCIt; C126330; X-linked dystonia parkinsonism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS64 ! MIN14i-33363.C
SX Male
CA Induced pluripotent stem cell
//
ID MIN16i-33808.A
AC CVCL_AS66
SY MIN33808 A; 33808-A
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min16i-33808-a.cmsx
DI NCIt; C126330; X-linked dystonia parkinsonism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS67 ! MIN17i-33808.B
SX Male
CA Induced pluripotent stem cell
//
ID MIN17i-33808.B
AC CVCL_AS67
SY MIN33808 B; 33808-B
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min17i-33808-b.cmsx
DI NCIt; C126330; X-linked dystonia parkinsonism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS66 ! MIN16i-33808.A
SX Male
CA Induced pluripotent stem cell
//
ID MIN18i-33811.A
AC CVCL_AS68
SY MIN33811 A; 33811-A
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min18i-33811-a.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS69 ! MIN19i-33811.D
SX Female
CA Induced pluripotent stem cell
//
ID MIN19i-33811.D
AC CVCL_AS69
SY MIN33811 D; 33811-D
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min19i-33811-d.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS68 ! MIN18i-33811.A
SX Female
CA Induced pluripotent stem cell
//
ID MIN20i-34363.A
AC CVCL_AS70
SY MIN34363 A; 34363-A
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min20i-34363-a.cmsx
DI NCIt; C126330; X-linked dystonia parkinsonism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS71 ! MIN21i-34363.B
SX Male
CA Induced pluripotent stem cell
//
ID MIN21i-34363.B
AC CVCL_AS71
SY MIN34363 B; 34363-B
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min21i-34363-b.cmsx
DI NCIt; C126330; X-linked dystonia parkinsonism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS70 ! MIN20i-34363.A
SX Male
CA Induced pluripotent stem cell
//
ID MIN22i-33113.2I
AC CVCL_AS72
SY MIN33113 2I; 33113-2I
RX PubMed=26769797;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min22i-33113-2i.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS57 ! MIN07i-33113.2D
SX Male
CA Induced pluripotent stem cell
//
ID MIN6
AC CVCL_0431
SY Min6; MIN-6; Mouse INsulinoma 6
DR BTO; BTO:0002284
DR EFO; EFO_0002829
DR MCCL; MCC:0000326
DR BCRJ; 0293
DR PRIDE; PXD000589
DR PRIDE; PXD001081
DR Wikidata; Q12513178
RX PubMed=2163307;
RX PubMed=18845907;
RX PubMed=22538498;
RX PubMed=22808281;
RX PubMed=25546123;
RX PubMed=25894527;
WW http://www.addexbio.com/productdetail?pid=403
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-93.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Cell surface proteome.
CC Omics: Endoplasmic reticulum proteome analysis.
CC Breed/subspecies: C57BL/6.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MIN6-m14
AC CVCL_4372
DR BTO; BTO:0003538
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0431 ! MIN6
CA Transformed cell line
//
ID MIN6-m9
AC CVCL_4371
DR BTO; BTO:0003537
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0431 ! MIN6
CA Transformed cell line
//
ID MIN6N8
AC CVCL_D686
SY MIN6-N8; Min6 N8
DR BTO; BTO:0005320
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0431 ! MIN6
CA Transformed cell line
//
ID MIN6N8a
AC CVCL_0432
DR MCCL; MCC:0000327
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D686 ! MIN6N8
CA Transformed cell line
//
ID MIN7
AC CVCL_J994
SY Mouse INsulinoma 7
RX PubMed=2163307;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Minami-1
AC CVCL_8528
DR JCRB; JCRB1404
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,10
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C3209; Follicular lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Minami-2
AC CVCL_8529
DR JCRB; JCRB1405
CC Characteristics: EBV-negative.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,11
ST D7S820: 9,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MINE
AC CVCL_B867
SY IMHe007-A
DR hPSCreg; IMHe007-A
DR ISCR; 1119
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Minnesota EE
AC CVCL_8264
SY Minnesota-EE; Minn. EE
DR ATCC; CCL-4
DR BioSample; SAMN03151744
RX PubMed=566722;
RX PubMed=1246601;
RX PubMed=13472685;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: ATCC; CCL-4; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID Mino
AC CVCL_1872
SY MINO
DR ATCC; CRL-3000
DR BioSample; SAMN03471705
DR CCLE; MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 2078181
DR Cosmic; 2088019
DR DSMZ; ACC-687
DR GEO; GSM887321
DR GEO; GSM888397
DR GEO; GSM907522
DR GEO; GSM1670110
DR Lonza; 165
RX PubMed=12127561;
RX PubMed=12683869;
RX PubMed=22460905;
RX PubMed=25315077;
RX PubMed=25355872;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 72 hours (PubMed=25315077); ~50 hours (DSMZ).
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MIO-M1
AC CVCL_0433
SY Moorfields/Institute of Ophthalmology-Muller 1
DR BTO; BTO:0003062
DR MCCL; MCC:0000328
RX PubMed=11867609;
RX PubMed=22065927;
WW http://www.e-lucid.com/i/materials/MIO_M1_cells.html
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Spontaneously immortalized cell line
//
ID MIP-101
AC CVCL_H689
SY MIP 101; MIP101
DR Cosmic; 1374639
DR GEO; GSM587038
DR GEO; GSM1448116
RX PubMed=2228514;
RX PubMed=3442732;
RX PubMed=15902309;
RX PubMed=20835245;
RX PubMed=23671654;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=23671654; PubMed=25926053).
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MIP/5FU
AC CVCL_HE61
SY MIP5FU
DR GEO; GSM587039
RX PubMed=15902309;
RX PubMed=20835245;
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC Omics: Deep RNAseq analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H689 ! MIP-101
SX Male
CA Cancer cell line
//
ID MIP/CIS
AC CVCL_HE62
RX PubMed=15902309;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H689 ! MIP-101
SX Male
CA Cancer cell line
//
ID MIP/CPT
AC CVCL_HE63
RX PubMed=15902309;
CC Selected for resistance to: ChEBI; CHEBI:80630; Irinotecan (Camptothecin-11; CPT-11).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H689 ! MIP-101
SX Male
CA Cancer cell line
//
ID MIP/ETO
AC CVCL_HE64
RX PubMed=15902309;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H689 ! MIP-101
SX Male
CA Cancer cell line
//
ID MIPS-2
AC CVCL_M826
RX PubMed=15277221;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MIRJT6i-mND1-4
AC CVCL_U172
SY mND1-4
DR ISCR; 2143
RX PubMed=21478862;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/mirjt6i-mnd1-4.cmsx
WW http://shared.eagle-i.net/i/00000144-8e8f-244a-5797-c9ee80000000
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID MIRJT7i-mND2-0
AC CVCL_U173
SY mND2-0
DR ISCR; 2144
RX PubMed=21478862;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/mirjt7i-mnd2-0.cmsx
WW http://shared.eagle-i.net/i/00000144-8e87-5f87-5797-c9ee80000000
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID MISCES-01
AC CVCL_C655
DR ISCR; 1380
RX PubMed=20178002;
CC From: Monash University; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID MISK81-5
AC CVCL_W332
RX PubMed=7531680;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MIT
AC CVCL_D526
RX PubMed=7949178;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID mitoLUHMES
AC CVCL_HL95
RX PubMed=27832395;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transfected with: DsRed2; a bright red fluorescent protein derived from drFP583 (DsRed).
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B056 ! LUHMES
SX Female
CA Conditionally immortalized cell line
//
ID Miz-1
AC CVCL_3025
DR IFO; IFO50300
CC Discontinued: IFO; IFO50300; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID Miz-hES1
AC CVCL_9262
SY MizhES1; MIZ1; MI01; MIZMe001-A
DR hPSCreg; MIZMe001-A
DR ISCR; 1120
RX PubMed=12930726;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Miz-hES10
AC CVCL_9263
SY MIZMe012-A
DR hPSCreg; MIZMe012-A
DR ISCR; 1121
RX PubMed=15750339;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Miz-hES11
AC CVCL_9264
SY MIZMe013-A
DR hPSCreg; MIZMe013-A
DR ISCR; 1122
RX PubMed=15750339;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Miz-hES12
AC CVCL_9265
SY MIZMe014-A
DR hPSCreg; MIZMe014-A
DR ISCR; 1123
RX PubMed=15750339;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Miz-hES13
AC CVCL_9266
SY MIZ13; MIZMe015-A
DR hPSCreg; MIZMe015-A
DR ISCR; 1124
RX PubMed=15750339;
CC From: MizMedi Hospital; Seoul; South Korea.
DI NCIt; C36425; Trisomy 3
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Miz-hES14
AC CVCL_9267
SY MIZMe005-A
DR hPSCreg; MIZMe005-A
DR ISCR; 1125
RX PubMed=15317691;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Miz-hES15
AC CVCL_9268
SY MIZMe006-A
DR hPSCreg; MIZMe006-A
DR ISCR; 1126
RX PubMed=15317691;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Miz-hES2
AC CVCL_9269
SY MIZMe002-A
DR hPSCreg; MIZMe002-A
DR ISCR; 1127
RX PubMed=12930726;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Miz-hES3
AC CVCL_9270
SY MIZMe003-A
DR hPSCreg; MIZMe003-A
DR ISCR; 1128
RX PubMed=12930726;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Miz-hES4
AC CVCL_9271
SY Miz-hES 4; Kor-hES12; MIZ4; MIZMe007-A
DR hPSCreg; MIZMe007-A
DR ISCR; 1129
RX PubMed=15750339;
RX PubMed=17464211;
RX PubMed=24159464;
CC From: MizMedi Hospital; Seoul; South Korea.
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010016.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Miz-hES5
AC CVCL_9272
SY MIZMe008-A
DR hPSCreg; MIZMe008-A
DR ISCR; 1130
RX PubMed=15750339;
RX PubMed=17464211;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Miz-hES6
AC CVCL_9273
SY MIZ6; MIZMe009-A
DR hPSCreg; MIZMe009-A
DR ISCR; 1131
RX PubMed=15750339;
RX PubMed=17464211;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Miz-hES7
AC CVCL_9274
SY MIZMe010-A
DR hPSCreg; MIZMe010-A
DR ISCR; 1132
RX PubMed=15750339;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Miz-hES8
AC CVCL_9275
SY MIZMe011-A
DR hPSCreg; MIZMe011-A
DR ISCR; 1133
RX PubMed=15750339;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Miz-hES9
AC CVCL_9276
SY MIZMe004-A
DR hPSCreg; MIZMe004-A
DR ISCR; 1134
RX PubMed=15317691;
CC From: MizMedi Hospital; Seoul; South Korea.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID MJ
AC CVCL_1414
SY G11
DR CLO; CLO_0007731
DR EFO; EFO_0002237
DR ATCC; CRL-8294
DR BCRC; 60543
DR BioSample; SAMN03471200
DR CCLE; MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 908137
DR GEO; GSM887322
DR GEO; GSM888398
DR IGRhCellID; MJ
RX Patent=US4743678;
RX PubMed=6604130;
RX PubMed=22460905;
RX PubMed=25355872;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 8,11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MJ-170
AC CVCL_AQ03
SY 3A3-2A6
DR ATCC; PTA-5286
RX Patent=US7202346;
CC Monoclonal antibody target: UniProtKB; P15941; Human MUC1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID MJ-171
AC CVCL_AQ04
SY 4E2-2D1-1B10
DR ATCC; PTA-5287
RX Patent=US7202346;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID MJ-172
AC CVCL_AQ05
SY 2F9-1F8-1C10
DR ATCC; PTA-5288
RX Patent=US7202346;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID MJ-173
AC CVCL_AQ06
SY 2F9-1E8-1D7
DR ATCC; PTA-5302
RX Patent=US7202346;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID MJD1-11
AC CVCL_W570
DR SKIP; SKIP000310
RX PubMed=22113611;
CC From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.
DI NCIt; C84830; Machado-Joseph disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W571 ! MJD1-9
SX Male
CA Induced pluripotent stem cell
//
ID MJD1-9
AC CVCL_W571
SY LB-32-R9; iLB-MJD1-32m-r9; UKBi003-A
DR BioSamples; SAMEA2614075
DR EBiSC; UKBi003-A
DR ECACC; 66540007
DR hPSCreg; UKBi003-A
DR SKIP; SKIP000309
RX PubMed=22113611;
CC From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.
DI NCIt; C84830; Machado-Joseph disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W570 ! MJD1-11
SX Male
CA Induced pluripotent stem cell
//
ID MJD2-2
AC CVCL_W572
SY iLB-MJD2-29m-R2; UKBi001-A
DR hPSCreg; UKBi001-A
DR SKIP; SKIP000311
RX PubMed=22113611;
CC From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.
DI NCIt; C84830; Machado-Joseph disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W573 ! MJD2-9
SX Male
CA Induced pluripotent stem cell
//
ID MJD2-9
AC CVCL_W573
SY UKBi001-B
DR BioSamples; SAMEA3855072
DR EBiSC; UKBi001-B
DR ECACC; 66540043
DR hPSCreg; UKBi001-B
DR SKIP; SKIP000312
RX PubMed=22113611;
CC From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.
DI NCIt; C84830; Machado-Joseph disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W572 ! MJD2-2
SX Male
CA Induced pluripotent stem cell
//
ID MJD3-5
AC CVCL_W574
SY UKBi007-A; LB-33-5; iLB-MJD3-33f-r5
DR BioSamples; SAMEA2825788
DR EBiSC; UKBi007-A
DR ECACC; 66540011
DR hPSCreg; UKBi007-A
DR SKIP; SKIP000313
RX PubMed=22113611;
CC From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.
DI NCIt; C84830; Machado-Joseph disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID MJD4-1
AC CVCL_W575
SY LB-34-1; iLB-MJD4-34m-r1; UKBi008-A
DR BioSamples; SAMEA2590882
DR EBiSC; UKBi008-A
DR ECACC; 66540003
DR hPSCreg; UKBi008-A
DR SKIP; SKIP000314
RX PubMed=22113611;
CC From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.
DI NCIt; C84830; Machado-Joseph disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID MJM
AC CVCL_J312
DR Cosmic; 1132583
RX PubMed=752115;
RX PubMed=6819484;
CC Doubling time: ~63 hours (PubMed=752115).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MK-1
AC CVCL_W863
RX PubMed=6802943;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MK-D6
AC CVCL_4543
DR CLO; CLO_0007732
DR CLDB; cl5232
DR ATCC; HB-3
DR IZSLER; BS Hy 30
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MK-S4
AC CVCL_G336
DR CLO; CLO_0007734
DR ATCC; HB-4
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4090 ! 45.6.TG1.7
CA Hybridoma
//
ID MK/T-1
AC CVCL_9Y67
RX PubMed=11344338;
CC Transfected with: HGNC; 11730; TERT.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Telomerase immortalized cell line
//
ID mK1
AC CVCL_9T76
SY mouse Kidney 1
RX CelloPub=CLPUB00308;
RX PubMed=11850199;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mK10
AC CVCL_9T77
SY mouse Kidney 10
RX CelloPub=CLPUB00308;
RX PubMed=12060755;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mK2
AC CVCL_9T78
SY mouse Kidney 2
RX CelloPub=CLPUB00308;
RX PubMed=11850199;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MK2-23
AC CVCL_4W11
DR ATCC; HB-10288
RX Patent=US5493009;
CC Discontinued: ATCC; HB-10288; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID mK3
AC CVCL_9T79
SY MK3; mouse Kidney 3
RX CelloPub=CLPUB00308;
RX PubMed=11850199;
RX PubMed=23867747;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: CHIP-Seq histone signature analysis.
CC Omics: Transcriptome analysis.
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mK4
AC CVCL_9T80
SY MK4; mouse Kidney 4
RX CelloPub=CLPUB00308;
RX PubMed=11850199;
RX PubMed=23867747;
WW http://discovery.lifemapsc.com/stem-cell-differentiation/in-vitro-cells/kidney-mus-musculus-mk4-childrens-hospital-medical-center-cincinnati
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: CHIP-Seq histone signature analysis.
CC Omics: Transcriptome analysis.
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MKB-1
AC CVCL_8265
DR BioSample; SAMN03151620
DR Cosmic; 999729
DR Cosmic; 1524807
RX PubMed=2486667;
RX PubMed=9933131;
RX PubMed=10508494;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=10508494, PubMed=12592342, PubMed=20143388).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID MKL-1
AC CVCL_2600
SY MKL1
DR Cosmic; 1693072
DR Cosmic; 1699817
DR Cosmic; 2273916
DR ECACC; 09111801
RX PubMed=3546933;
RX PubMed=20444890;
CC Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.
CC Doubling time: ~120 hours (ECACC).
CC Derived from metastatic site: Left axillary lymph node.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 10,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_ER19 ! MKL-1-FB
SX Male
CA Cancer cell line
//
ID MKL-1 subclone 1
AC CVCL_EQ70
SY MKL-1 (subclone 1)
RX PubMed=12209990;
CC Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.
CC Derived from metastatic site: Left axillary lymph node.
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2600 ! MKL-1
SX Male
CA Cancer cell line
//
ID MKL-1 subclone 2
AC CVCL_EQ71
SY MKL-1-subclone-2; MKL-1 (subclone 2)
DR GDSC; 1333014
RX PubMed=12209990;
CC Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.
CC Derived from metastatic site: Left axillary lymph node.
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2600 ! MKL-1
SX Male
CA Cancer cell line
//
ID MKL-1-FB
AC CVCL_ER19
RX PubMed=3546933;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2600 ! MKL-1
SX Male
CA Finite cell line
//
ID MKL-2
AC CVCL_D027
SY MKL2
DR Cosmic; 1693073
DR Cosmic; 2273917
DR GDSC; 1333015
RX PubMed=1717086;
RX PubMed=12209990;
RX PubMed=20444890;
CC Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MKN-1/CMV-Luc
AC CVCL_J261
DR JCRB; JCRB1433
DR JCRB; NIHS0720
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 10,12
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 10
ST TH01: 9
ST TPOX: 8
ST vWA: 16
DI NCIt; C5474; Gastric adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1415 ! MKN1
SX Male
CA Cancer cell line
//
ID MKN-45P
AC CVCL_Y476
RX PubMed=17380436;
RX PubMed=22531121;
CC Transfected with: HGNC; 11820; TIMP1.
CC Derived from metastatic site: Liver.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 10
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0434 ! MKN45
SX Female
CA Cancer cell line
//
ID MKN1
AC CVCL_1415
SY MKN-1
DR BTO; BTO:0002384
DR CLO; CLO_0050804
DR EFO; EFO_0002830
DR BioSample; SAMN03473129
DR CCLE; MKN1_STOMACH
DR CGH-DB; 117-1
DR CGH-DB; 9019-4
DR ChEMBL-Cells; CHEMBL3307492
DR ChEMBL-Targets; CHEMBL614352
DR Cosmic; 733174
DR Cosmic; 801337
DR Cosmic; 848145
DR Cosmic; 848379
DR Cosmic; 887252
DR Cosmic; 888824
DR Cosmic; 897532
DR Cosmic; 908138
DR Cosmic; 922692
DR Cosmic; 926111
DR Cosmic; 1007600
DR Cosmic; 1090459
DR Cosmic; 1187282
DR Cosmic; 1223586
DR Cosmic; 1436023
DR Cosmic; 1482076
DR Cosmic; 1627263
DR Cosmic; 1995508
DR Cosmic; 2443801
DR Cosmic; 2484957
DR Cosmic-CLP; 908138
DR GDSC; 908138
DR GEO; GSM562394
DR GEO; GSM827531
DR GEO; GSM844606
DR GEO; GSM887323
DR GEO; GSM888399
DR GEO; GSM1374680
DR GEO; GSM1670111
DR JCRB; JCRB0252
DR KCLB; 80101
DR RCB; RCB1003
RX PubMed=1778766;
RX PubMed=9290701;
RX PubMed=11107048;
RX PubMed=15723654;
RX PubMed=15767549;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MKN-1
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; KCLB; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 10,12
ST D16S539: 11,12
ST D18S51: 13,16
ST D21S11: 29
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 14
ST FGA: 20,23
ST Penta D: 10
ST Penta E: 21
ST TH01: 9
ST TPOX: 8
ST vWA: 16
DI NCIt; C5474; Gastric adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MKN28
AC CVCL_1416
SY MKN-28; MKN 28
DR BTO; BTO:0002381
DR EFO; EFO_0002831
DR BioSample; SAMN03151847
DR CGH-DB; 119-1
DR CGH-DB; 9021-4
DR ChEMBL-Cells; CHEMBL3307602
DR ChEMBL-Targets; CHEMBL614353
DR Cosmic; 801338
DR Cosmic; 848146
DR Cosmic; 848371
DR Cosmic; 873710
DR Cosmic; 875905
DR Cosmic; 877041
DR Cosmic; 887249
DR Cosmic; 888826
DR Cosmic; 897534
DR Cosmic; 908139
DR Cosmic; 918496
DR Cosmic; 922694
DR Cosmic; 926113
DR Cosmic; 968348
DR Cosmic; 983726
DR Cosmic; 1066230
DR Cosmic; 1067208
DR Cosmic; 1090460
DR Cosmic; 1223588
DR Cosmic; 1436025
DR Cosmic; 1460710
DR Cosmic; 1482081
DR Cosmic; 1627264
DR Cosmic; 1995509
DR Cosmic; 2036660
DR Cosmic; 2069778
DR Cosmic-CLP; 908139
DR GDSC; 908139
DR GEO; GSM562396
DR GEO; GSM1670112
DR JCRB; JCRB0253
DR JCRB; NIHS0324
DR JCRB; NIHS0325
DR KCLB; 80102
DR RCB; RCB1000
RX PubMed=3962675;
RX PubMed=9290701;
RX PubMed=11107048;
RX PubMed=15723654;
RX PubMed=15767549;
RX PubMed=20143388;
RX PubMed=22336246;
RX PubMed=23671654;
RX PubMed=27397505;
WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a MKN74 derivative (PubMed=20143388).
CC Part of: JFCR39 cancer cell line panel.
CC Part of: JFCR45 cancer cell line panel.
CC Doubling time: 28-32 hours (PubMed=3962675).
CC Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; NIHS0324; true.
CC Discontinued: JCRB; NIHS0325; true.
CC Discontinued: RCB; RCB1000; true.
CC Derived from metastatic site: Liver.
ST Source(s): Cosmic-CLP; JCRB; KCLB; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9,11
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 9
ST FGA: 23
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,20
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2791 ! MKN74
SX Female
CA Cancer cell line
//
ID MKN45
AC CVCL_0434
SY MKN-45; MKN 45
DR BTO; BTO:0001225
DR CLO; CLO_0007733
DR CLO; CLO_0050797
DR EFO; EFO_0002832
DR MCCL; MCC:0000329
DR BioSample; SAMN03473237
DR BioSample; SAMN03473585
DR CCLE; MKN45_STOMACH
DR CCRID; 3111C0001CCC000229
DR CGH-DB; 120-1
DR CGH-DB; 9022-4
DR ChEMBL-Cells; CHEMBL3307603
DR ChEMBL-Targets; CHEMBL614354
DR Cosmic; 685596
DR Cosmic; 801339
DR Cosmic; 848147
DR Cosmic; 848373
DR Cosmic; 873711
DR Cosmic; 877042
DR Cosmic; 887256
DR Cosmic; 888827
DR Cosmic; 897535
DR Cosmic; 918497
DR Cosmic; 922696
DR Cosmic; 925340
DR Cosmic; 926114
DR Cosmic; 983727
DR Cosmic; 1001651
DR Cosmic; 1001655
DR Cosmic; 1007602
DR Cosmic; 1090461
DR Cosmic; 1187283
DR Cosmic; 1223589
DR Cosmic; 1329185
DR Cosmic; 1436026
DR Cosmic; 1460707
DR Cosmic; 1518241
DR Cosmic; 1518255
DR Cosmic; 1582430
DR Cosmic; 1627265
DR Cosmic; 1995510
DR Cosmic; 2036663
DR Cosmic-CLP; 925340
DR DSMZ; ACC-409
DR GDSC; 925340
DR GEO; GSM562395
DR GEO; GSM618013
DR GEO; GSM618014
DR GEO; GSM618015
DR GEO; GSM618016
DR GEO; GSM827532
DR GEO; GSM828836
DR GEO; GSM844607
DR GEO; GSM887324
DR GEO; GSM888400
DR GEO; GSM1374681
DR GEO; GSM1670113
DR JCRB; JCRB0254
DR KCLB; 80103
DR NCBI_Iran; C615
DR RCB; RCB1001
DR Wikidata; Q28473066
RX PubMed=1486568;
RX PubMed=1778766;
RX PubMed=3962675;
RX PubMed=9290701;
RX PubMed=9665481;
RX PubMed=11107048;
RX PubMed=15723654;
RX PubMed=15767549;
RX PubMed=18804159;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=22531121;
RX PubMed=23671654;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-496.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 30-33 hours (PubMed=3962675); ~60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'MNK-45'.
CC Misspelling: Occasionally 'MNK45'.
CC Misspelling: Occasionally 'NKM-45'.
CC Misspelling: Occasionally 'NKM45'.
CC Derived from metastatic site: Liver.
ST Source(s): Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 10
ST D18S51: 16
ST D21S11: 31
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 10,11
ST D8S1179: 13,17
ST FGA: 19 (KCLB)
ST FGA: 19,24 (PubMed=25877200)
ST Penta D: 10
ST Penta E: 10
ST TH01: 7
ST TPOX: 8
ST vWA: 19
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MKN45-Luc
AC CVCL_J262
SY MKN-45-Luc
DR JCRB; JCRB1379
DR JCRB; NIHS0634
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0634; true.
CC Derived from metastatic site: Liver.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 10
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8
ST vWA: 19
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0434 ! MKN45
SX Female
CA Cancer cell line
//
ID MKN45/TP
AC CVCL_9645
SY MKN-45/TP
RX PubMed=18922971;
CC Transfected with: HGNC; 3148; TYMP.
CC Derived from metastatic site: Liver.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0434 ! MKN45
SX Female
CA Cancer cell line
//
ID MKN45R0.05
AC CVCL_Z941
RX CelloPub=CLPUB00210;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Liver.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0434 ! MKN45
SX Female
CA Cancer cell line
//
ID MKN45R0.08
AC CVCL_Z942
RX CelloPub=CLPUB00210;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Liver.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0434 ! MKN45
SX Female
CA Cancer cell line
//
ID MKN7
AC CVCL_1417
SY MKN-7; MKN 7
DR BTO; BTO:0002382
DR CLO; CLO_0050805
DR EFO; EFO_0002895
DR BioSample; SAMN03472197
DR BioSample; SAMN03473201
DR CCLE; MKN7_STOMACH
DR CGH-DB; 118-1
DR CGH-DB; 9020-4
DR ChEMBL-Cells; CHEMBL3307377
DR ChEMBL-Targets; CHEMBL614355
DR Cosmic; 733175
DR Cosmic; 848370
DR Cosmic; 877040
DR Cosmic; 888825
DR Cosmic; 889106
DR Cosmic; 897533
DR Cosmic; 922693
DR Cosmic; 924250
DR Cosmic; 926112
DR Cosmic; 968347
DR Cosmic; 983725
DR Cosmic; 1007601
DR Cosmic; 1066229
DR Cosmic; 1187284
DR Cosmic; 1223587
DR Cosmic; 1436024
DR Cosmic; 1460708
DR Cosmic; 1482077
DR Cosmic; 1518242
DR Cosmic; 1995511
DR Cosmic-CLP; 924250
DR GDSC; 924250
DR GEO; GSM562401
DR GEO; GSM827584
DR GEO; GSM844608
DR GEO; GSM887326
DR GEO; GSM888402
DR GEO; GSM1237677
DR GEO; GSM1237702
DR GEO; GSM1670114
DR JCRB; JCRB1025
DR RCB; RCB0999
DR TKG; TKG 0228
RX PubMed=3962675;
RX PubMed=11107048;
RX PubMed=15723654;
RX PubMed=15767549;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MKN-7
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: JFCR45 cancer cell line panel.
CC Doubling time: 64-66 hours (PubMed=3962675); 86 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 9,10
ST D18S51: 13,18
ST D21S11: 29,32.2
ST D3S1358: 17
ST D5S818: 9,13
ST D7S820: 9 (JCRB; PubMed=25877200; TKG)
ST D7S820: 9,11 (Cosmic-CLP; RCB)
ST D8S1179: 15
ST FGA: 23
ST Penta D: 10,11
ST Penta E: 18
ST TH01: 7,9
ST TPOX: 9
ST vWA: 17
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MKN7/CMV-Luc
AC CVCL_4Y05
SY MKN-7/CMV-Luc
DR JCRB; NIHS0721
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Lymph node.
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1417 ! MKN7
SX Male
CA Cancer cell line
//
ID MKN74
AC CVCL_2791
SY MKN-74; MKN 74
DR BTO; BTO:0002383
DR CLO; CLO_0050798
DR EFO; EFO_0002834
DR BioSample; SAMN01821701
DR BioSample; SAMN03473122
DR CCLE; MKN74_STOMACH
DR CGH-DB; 121-1
DR CGH-DB; 9023-4
DR ChEMBL-Cells; CHEMBL3307287
DR ChEMBL-Targets; CHEMBL614048
DR Cosmic; 685597
DR Cosmic; 801340
DR Cosmic; 848148
DR Cosmic; 848372
DR Cosmic; 873712
DR Cosmic; 877043
DR Cosmic; 887253
DR Cosmic; 888828
DR Cosmic; 897536
DR Cosmic; 918498
DR Cosmic; 922695
DR Cosmic; 926115
DR Cosmic; 983728
DR Cosmic; 1007603
DR Cosmic; 1067209
DR Cosmic; 1090462
DR Cosmic; 1122338
DR Cosmic; 1187285
DR Cosmic; 1223590
DR Cosmic; 1436027
DR Cosmic; 1460709
DR Cosmic; 1477424
DR Cosmic; 1518244
DR Cosmic; 2484974
DR GEO; GSM562418
DR GEO; GSM827533
DR GEO; GSM844609
DR GEO; GSM887325
DR GEO; GSM888401
DR GEO; GSM1374682
DR JCRB; JCRB0255
DR KCLB; 80104
DR RCB; RCB1002
RX PubMed=3962675;
RX PubMed=9290701;
RX PubMed=11107048;
RX PubMed=15723654;
RX PubMed=15767549;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 42-46 hours (PubMed=3962675).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
ST Source(s): JCRB; KCLB; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 12
ST D21S11: 32.2
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 11,16
ST FGA: 23
ST Penta D: 9
ST Penta E: 11,14,15
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,20
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MKN74/CMV-Luc
AC CVCL_4Y06
SY MKN-74/CMV-Luc
DR JCRB; NIHS0722
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Liver.
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2791 ! MKN74
SX Female
CA Cancer cell line
//
ID MKPL-1
AC CVCL_2116
DR BioSample; SAMN03473446
DR Cosmic; 787452
DR Cosmic; 975270
DR Cosmic; 1012091
DR Cosmic; 1281328
DR Cosmic; 2306219
DR DSMZ; ACC-697
DR JCRB; JCRB1325
DR JCRB; NIHS0536
RX PubMed=16408098;
CC Doubling time: ~50-60 hours (DSMZ).
CC Discontinued: JCRB; NIHS0536; true.
ST Source(s): DSMZ; JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 8,9.3
ST TPOX: 10,11
ST vWA: 17,18
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID mKS-A TU-5
AC CVCL_5T88
SY TU-5; TU5
RX PubMed=4310402;
RX PubMed=4348218;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MKT-BR
AC CVCL_7080
SY MKTBR; MkTBr
DR BTO; BTO:0002735
DR Cosmic; 986618
DR GEO; GSM276741
RX PubMed=9154388;
RX PubMed=15714118;
RX PubMed=17487557;
CC Omics: Transcriptome analysis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ML
AC CVCL_W799
DR Cosmic; 706110
DR Cosmic; 888853
RX PubMed=9692547;
RX PubMed=10766161;
RX PubMed=15009714;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ML-1 [Human bone marrow]
AC CVCL_IQ95
DR ATCC; CRL-11451
RX Patent=US5981708;
CC Discontinued: ATCC; CRL-11451; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Spontaneously immortalized cell line
//
ID ML-1 [Human leukemia]
AC CVCL_0436
SY ML1
DR BTO; BTO:0001884
DR CLO; CLO_0007735
DR MCCL; MCC:0000331
DR CLDB; cl3489
DR Cosmic; 787453
DR Cosmic; 798669
DR Cosmic; 919125
DR Cosmic; 924048
DR Cosmic; 947369
DR Cosmic; 994171
DR Cosmic; 998746
DR Cosmic; 999727
DR Cosmic; 1037658
DR Cosmic; 1078735
DR Cosmic; 1078738
DR Cosmic; 1127255
DR Cosmic; 2089662
DR Cosmic; 2301563
DR ECACC; 88113007
RX PubMed=3458526;
RX PubMed=6091813;
RX PubMed=8814454;
RX PubMed=23955599;
ST Source(s): COG; ECACC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 9,12
ST D18S51: 14,18
ST D19S433: 14
ST D21S11: 29
ST D2S1338: 16,17
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 8,13
ST FGA: 23,25
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1418 ! ML-2
OI CVCL_H526 ! ML-3
SX Male
CA Cancer cell line
//
ID ML-1 [Human thyroid carcinoma]
AC CVCL_H525
SY ML1
DR BioSample; SAMN03473557
DR CCLE; ML1_THYROID
DR Cosmic; 1239975
DR Cosmic; 2054099
DR Cosmic-CLP; 1240178
DR DSMZ; ACC-464
DR GDSC; 1240178
DR GEO; GSM887327
DR GEO; GSM888403
DR GEO; GSM1670115
RX PubMed=10794546;
RX PubMed=18713817;
RX PubMed=22460905;
RX PubMed=23833040;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~4-7 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=18713817
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 10
ST D16S539: 10,12
ST D18S51: 18
ST D21S11: 31.2,33.2
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 10,13
ST FGA: 22,25
ST TH01: 8
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C8054; Thyroid gland follicular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ML-1a
AC CVCL_0435
SY ML1a
DR MCCL; MCC:0000330
CC From: Takeda K.; Showa University; Tokyo; Japan.
DI NCIt; C7463; Acute myelomonocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ML-2
AC CVCL_1418
SY ML2
DR BTO; BTO:0001885
DR CLO; CLO_0007736
DR EFO; EFO_0002238
DR CLDB; cl3490
DR BioSample; SAMN03472168
DR ChEMBL-Cells; CHEMBL3307604
DR ChEMBL-Targets; CHEMBL614356
DR Cosmic; 787454
DR Cosmic; 908141
DR Cosmic; 975271
DR Cosmic; 999728
DR Cosmic; 1012092
DR Cosmic; 1078727
DR Cosmic; 1078739
DR Cosmic; 1151785
DR Cosmic; 1181602
DR Cosmic; 1281329
DR Cosmic; 1524834
DR Cosmic; 2131545
DR Cosmic; 2391904
DR Cosmic-CLP; 908141
DR DSMZ; ACC-15
DR GDSC; 908141
DR GEO; GSM236791
DR GEO; GSM236827
DR GEO; GSM482497
DR GEO; GSM1374683
DR GEO; GSM1670116
DR IGRhCellID; ML2
RX PubMed=3458526;
RX PubMed=6091813;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=25485619;
RX PubMed=27397505;
CC Doubling time: ~60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 9,12
ST D18S51: 15,18
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 8,13
ST FGA: 23,25
ST Penta D: 12
ST Penta E: 5,7
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0436 ! ML-1 [Human leukemia]
OI CVCL_H526 ! ML-3
SX Male
CA Cancer cell line
//
ID ML-3
AC CVCL_H526
SY ML3
DR Cosmic; 1070691
DR Cosmic; 1176586
RX PubMed=3458526;
RX PubMed=6091813;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0436 ! ML-1 [Human leukemia]
OI CVCL_1418 ! ML-2
SX Male
CA Cancer cell line
//
ID ML-DmBG1
AC CVCL_Z709
DR DGRC; 49
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG1-c1
AC CVCL_Z857
SY BG1c1
DR EFO; EFO_0005821
DR DGRC; 50
DR ENCODE; ENCBS002ZRD
DR GEO; GSM409485
DR GEO; GSM409486
DR GEO; GSM409487
DR GEO; GSM609222
DR GEO; GSM980233
RX CelloPub=CLPUB00203;
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z709 ! ML-DmBG1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2
AC CVCL_Z710
DR DGRC; 51
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c1
AC CVCL_Z717
DR DGRC; 52
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c10
AC CVCL_Z718
DR DGRC; 62
RX CelloPub=CLPUB00203;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c11
AC CVCL_Z797
DR DGRC; 63
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c12
AC CVCL_Z798
DR DGRC; 64
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c2
AC CVCL_Z719
SY BG2-c2; BG2c2
DR EFO; EFO_0005822
DR DGRC; 53
DR ENCODE; ENCBS193GRU
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
RX PubMed=21177962;
RX PubMed=24434506;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c3
AC CVCL_Z720
DR DGRC; 54
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c4
AC CVCL_Z721
DR DGRC; 55
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c5
AC CVCL_Z722
DR DGRC; 56
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c6
AC CVCL_Z723
SY BG2-C6
DR DGRC; 3
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
WW http://www.entu.cas.cz/zurovec/eng/research/cultures.html
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c7
AC CVCL_Z724
RX CelloPub=CLPUB00203;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c8
AC CVCL_Z725
DR DGRC; 60
RX CelloPub=CLPUB00203;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG2-c9
AC CVCL_Z726
RX CelloPub=CLPUB00203;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z710 ! ML-DmBG2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG3
AC CVCL_Z711
DR DGRC; 66
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG3-c1
AC CVCL_Z727
SY BG3-c1
DR DGRC; 67
RX CelloPub=CLPUB00203;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z711 ! ML-DmBG3
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG3-c2
AC CVCL_Z728
SY BG3-c2; BG3c2
DR EFO; EFO_0005823
DR DGRC; 68
DR ENCODE; ENCBS005WGE
DR ENCODE; ENCBS073JKW
DR ENCODE; ENCBS101CUQ
DR ENCODE; ENCBS108FTY
DR ENCODE; ENCBS174JPC
DR ENCODE; ENCBS216EMV
DR ENCODE; ENCBS275KHY
DR ENCODE; ENCBS303TQC
DR ENCODE; ENCBS315UOB
DR ENCODE; ENCBS329HUS
DR ENCODE; ENCBS417TZL
DR ENCODE; ENCBS424ESD
DR ENCODE; ENCBS489VDG
DR ENCODE; ENCBS494EED
DR ENCODE; ENCBS557LTF
DR ENCODE; ENCBS565CSY
DR ENCODE; ENCBS637AYT
DR ENCODE; ENCBS745OPA
DR ENCODE; ENCBS804ZFU
DR ENCODE; ENCBS832ABW
DR ENCODE; ENCBS834HSY
DR ENCODE; ENCBS843UOH
DR ENCODE; ENCBS848TVS
DR ENCODE; ENCBS927DOE
DR ENCODE; ENCBS936VAG
DR ENCODE; ENCBS946SBT
DR ENCODE; ENCBS980BNS
DR ENCODE; ENCBS985ADJ
DR ENCODE; ENCBS987RFJ
RX CelloPub=CLPUB00203;
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Part of: modENCODE project cell lines.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z711 ! ML-DmBG3
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG3-c2-Mt-GFP-Act5C
AC CVCL_Z853
DR DGRC; 174
RX PubMed=24434506;
CC Group: Insect cell line.
CC Transfected with: FlyBase; FBgn0000042; Act5C.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z728 ! ML-DmBG3-c2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG3-c3
AC CVCL_Z729
DR DGRC; 69
RX CelloPub=CLPUB00203;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z711 ! ML-DmBG3
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG3-c4
AC CVCL_Z730
RX CelloPub=CLPUB00203;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z711 ! ML-DmBG3
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG3-c5
AC CVCL_Z731
RX CelloPub=CLPUB00203;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z711 ! ML-DmBG3
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG4
AC CVCL_Z712
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG5
AC CVCL_Z713
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG6
AC CVCL_Z714
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG7
AC CVCL_Z715
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmBG8
AC CVCL_Z716
DR DGRC; 77
RX CelloPub=CLPUB00203;
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD1
AC CVCL_Z736
SY ML-DmD 1
RX PubMed=3117765;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD1-c3
AC CVCL_Z756
DR DGRC; 81
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z736 ! ML-DmD1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD1-c4
AC CVCL_Z757
DR DGRC; 82
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z736 ! ML-DmD1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD1-c5
AC CVCL_Z758
DR DGRC; 122
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z736 ! ML-DmD1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD1-c6
AC CVCL_Z759
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z736 ! ML-DmD1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD1-c7
AC CVCL_Z760
DR DGRC; 83
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z736 ! ML-DmD1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD1-c8
AC CVCL_Z761
DR DGRC; 84
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z736 ! ML-DmD1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD10
AC CVCL_Z737
SY ML-DmD 10
RX PubMed=3117765;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD11
AC CVCL_Z738
SY D11
DR EFO; EFO_0005824
DR DGRC; 94
DR ENCODE; ENCBS640WXH
RX PubMed=21177962;
RX PubMed=24434506;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD11-c1
AC CVCL_Z762
DR DGRC; 208
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z738 ! ML-DmD11
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD11-c2
AC CVCL_Z763
DR DGRC; 209
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z738 ! ML-DmD11
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD11-c3
AC CVCL_Z764
DR DGRC; 210
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z738 ! ML-DmD11
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD15
AC CVCL_Z739
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD16
AC CVCL_Z740
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD16-c1
AC CVCL_Z765
DR DGRC; 96
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z740 ! ML-DmD16
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD16-c3
AC CVCL_Z766
SY D16c3
DR EFO; EFO_0005825
DR DGRC; 97
DR ENCODE; ENCBS810BML
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z740 ! ML-DmD16
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD16-c4
AC CVCL_Z767
DR DGRC; 98
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z740 ! ML-DmD16
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD16-c6
AC CVCL_Z768
DR DGRC; 100
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z740 ! ML-DmD16
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD16-c7
AC CVCL_Z769
DR DGRC; 101
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z740 ! ML-DmD16
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD16-c8
AC CVCL_Z770
DR DGRC; 102
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z740 ! ML-DmD16
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD16-c9
AC CVCL_Z771
DR DGRC; 103
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z740 ! ML-DmD16
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD17
AC CVCL_Z741
RX PubMed=8069443;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD17-c3
AC CVCL_Z772
SY D17c3
DR EFO; EFO_0005826
DR DGRC; 107
DR ENCODE; ENCBS006QKV
DR ENCODE; ENCBS122LBB
DR ENCODE; ENCBS141CJX
DR ENCODE; ENCBS146SLV
DR ENCODE; ENCBS166WDM
DR ENCODE; ENCBS203HRH
DR ENCODE; ENCBS248SBY
DR ENCODE; ENCBS332YXG
DR ENCODE; ENCBS342RHG
DR ENCODE; ENCBS361KVW
DR ENCODE; ENCBS397DQG
DR ENCODE; ENCBS434TLI
DR ENCODE; ENCBS468KEJ
DR ENCODE; ENCBS476QMP
DR ENCODE; ENCBS635RCT
DR ENCODE; ENCBS787HWT
DR ENCODE; ENCBS817KQD
DR ENCODE; ENCBS866KNJ
DR ENCODE; ENCBS896CUM
DR ENCODE; ENCBS919OTC
DR ENCODE; ENCBS999UOC
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z741 ! ML-DmD17
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD2
AC CVCL_Z742
SY ML-DmD 2
RX PubMed=3117765;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD20
AC CVCL_Z743
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD20-c1
AC CVCL_Z773
DR DGRC; 108
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z743 ! ML-DmD20
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD20-c2
AC CVCL_Z774
SY D20-c2; D20c2
DR EFO; EFO_0005827
DR DGRC; 109
DR ENCODE; ENCBS695UGH
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z743 ! ML-DmD20
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD20-c4
AC CVCL_Z775
DR DGRC; 111
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z743 ! ML-DmD20
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD20-c5
AC CVCL_Z776
SY D20-c5; D20c5
DR EFO; EFO_0005828
DR DGRC; 112
DR ENCODE; ENCBS752KGT
DR GEO; GSM609217
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z743 ! ML-DmD20
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD21
AC CVCL_Z744
SY D21
DR EFO; EFO_0005829
DR DGRC; 86
DR ENCODE; ENCBS360NKZ
DR GEO; GSM609220
DR GEO; GSM609249
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
- 公告/新闻
